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Título: Caracterización funcional de la proteína efectora SteA de Salmonella 
Typhimurium mediante expresión heteróloga en Saccharomyces cerevisiae 
Introducción 
Salmonella enterica es un patógeno bacteriano intracelular facultativo que causa 
una amplia variedad de enfermedades en humanos (Figueira & Holden, 2012). La 
virulencia de S. enterica se basa en la translocación de dos conjuntos de efectores 
bacterianos en las células huésped a través de sistemas de secreción de tipo 3 (T3SS) 
codificados por las 2 islas de patogenicidad SPI-1 y SPI-2. Los efectores del T3SS de la 
SPI-1 permiten a las bacterias invadir la célula huésped, mientras que los efectores del 
T3SS de la SPI-2 son responsables de la replicación intracelular y supervivencia de 
Salmonella dentro de una vacuola llamada Salmonella-containing vacuole (SCV) 
(Figueira y Holden, 2012; LaRock et al., 2015). SteA está entre el grupo de efectores de 
Salmonella que pueden ser translocados tanto por el T3SS de la SPI-1 como el de laSPI-
2 (Geddes et al., 2005; Cardenal-Muñoz y Ramos-Morales, 2011). Los mutantes 
carentes de este efector en S. Typhimurium muestran atenuación de la virulencia en 
modelos murinos de infección sistémica (Geddes et al., 2005, Lawley et al., 2006). Sin 
embargo, a pesar de su importancia para la patogénesis de S. Typhimurium, se han 
publicado pocos estudios sobre la función de SteA. Se ha descrito que SteA se localiza 
en la red trans-Golgi (TGN) cuando se expresa ectópicamente en células de mamífero 
no infectadas o se secreta por S. Typhimurium en células infectadas (Geddes et al., 
2005). Sin embargo, en un estudio diferente, se demostró que el efector SteA 
translocado por la bacteria se localiza en los filamentos inducidos por Salmonella (SIFs) 
enriquecidos en el marcador del TGN 1,4-galactosiltransferasa (GalT) (Van 
Engelenburg & Palmer, 2010). Además, SteA contribuye al control de la dinámica de la 
membrana de la SCV y a la formación de SIFs, ya que las células infectadas con un 
mutante ΔsteA muestran menos SIFs, aumento de la agrupación de SCVs y vacuolas 
morfológicamente anormales que contienen más de una bacteria (Domingues et al., 
2014). 
 Desde hace más de cincuenta años se ha utilizado a la levadura S. cerevisiae 
como organismo modelo para el estudio de procesos celulares de células eucarióticas, 
como la transcripción y la traducción de ADN, el procesamiento de ARN, la 
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señalización celular, la regulación del citoesqueleto y el tráfico intracelular (Duina et 
al., 2014). Entre las posibles aplicaciones del modelo de levadura se encuentra la 
caracterización funcional de efectores bacterianos que son secretados por el T3SS para 
modificar los procesos celulares con el objetivo de permitir la supervivencia del 
patógeno y contribuir a la enfermedad (Popa et al., 2016). Este modelo permite el 
estudio de efectores de patógenos difíciles de cultivar o manipular, requiriendo sólo el 
ADN del patógeno en cuestión. La expresión de los efectores bacterianos en la levadura 
a menudo da lugar a una variedad de fenotipos o alteraciones del crecimiento, que 
pueden dar pistas sobre sus funciones en la célula hospedadora y su papel en la 
patogénesis, lo que puede ser confirmado por nuevas pruebas en levaduras u otros 
modelos celulares antes de realizar  experimentos de infección en animales. 
Objetivos 
Nuestros objetivos están dirigidos a caracterizar funcionalmente la proteína efectora 
SteA de Salmonella Typhimurium en el modelo de levadura y son los siguientes: 
− Caracterización de los efectos fenotípicos de la expresión de SteA en S. 
cerevisiae. 
− Estudio de la localización subcelular de SteA en S. cerevisiae y sus 
determinantes. 
− Identificación de las posibles dianas de SteA en el modelo de levadura. 
Resultados y discusión 
1. SteA causa inhibición del crecimiento y graves defectos en la morfología 
mitocondrial tras su expresión en células de levadura 
La sobreexpresión de SteA en S. cerevisiae causó una inhibición significativa 
del crecimiento celular, acompañado de alteraciones en la morfología mitocondrial 
caracterizada por la aparición de mitocondrias condensadas. Este estudio ha permitido 
asignar un papel funcional al dominio amino-terminal de SteA, ya que los efectos 
observados eran dependientes de esta dicha región. Curiosamente, la lisina 36, dentro de 
un grupo de residuos básicos en la región amino-terminal de SteA, fue esencial para 
todos los efectos causados por SteA en las células de levadura. Uno de los complejos 
que mantienen la morfología tubular mitocondrial en la levadura es el complejo ERMES 
RESUMEN 
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(Mmm1, Mdm10, Mdm12 y Mdm34), localizado en la membrana externa de las 
mitocondrias y responsable del contacto de estos orgánulos con el  retículo 
endoplásmico (RE). La mutación en cualquiera de estas proteínas conduce a una 
morfología mitocondrial anormal, pero con el citoesqueleto de actina intacto (Boldogh 
& Pon, 2006), lo que es similar al efecto que provoca SteA sobre las mitocondrias. 
2. La capacidad de SteA de unirse a PI(4)P es un determinante de su localización 
subcelular dentro de las células de levadura 
 Nuestros resultados mostraron que SteA se localiza tanto en la membrana 
plasmática (MP) como en la vacuola cuando se expresa en levadura, y que los 
fosfoinositidos son marcadores diferenciales para la localización en dichas membranas 
celulares. Se encontró que la localización de SteA en la levadura era independiente del 
marcador principal de lamembrana plasmática, el PI (4,5) P2. Además, en un mutante 
pik1-ts de S. cerevisiae, defectuoso en la PI 4-quinasa localizada en Golgi, SteA 
mantuvo intacta su localización. Sin embargo, la inactivación de la PI 4-quinasa Stt4 
asociada con la membrana plasmática provocó la desaparición de SteA de dicha 
membrana, mientras que la localización vacuolar no se vio afectada. Estos resultados 
indican que la localización de la SteA en la membrana plasmática en células de levadura 
depende de su capacidad de unirse al fosfoinositido PI(4)P generado por Stt4. Como se 
ha descrito para SteA, otros efectores de Salmonella (SifA, SopD2, PipB2, SseF y SteC) 
se localizan tanto en los SIFs como en la membrana de la SCV en células de mamíferos 
(Schroeder et al., 2011), mientras que otros se localizan solo en la SCV, como SopE/E2 
(Vonaesch et al., 2014) y SopB (Patel et al., 2009), pero ninguno de ellos se ha descrito 
que se una directamente a fosfoinositidos. Sin embargo, se sabe que efectores de otras 
bacterias explotan los fosfoinositidos de la células hospedadora para su orientación 
subcelular, tales como efectores de Legionella (LpnE, RidL, SetA, LidA, SidC y SidM), 
que se unen a PI(3)P y/o PI(4)P en la membrana de la Legionella-containing vacuole 
(LCV) (Weber et al., 2006; Ragaz et al., 2008; Brombacher et al., 2009; Weber et al., 
2009ª; Jank et al., 2012; Finsel et al. , 2013). Por lo tanto, la unión a fosfoinositidos no 
se había encontrado como un mecanismo de localización subcelular para ningún s 
efector de Salmonella antes de este trabajo. En este trabajo, hemos demostrado que la 
presencia de residuos básicos (región rica en lisina), y particularmente la lisina 36, en la 
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región N-terminal de SteA es esencial para su actividad de unión a PI(4)P y su 
localización tanto en la MPcomo en la vacuola en levadura. Esto sugiere que SteA 
también podría estar reconociendo este fosfoinositido en la membrana vacuolar. Se 
obtuvieron resultados similares de nuestro colaborador Dr. Mota en células de 
mamíferos, en los que PI(4)P fue necesario para la localización de SteA en la MP 
cuando se expresó ectópicamente en células HeLa, así como para su presencia en la 
membrana de la SCV y en los SIFs dentro de las células hospedadoras después de la 
infección por S. Typhimurium (Domingues et al., 2016). 
Sorprendentemente, la sonda del PI(4)P, P4C, derivada del efector de Legionella 
SidC, no marcó la vacuola pero mostró más localización en la MP cuando se co-expresó 
con SteA que cuando se expresó sola, lo que sugiere que SteA podría estar regulando 
los niveles de PI(4)P en S. cerevisiae. Aunque se requieren estudios detallados 
adicionales sobre la estructura y la función de la actividad de unión a PI(4)P de SteA 
para entender los detalles estructurales de cómo se produce el reconocimiento de 
fosfoinositidos en este caso, nuestros resultados muestran que SteA y P4C podrían 
utilizarse para distinguir entre el PI(4)P generado en diferentes localizaciones 
subcelulares. 
3. La vía VPS (vacuolar protein sorting) es necesaria para la localización de SteA en la 
vacuola de S. cerevisiae 
 En levadura, las proteínas son transportadas desde el retículo endoplásmico hasta 
el Golgi, donde se dirigen directamente hacia la vacuola a través de la vía de la fosfatasa 
alkalina (ALP) o a través de endosomas tempranos y endosomas tardíos/cuerpos 
multivesicular (MVB) a través de la vía VPS/CPY. Las proteínas derivadas de la 
membrana plasmática pueden ser internalizadas por endocitosis y transportadas a 
endosomas donde también pueden dirigirse a la vacuola a través de la vía VPS/CPY 
(Feyder et al., 2015). Nuestros resultados mostraron que SteA no se localiza en la 
vacuola en mutantes vps de la clase D y E, afectados en las proteínas de los complejos 
CORVET y ESCRT respectivamente. En su lugar, se acumuló en un compartimiento 
adyacente a la vacuola que co-localizó con el marcador de las endosomas tardios FM4-
64 en los mutantes vps de clase E, o en puntos de diferente naturaleza en mutantes vps 
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de clase D. Estos resultados indican que SteA está dirigido a la vacuola a través del 
MVB. 
4. La sobreexpresión de SteA muestra interacciones genéticas con mutaciones en genes 
relacionados con la homeostasis de las vacuolas 
Además, nuestros resultados demostraron que la sobreexpresión de SteA mostró 
una interacción genética negativa con los mutantes fab1Δ y vac14Δ (defectuosos en los 
componentes del complejo proteico asociado a la vacuola que genera PI(3,5)P2 en 
células de levadura), pero no se detectó ni una interacción física con dichos 
componentes ni la localización subcelular de SteA se vio afectada en estos mutantes. 
Este resultado sugiere que SteA está relacionado funcionalmente con el complejo Fab1, 
aunque la presencia de este complejo no es necesaria para dirigir SteA hacia la vacuola. 
Otros mutantes que mostraban una interacción genética negativa con SteA fueron vps3, 
vps1 y vps35, mutantes que carecían de la quinasa PAK de Cla4, la subunidad de 
dineína (Dyn3) o proteínas relacionadas con el ensamblaje y la función de la v-ATPasa, 
como Vma1 o Vma21. Además, se encontró que la pérdida de Voa1, el factor de 
ensamblaje  del sector V0 de la v-ATPasa, fue capaz de suprimir la toxicidad causada 
por la sobreexpresión de SteA. Todos estos hallazgos relacionados con la expresión de 
este efector de Salmonella en células de levadura, junto con la interacción específica de 
SteA con PI(4)P, indican que es probable que SteA interfiera con varios procesos 
relacionados con el tráfico de la membrana en células eucarióticas. 
Conclusiones 
1.  SteA está altamente conservado entre diferentes serovares de S. enterica, y es 
específico para el género Salmonella. 
2. La sobreexpresión de SteA en levadura provoca una inhibición significativa del 
crecimiento dependiente de su región amino-terminal. 
3. La sobreexpresión de SteA conduce a defectos en la morfología mitocondrial, 
caracterizada por la aparición de mitocondrias condensadas. La región amino-terminal 
de SteA es necesaria y suficiente para causar este fenotipo mitocondrial. 
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4. SteA se localiza en la membrana plasmática y la vacuola cuando se expresa en S. 
cerevisiae, mientras que el fragmento amino-terminal correspondiente a los primeros 98 
aminoácidos de SteA se localiza en el retículo endoplásmico. 
5. La localización de la membrana plasmática de SteA requiere la presencia de PI(4)P 
generado por la quinasa Stt4 asociado a la membrana plasmática . 
6. La unión de SteA a la membrana plasmática y la vacuola en S. cerevisiae requiere 
residuos básicos cerca de su extremo amino-terminal, específicamente la lisina 36. Este 
residuo básico también es necesario para inducir tanto la inhibición del crecimiento 
como la condensación mitocondrial en células de levadura. 
7. Proteínas Vps de Clase D y E son necesarias para la localización vacuolar de SteA, 
lo que apunta a la importancia de la clasificación a nivel de los endosomas tardios/MVB 
en la orientación de SteA a la vacuola. 
8. Los mutantes que carecen de las subunidades del complejo PI5-quinasa Vac14 y 
Fab1, muestran una interacción genética negativa con la sobreexpresión de SteA. 
9. Las mutaciones en CLA4, VPS1, VPS3 y VPS35 causan un agravamiento fenotípico 
fenotípico de la inhibición del crecimiento inducida por SteA. 
10. La ausencia de Voa1, una proteína del retículo endoplásmico que funciona en el 
ensamblaje del sector V0 de V-ATPasa, pero no de otras subunidades de V-ATPasa, 
suprime la inhibición del crecimiento inducida por SteA en S. cerevisiae. 
!
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Title: Functional characterization of the effector protein SteA of Salmonella 
Typhimurium through heterologous expression in Saccharomyces cerevisiae 
Introduction 
Salmonella enterica serovars are facultative intracellular bacterial pathogens 
causing a wide variety of diseases in humans (Figueira & Holden, 2012). S. enterica 
virulence relies on secreting two sets of bacterial effectors into host cells through the 
SPI-1 and SPI-2 T3SSs. SPI-1 effectors enable bacteria to invade the host cell while 
SPI-2 effectors are responsible for their intracellular replication and survival within the 
Salmonella-containing vacuole (SCV) (Figueira & Holden, 2012; Ramos-Morales, 
2012; LaRock et al., 2015). SteA is among the group of Salmonella effectors that can be 
translocated by both the SPI-1 and the SPI-2 T3SSs (Geddes et al., 2005; Cardenal-
Munoz & Ramos-Morales, 2011), and mutants lacking this effector in S. enterica 
serovar Typhimurium display virulence attenuation in mouse models of systemic 
infection (Geddes et al., 2005; Lawley et al., 2006). However, in spite of its importance 
for S. Typhimurium pathogenesis, only few studies on SteA function have been 
published. It has been reported that SteA localizes to the trans-Golgi network (TGN) 
when ectopically expressed in uninfected mammalian cells or delivered by S. 
Typhimurium into infected host cells (Geddes et al., 2005). However, in a different 
study, bacterially translocated SteA was shown to localize to Salmonella-induced 
tubules enriched in the TGN marker 1,4-galactosyltransferase (GalT) (Van Engelenburg 
& Palmer, 2010). In addition, SteA contributes to the control of SCV membrane 
dynamics and Salmonella-induced filaments (SIFs) formation, since cells infected with 
a ΔsteA mutant showed less SIFs, increased clustering of SCVs, and morphologically 
abnormal vacuoles containing more than one bacterium (Domingues et al., 2014).  
For over fifty years S. cerevisiae has been used as a model organism for the 
study of cellular processes that occur in eukaryotic cells, such as transcription and 
translation of DNA, RNA processing, cell division, cell signaling, regulation of 
cytoskeleton and intracellular trafficking (Duina et al., 2014). Among the possible 
applications of the yeast model, is the functional characterization of bacterial protein 
effectors secreted by the T3SS to subvert cellular processes with the aim of supporting 
pathogen survival and contributing to disease (Popa et al., 2016). This model system 
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allows the study of effectors from pathogens difficult to grow or manipulate, requiring 
only the DNA of the pathogen in question. The expression of bacterial effectors in yeast 
often results in a variety of robust phenotypes or growth alterations, which can generate 
hypotheses about their targets in the host cell and their role in pathogenesis, which can 
be further confirmed by additional tests in yeast or other cell models prior to costly 
infection experiments in animals. 
Objectives 
Our objectives aimed to functionally characterize the effector protein SteA of 
Salmonella Typhimurium in the yeast model and are the following: 
− Characterization of the phenotypic effects of SteA expression in S. cerevisiae. 
− Study of the subcellular localization of SteA in S. cerevisiae and its 
determinants. 
− Identification of putative heterologous targets of SteA in the yeast model. 
Results and discussion 
1. SteA caused growth inhibition and defects in mitochondrial morphology upon 
expression in yeast cells 
! Overexpression of SteA in S. cerevisiae led to a significant inhibition of cell 
growth, accompanied by alterations in mitochondrial morphology characterized by the 
appearance of condensed mitochondria. This study allowed assigning a functional role 
to the amino-terminal domain of SteA, since the observed effects were dependent on 
this region. Interestingly, Lys36, within a cluster of basic residues at the amino-terminal 
region of SteA, was essential for all SteA effects observed in the yeast cell. One of the 
complexes which maintain mitochondrial tubular morphology in yeast, is the ERMES 
complex (Mmm1, Mdm10, Mdm12 and Mdm34), located at the mitochondria outer 
membrane and tethering these organelles to the ER. Mutations in any of these proteins 
are known to lead to an abnormal mitochondrial morphology but intact actin 
cytoskeleton (Boldogh & Pon, 2006), similar to the effect caused by SteA, suggesting 
that the ERMES function could be affected by SteA expression. 
!
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2. The ability of SteA to bind PI(4)P is a determinant of its subcellular localization 
within yeast cells 
Our results showed that SteA localizes to both the plasma membrane (PM) and 
the vacuole when expressed in yeast, and phosphoinositide species are differential 
markers of cellular membranes. We found that SteA localization in yeast was 
independent on the main PM marker, PI(4,5)P2. Also, in a S. cerevisiae pik1-ts mutant, 
defective in the Golgi-located PI 4-kinase, SteA kept its localization intact. However, 
the inactivation of the PM-associated PI 4-kinase Stt4 led to disappearance of the PM 
pool of SteA, whereas the vacuolar localization was not affected. These results indicate 
that localization of SteA at the PM in yeast cells is dependent on its ability to bind the 
PI(4)P phosphoinositide pools generated by Stt4. As shown for SteA, other Salmonella 
effectors (SifA, SopD2, PipB2, SseF, and SteC) localize both at the SIFs and SCV 
membrane in mammalian cells (Schroeder et al., 2011), while others localized just at the 
SCV, such as SopE/E2 (Vonaesch et al., 2014) and SopB (Patel et al., 2009), but none 
of them had been described to directly bind phosphoinositides. However, other bacterial 
effectors are known to exploit host cell phosphoinositides for subcellular targeting, such 
as Legionella effectors (LpnE, RidL, SetA, LidA, SidC and SidM), which bind to 
PI(3)P and/or PI(4)P at the LCV (Legionella-containing vacuole) membrane (Weber et 
al., 2006; Ragaz et al., 2008; Brombacher et al., 2009; Weber et al., 2009a; Jank et al., 
2012; Finsel et al., 2013). Therefore, binding to phosphoinositides had not been 
previously recognized as a mechanism of subcellular targeting of Salmonella effectors. 
In this work, we have shown that the presence of basic residues (lysine-rich region), and 
particularly the K36, at the SteA N-terminal region was essential for its PI(4)P binding 
activity and its localization at both the PM and vacuole in yeast. This suggests that SteA 
might also be recognizing this phosphoinositide at the vacuolar membrane. Similar 
results were obtained from our collaborator Dr. Mota in mammalian cells, in which 
PI(4)P was necessary for localization of SteA at the PM when ectopically expressed in 
HeLa cells, as well as for its presence at the SCV membrane and SIFs within host cells 
upon S. Typhimurium infection (Domingues et al., 2016). 
Surprisingly, the PI(4)P probe P4C, derived from the Legionella effector SidC, 
did not mark the vacuole but showed an enhanced localization at the PM when co-
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expressed with SteA than when expressed alone, suggesting that SteA might be 
regulating PI(4)P levels in yeast. Although further detailed studies on structure and 
function of the PI(4)P binding activity of SteA are required to understand molecular 
details of how phosphoinositide recognition occurs, our results show that SteA and P4C 
have different preference for PI(4)P depending on its subcellular location and, therefore, 
these probes can be used to distinguish discrete PI(4)P cellular pools. 
3. The vacuolar protein sorting pathway is required for localization of SteA at the 
vacuole in yeast 
! In yeast, proteins are transported from the ER to Golgi where they are sorted 
either directly toward the vacuole through the ALP pathway or through early endosomes 
and late endosomes/multivesicular bodies (MVB) via the VPS/CPY pathway. PM 
proteins can be internalized by endocytosis and transported to endosomes where they 
can also be sorted to the vacuole via the VPS/CPY pathway (Feyder et al., 2015). Our 
results showed that SteA fails to localize to the vacuole in both class D and E vps 
mutants, affected in proteins of the CORVET and ESCRT complexes, respectively. 
Instead, it accumulated either in a compartment adjacent to the vacuole that co-localized 
with the late endosomal marker FM4-64 in class E vps mutants, or in puncta of different 
nature in class D vps mutants. These results indicate that SteA is targeted to the vacuole 
via MVB sorting. 
4. Overexpression of SteA shows genetic interactions with mutations in genes related to 
vacuole homeostasis 
In addition, our results showed that SteA overexpression displayed a negative 
genetic interaction with both fab1∆ and vac14∆ mutants (defective in components of the 
vacuole-associate protein complex that generates PI(3,5)P2 in yeast cells), but neither a 
physical interaction was detected nor the subcellular localization of SteA was affected 
in these mutants. This result suggests that SteA is functionally related to the Fab1 
complex although the presence of this complex is not needed for SteA targeting toward 
the vacuole. Other mutants showing a negative genetic interaction with SteA were vps3, 
vps1 and vps35, mutants lacking the PAK kinase Cla4, the dynein subunit Dyn3, or 
proteins related to v-ATPase assembly and function, like Vma1 or Vma21. Moreover, 
we found that loss of Voa1, the assembly factor of the v-ATPase V0 sector, was able to 
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suppress SteA toxicity. All these findings related to the expression of this Salmonella 
effector in yeast cells, together with the specific interaction of SteA with PI(4)P, 
indicate that SteA is likely interfering with several processes related to eukaryotic 
membrane trafficking. 
Conclusions: 
1. SteA is highly conserved among different S. enterica serovars, and it is specific for 
the Salmonella genus. 
2. Overexpression of SteA in yeast provokes a significant growth inhibition dependent 
on its amino-terminal region. 
3. SteA overexpression leads to defects in the mitochondrial morphology, characterized 
by the appearance of condensed mitochondria. The amino-terminal region of SteA is 
necessary and sufficient to cause this mitochondrial phenotype. 
4. SteA localizes at the plasma membrane and vacuole when expressed in S. cerevisiae, 
whereas the amino-terminal fragment corresponding to the first 98 amino acids of SteA 
localizes to the ER. 
5. The plasma membrane localization of SteA requires the presence of PI(4)P pools 
generated by the PM-associated PI 4-kinase Stt4. 
6. Tethering SteA to the plasma membrane and vacuole in S. cerevisiae requires basic 
residues near its N-terminus, specifically Lys36. This basic residue is also necessary to 
induce both growth inhibition and mitochondrial condensation in yeast cells. 
7. Class D and E Vps proteins are necessary for vacuolar localization of SteA, pointing 
to the importance of sorting at late endosome/MVB in SteA targeting to the vacuole. 
8. Mutants lacking PI(3)P 5-kinase complex subunits Vac14 and Fab1, show a negative 
genetic interaction with SteA overexpression. 
9. Mutations in CLA4, VPS1, VPS3 and VPS35 cause phenotypic enhancement of SteA-
induced growth inhibition. 
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10. The absence of Voa1, an ER protein that functions in assembly of the V0 sector of 
V-ATPase, but not that of other V-ATPase subunits, suppresses SteA-induced growth 
inhibition in S. cerevisiae. 
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 THE GENUS Salmonella: MOLECULAR BASIS OF ITS I.
PATHOGENICITY 
I.1. Salmonella: generalities, taxonomy and nomenclature 
  Salmonella is a genus of Gram-negative facultative intracellular bacterial 
pathogens causing a wide variety of animal and human diseases ranging from mild 
enteritis to serious systemic infections such as typhoid fever (Schlumberger & Hardt, 
2006; McGhie et al., 2009; Figueira & Holden, 2012). 
  The genus Salmonella lies within the phylum Proteobacteria, class 
Gammaproteobacteria, order Enterobacteriales and family Enterobacteriaceae. 
Salmonella is divided into two species, S. bongori and S. enterica. There are 6 
subspecies within Salmonella enterica: salame, arizonae, diarizonae, houtenae, indica 
and enterica (Heyndrickx et al., 2005; Tindall et al., 2005; Fàbrega & Vila, 2013). 
Salmonella enterica contains more than 2600 serovars based on their flagellar (H) and 
LPS (O) antigen structures (Gal-Mor et al., 2014). Most S. enterica serovars associated 
with diseases in humans and other warm-blooded animals belong to the subspecies 
enterica. These serovars can be either host-adapted or non-host-adapted (Gal-Mor et al., 
2014). Host-adapted serovars cause life-threatening systemic disease in a limited 
number of related species, while non-host-adapted strains may cause gastroenteritis in 
many different host species. 
  Among the serovars considered as pathogens for the human being, it is important 
to distinguish between those causing typhoid or enteric fever, i. e. “typhoidal” serovars, 
from “non-typhoidal” serovars causing enteritis syndromes (Gal-Mor et al., 2014). 
   The serovars causing enteric fever are S. Typhi and S. Paratyphi A, B, and C, 
which produce respectively typhoid fever and paratyphoid fever. They are pathogens 
that exclusively infect humans and are transmitted through ingestion of contaminated 
water or food. Enteric fever actually happens endemically in developing countries, 
being endemic in regions of Central Africa and Latin America and reaching high 
incidences in India and Southeastern Asia. It is associated with fever and abdominal 
symptoms, which appear after an incubation period that fluctuates between 3 and 21 
days. After an initial phase with systemic symptoms such as diaphoresis, headache, dry 
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cough, myalgia and arthralgia, the fever appears. It can be accompanied with 
maculopapular rash and hepatic symptoms. The abdominal symptoms are common 
including pain and constipation (even more common than diarrhea). In some cases the 
disease turns to be chronic. The treatment of enteric fever involves hospitalization and 
intravenous or oral antibiotic therapy (Gal-Mor et al., 2014). 
  Within the non-thypoidal serovars, there is a big variety of strains, included in 
the Salmonella enterica subspecies enterica serovars Typhimurium and Enteritidis (S. 
Typhimurium and S. Enteritidis), which fall in the non-host-adapted strains, and are thus 
able to cause diseases in a variety of host species. In humans, infection with either of 
these serovars results in a self-limiting gastroenteritis (salmonellosis) involving fever, 
diarrhea, and abdominal pain. Symptoms appear between 6 and 72 hours after the 
ingesta of contaminated food. In 5% of the cases a bacteremia can occur; it can also 
evolve into complications such as endocarditis, aneurism, osteomyelitis and reactive 
arthritis (Townes, 2010). The treatment consists of oral rehydration and nasogastric or 
intravenous rehydration in some occasions (Boyle et al., 2007). These serovars are able 
to induce a systemic infection in mice, and young calves. In addition, they are also able 
to colonize poultry and adult cattle without symptoms (Zhang & Mosser, 2008, Boyle et 
al., 2007). 
I.2. Salmonella virulence: invasion of the intestinal epithelium 
Salmonella invades both non-phagocytic and phagocytic cells. The analysis of 
Salmonella pathogenesis revealed the presence of two key virulence mechanisms: the 
interaction of Salmonella with epithelial cells and its survival and replication inside the 
phagocytes. The Salmonella pathogenicity island 1 (SPI-1) function is required for the 
former stage of Salmonella infection and the Salmonella pathogenicity island 2 (SPI-2) 
for the latter stage. The epithelial barrier can be crossed by bacteria either by passive 
transport facilitated by dendritic cells, extending pseudopods between epithelial cells, or 
by active invasion. As a gate of entry, Salmonella uses the epithelial M cells of the 
Peyer´s patches for translocation across the epithelial barrier. Once across the epithelial 
barrier, Salmonella is confronted by macrophages and can actively invade them or may 
be phagocyted (Fig. 1) (Hurley et al., 2014). 
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Figure 1. Schematic representation of host-pathogen interactions during pathogenesis of 
Salmonella infections. After oral ingestion, Salmonella cells reach the lower intestine, and then 
invasion of host epithelial cells can occur by translocation of Salmonella across epithelial 
barrier either using the epithelial M cells of the Peyer´s patches or via active invasion mediated 
by the secretion of SPI-1-encoded T3SS effector proteins. Afterwards, Salmonella is engulfed 
by the closest macrophages, where effector proteins of the SPI-2 are secreted in order to prevent 
fusion of the phagosome with the lysosome, and promote the survival and proliferation of 
Salmonella within SCV, resulting in cytokine secretion by the macrophage. Finally, the 
macrophages undergo apoptosis, and Salmonella escapes to re-invade epithelial cells or other 
phagocytic cells (adapted from Hurley et al., 2014). 
 
 Internalization of Salmonella in non-phagocytic cells of the intestinal 
epithelium occurs by a process that involves changes in the epithelial membrane such as 
cell microvilli degeneration, reorganization of the actin cytoskeleton and appearance of 
membrane extensions called ruffles that surround the bacterium. Thus, bacteria are 
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internalized and enclosed in a membrane-bound compartment called SCV (Salmonella 
containing vacuole) (Ramsden et al., 2007; Bakowski et al., 2008; Steele-Mortimer, 
2008). The SCV biogenesis can be divided in three phases (Fig. 2): 
 
Figure 2. Schematic representation of the biogenesis of SCV. Salmonella internalization and the 
formation of the SCV start by the formation of ruffles at the host cell plasma membrane. During early 
SCV formation, the SCV acquires early endosomal markers, then those markers are replaced by late 
endosomal markers, leading to the formation of the intermediate SCV. Finally, Salmonella replicates and 
induces the formation of Salmonella-induced filaments (SIFs) along microtubules. MTOC stands for the 
microtubule-organizing center. 
 
1) Early SCV (0-1 h post-infection): the vacuole acquires early endosome markers, 
such as early endosome antigen 1 (EEA1), GTPases Rab5 and Rab11, and the 
transferrin receptor TnfR (Ramsden et al., 2007; Malik-Kale et al., 2011; 
Schroeder et al., 2011; Ramos-Morales, 2012). 
2) Intermediate SCV (1-4 h post-infection): the markers of the early stage are 
immediately replaced with late endosomal markers, such as lysosomal 
associated membrane protein 1 (LAMP1), GTPase Rab7, lysosomal 
glycoproteins (lgps), and the vacuolar ATPase (vATPase), causing an 
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acidification of the lumen (Ramsden et al., 2007; Malik-Kale et al., 2011; 
Schroeder et al., 2011; Ramos-Morales, 2012). 
3) Late SCV (> 4 h post-infection): Salmonella replicates inside the SCV and 
induces the elongation of the vacuole into tubular structures called Salmonella 
induced filaments (SIFs), rich in LAMP1, vATPase and cathepsin D, that extend 
from the SCV along microtubules towards the cell periphery. Microcolonies 
appear, surrounded by Golgi membranes (Ramsden et al., 2007; Malik-Kale et 
al., 2011; Schroeder et al., 2011; Ramos-Morales, 2012). 
 
I.3. Salmonella pathogenicity islands and type III secretion system 
 The Salmonella Typhimurium genome has a size of 4,857 Kb (McClelland et 
al., 2001). In addition, many strains contain a virulence plasmid of 94 Kb. The 
chromosome of S. Typhimurium contains 4,489 annotated CDS (coding sequences) and 
pseudogenes. A recent pangenomic approach on 12 S. Typhimurium strains recorded 
3,192 genes in the core genome (Yue et al., 2015). Among these, regions can be 
distinguished that are unique to certain strains, termed islands. Sometimes they encode 
for pathogenicity genes, and in such case they are called Salmonella pathogenicity 
islands (SPIs). These islands are found in regions adjacent to tRNA genes and have a 
G+C content different from the rest of the chromosome, which is 52% in the case of 
Salmonella, suggesting that they have been acquired by horizontal transmission. So far, 
23 SPIs have been described and characterized, but only five of them (SPI-1 to SPI-5) 
are common to all serovars of S. enterica (Espinoza et al., 2017). 
 The two most important pathogenicity islands of Salmonella are the SPI-1 and 
SPI-2, which encode type III secretion systems (T3SS) that enable bacteria either to 
invade eukaryotic cell or to replicate and survive inside a vacuole by injecting effector 
proteins into the cytoplasm through the plasma or vacuolar membrane respectively (Yip 
et al., 2005; Galan & Wolf-Watz, 2006). The T3SS-1 apparatus or injectosome consists 
of two lower rings integrated into the plasma membrane (InvG), 40 nm diameter and 20 
nm wide; two upper rings integrated in the outer membrane and peptidoglycan layer of 
the bacterium (PrgH) of 20 nm diameter and 18 nm wide united together through a 
shank (PrgK) and needle complex 50 nm long and 8 nm wide that protrudes from the 
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surface of the bacterium (PrgI) (Schraidt et al., 2010) (Fig. 3). The injection process 
requires the presence of translocator proteins forming a pore in the host membrane. This 
injectosome has a common evolutionary origin with the bacterial flagellum, as their 
basal bodies are formed by proteins with conserved structures and both are able to 
export their own distal components (Diepold & Wagner, 2014 ). 
 The assembly of this structure occurs in several stages: first the proteins 
forming the base of the complex are secreted through the secretory pathway sec. Once 
in the periplasm, these proteins are associated with the inner membrane proteins 
forming a complex capable of exporting the components of the needle, whose length is 
controlled by another protein, InvJ (Diepold & Wagner, 2014). Once the complex of the 
needle is formed, the T3SS is able to export the corresponding effectors (Fig. 3). The 
T3SS is highly regulated at both transcriptional and post-transcriptional levels so that 
the effector proteins are secreted in a coordinated fashion in time and place (Galán, 
2001). 
 The best-characterized Salmonella pathogenicity island is the SPI-1 (40 Kb), 
which contains genes that enable bacteria to invade non phagocytic cells. Unlike other 
SPIs, it is not located in an area adjacent to tRNA-encoding genes. The SPI-2 is a 
segment of 40 Kb adjacent to tRNA valV genes and contains 32 genes involved in the 
ability of developing systemic infection and intracellular survival. The SPI-1 appears in 
all subspecies of Salmonella enterica, while the SPI-2 does not, which indicates that it 
was probably acquired after the SPI-1, providing the ability to cause systemic infection 
(Marcus et al., 2000). The action of the main effectors secreted by these two T3SS of 
Salmonella is shown in figure 4. 
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Figure 3. Schematic representation of the T3SS or injectosome. The left and middle panels show 3D 
representations of the injectosome and its components; inner membrane (IM), and outer membrane (OM). 
The right panel shows a drawing of the type III secretion system indicating all its components. Needle tip 
and translocated proteins in green, base and needle components in blue, cytoplasmic components are 
shaded in yellow, export apparatus components are depicted in red (Diepold & Wagner, 2014). 
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Figure 4. Schematic representation of the function of the main Salmonella T3SS effectors. 
Salmonella invade non-phagocytic cells by inducing membrane ruffling, enclosing bacteria in SCV, 
which traffic towards the perinuclear region of the host cell and mature via selective interactions with 
the endocytic pathway. Once the SCV is positioned next to the Golgi apparatus, intracellular bacterial 
replication begins. This stage is characterized by the formation of SIFs and the accumulation of F-
actin around the bacterial phagosome (actin nest). Intestinal inflammation and diarrhea are caused by 
Cl- secretion and polymorphonuclear leukocyte transmigration. Salmonella serovars associated with 
systemic disease are able to enter intestinal macrophages, inducing cell death as well as using them as 
a way to disseminate to the liver and spleen via the bloodstream and lymphatic system. SPI-1 and 
SPI-2 effectors involved in each individual infection stage are indicated (McGhie et al., 2009). 
 
 
I.3.1. Effectors of the Salmonella pathogenicity island 1 type III 
secretion system 
  The SPI-1 is located on the centisome 63 of Salmonella´s chromosome and 
contains approximately 40 genes encoding structure components of the T3SS-1, 
secreted effectors, their chaperones and transcriptional regulators (Que et al., 2013). 
The SPI-1 T3SS is expressed in the intestinal lumen and its main function is to mediate 
entry of the bacteria into the host cells. SPI-1 is not required for systemic infection, so 
that mutants lacking this system have attenuated virulence in mice when orally 
inoculated, but are fully virulent after intraperitoneal inoculation (Groisman & 
Mouslim, 2000; Patel & Galan, 2005). 
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The T3SS SPI-1 secretes at least 19 polypeptides, including components of the 
secretion complex and the needle (Kimbrough & Miller, 2000). Other secreted proteins 
are effectors with various functions during the process of invasion (Haraga et al, 2008; 
Ramos-Morales, 2012) (Fig. 4 and Table I). 
 
Table I. Salmonella pathogenicity island 1 type III secretion system effectors (* refers to the effectors 
translocated by both SPI-1 and SPI-2) 
Effector Function  Reference 
SipA 
-Actin polymerization 
-Ruffle formation 
-SCV maturation and positioning through 
cooperation with SifA 
 
(Jepson et al., 
2001; Lilic et 
al., 2003; 
Raffatellu et al., 
2005; Li et al., 
2013) 
SipB 
-Involved in autophagy 
-Induces apoptosis by activation of caspase-1 
-Required for attachment to host epithelial 
cells 
(Hersh & 
Zychlinsky, 
1999; Hayward, 
2000; Raffatellu 
et al., 2005) 
SipC 
-Involved in actin bundling 
-Required for attachment to host epithelial 
cells 
-Regulates the trafficking of the host 
membrane protein PERP (p53-effector related 
to PMP-22) 
(McGhie et al., 
2001; Myeni & 
Zhou, 2010; 
Hallstrom & 
McCormick, 
2016) 
SipD -E3 ubiquitin ligase -Required for adhesion to host cells 
(Lara-Tejero & 
Galan, 2009) 
SlrP* 
-Involved in cell death 
-Ubiquitination of Trx1, targets the human 
chaperone ERdj3 
(Bernal-Bayard 
& Ramos-
Morales, 2009; 
Bernal-Bayard 
et al., 2010) 
SopA 
-E3 ubiquitin ligase 
-Phosphoinositide phosphatase 
-Migration of PMN 
-Mitochondrial alteration 
(Layton et al., 
2005; Zhang et 
al., 2006; 
Giacomodonato 
et al., 2007) 
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Table II. Continued 
Effector Function  Reference 
SopB/SigD 
 
-Invasion of Salmonella 
-Actin polymerization during invasion 
-Induction of pro-inflammatory cytokines 
-Disruption of tight junctions 
-SCV maturation and positioning 
-Elimination of PIP2 from the membrane 
-Recruiting of Rab5 and Vps34 to the SCV 
-Actin reorganization 
-Akt activation and inhibition of apoptosis 
-Modulates host cell exocytosis 
-Manipulates membrane surface charge and -
trafficking of the SCV 
(Marcus, 2002; Knodler et 
al., 2005; Raffatellu et al., 
2005; Bakowski et al., 2010; 
Perrett & Zhou, 2013) 
SopE 
-GEF of Cdc42, Rac1 and Rab5 
-Induces inflammation 
-Disrupts the intestinal epithelial cell tight 
junctions 
-SCV maturation 
-Activation of caspase-1 in macrophages 
-Activation of Rab5, inhibiting the 
phagosome-lysosome fusion 
-Ruffles formation 
-Activates different sets of Rho GTPases 
-Contributes to the intracellular replication of 
Salmonella 
(Friebel et al., 2001; 
Deleu et al., 2006; 
Humphreys et al., 
2012) 
SopE2 
-GEF of Cdc42 and Rac1 
-Ruffles formation 
-Actin polymerization 
-Induces inflammation, by secretion of IL-8 
-Disrupts the intestinal epithelia cell tight 
junctions 
(Bakshi et al., 2000; 
Friebel et al., 2001; 
Raffatellu et al., 
2005; 
Giacomodonato et 
al., 2007) 
AvrA -Acetyltransferase 
-Homolog toYopJ (Yersinia) 
-Inhibits apoptosis and inflammation 
-Stabilizes tight junctions 
-Mediates intracellular Salmonella survival 
-Inhibits NF-κB 
(Collier-Hyams et 
al., 2002; Liao et al., 
2008; Wu et al., 
2012) 
 
! !
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Table I. Continued 
Effector Function Reference 
SptP 
-Tyrosine phosphatase/GTPase activating 
protein 
-Promotes Salmonella intracellular replication 
-Downregulates of inflammation 
-Inhibits the mitogen-activated protein kinase 
(MAPK) pathway by inhibiting Raf activation 
-Binds and dephosphorylates the host 
AAA+ ATPase valosin-containing protein 
(VCP) 
(Lin et al., 2003; 
Humphreys et al., 
2009) 
!
I.3.2. Effectors of the SPI-2 type III secretion system 
 The SPI-2 is located on the centisome 31 and was probably acquired 
subsequently to the SPI-1. Identification of proteins secreted by SPI-2 T3SS is 
conditioned by the fact that this system is not expressed in normal laboratory 
conditions, but only after entry of the bacteria into the host cell, at acid pH and low 
concentration of Mg2+, Ca2+ and phosphate, and also requires the presence of the two 
components system SsrA/SsrB, regulated in turn by a second system, OmpR/EnvZ 
(Garmendia et al., 2003; Kuhle & Hensel, 2004). 
 The T3SS SPI-2 is required for a later stage of infection (systemic spread), as 
well as for survival and intracellular replication (Figueira and Holden, 2012). It is also 
implicated in the induction of apoptosis in macrophages and allows S. Typhimurium to 
avoid NADPH oxidase-dependent killing by macrophages (Imke Hansen-Wester, 2001; 
Schlumberger & Hardt, 2006). Effectors secreted by the SPI2-T3SS are shown in Figure 
4 and Table II. 
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Table II. Salmonella pathogenicity island 2 type III secretion system effectors (* refers to the effectors 
translocated by both SPI-1 and SPI-2) 
Effector Function Reference 
GogB Unknown (Coombes et al., 2005; Pilar et al., 2012) 
GtgA Unknown (Ramos-Morales, 2012) 
GtgB Unknown (Ramos-Morales, 2012) 
GtgE* -Protease (Ramos-Morales, 2012) 
PipB -SIFs formation but not required for 
virulence 
(Knodler et al., 2004) 
PipB2* 
-SIFs formation 
-Recruits kinesin-1 to SCV 
-Reorganization of late endosomes and 
lysosomes to mediate SIFs extension 
(Knodler & Steele-Mortimer, 
2005; Henry et al., 2006; 
Baison-Olmo et al., 2012) 
SopD* 
-Contribute to virulence 
-Actin rearrangement during entry  
-SCV positioning 
-Membrane fission 
(Jiang et al., 2004; Raffatellu 
et al., 2005; Bakowski et al., 
2007) 
SopD2 
-Involved in SIFs and SCV formation 
-Blocks delivery of endocytic cargo to 
lysosomes 
-Interacts with Rab7 by impairing its 
ability to bind RILP and FYCO1 
(Brumell et al., 2003; 
Schroeder et al., 2010; 
D'Costa et al., 2015) 
SsaB (SpiC) 
-Prevents fusion of late endosomes with 
SCV 
-Targets the mammalian Hook3 function 
to alter cellular traffic 
-Induces the secretion of IL-10 
-Activation of MAPK in macrophages 
for the regulation of the expression of 
flagellin 
-Secretion of translocon proteins SseB 
and SseC 
(Yu & Garvis, 2002; Freeman 
et al., 2003; Uchiya & Nikai, 
2008; Uchiya et al., 2009) 
SpvB -Inhibits actin polymerization associated with SCV 
(Otto, 2000;. Lesnick, 2001; 
Hochmann et al., 2006) 
SpvC* 
-Downregulation of inflammation 
during intestinal phase of infection 
-Phosphothreonine lyase of MAPK 
proteins 
(Mazurkiewicz et al., 2008; 
Guiney & Fierer, 2011; 
Haneda et al., 2012) 
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Table II. Continued 
Effector Function Reference 
SpvD* 
-Prevent the activation of an NF-ĸB-
dependent promoter 
-Causes nuclear accumulation of 
importin-α 
(Rolhion et al., 2016) 
SrfH (SseI) 
-Involved in macrophage motility 
-Important for early dissemination 
Salmonella to spleens in mice 
-Targets Filamin A, TRIP6, IQGAP1 
(Worley et al., 2006; 
McLaughlin et al., 2009) 
SseF 
-SCV formation and positioning through 
recruitment of dynein, in harmony with 
SseG and SifA 
(Deiwick et al., 2006; Muller 
et al., 2012; Ustun et al., 
2012) 
SseG -SCV formation and positioning (Deiwick et al., 2006) 
SseJ 
-Cholesterol acetyltransferase  
-Regulation of SCV membrane together 
with SifA 
-Promotes virulence by RhoA activation  
(Ruiz-Albert, 2002; Lossi et 
al., 2008; LaRock et al., 2012) 
SseL 
-Modulates host´s inflammatory 
response by inhibiting NF-κB signaling 
activity and deubiquitination of IκBα 
(Coombes et al., 2007; 
Rytkonen et al., 2007; 
Mesquita et al., 2012) 
SseK1 
-Localized to host cell cytoplasm 
-Inhibits TFNα-induced NF-κB 
activation 
(Kujat Choy et al., 2004; !
Günster et al., 2017) 
SseK2 
-Localized to host cell cytoplasm 
-Inhibits TFNα-induced NF-κB 
activation 
(Kujat Choy et al., 2004;  
Günster et al., 2017) 
SseK3 
-Binds TRIM32 
-Modulates host’s NF-κB signaling 
activity 
-Inhibits TFNα-induced NF-κB 
activation 
(Yang et al., 2015; Günster et 
al., 2017) 
SifA 
-GEF 
-Positioning of SCV 
-Formation and positioning of SIFs 
-Interaction with Rab7 impairing its 
ability to recruit RILP 
-Formation of tubular structure along 
with SseJ and RhoA 
-Reduction of recruitment of kinesin to 
the microtubules through interaction 
with SKIP, impairing its ability to bind 
with Rab9 
(Brumell et al., 2001; Brumell  
et al., 2002; Boucrot et al., 
2003; Zhao et al., 2015) 
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Table II. Continued 
Effector Function Reference 
   
SifB -Localized on SCV and SIFs (Freeman et al., 2003) 
SspH1* 
-E3 ubiquitin ligase 
-Downregulates inflammatory response 
by inhibiting NF-κB signaling activity, 
Inhibition of IL-8 and ubiquitination of 
PKN1 (protein kinase N1) 
(Haraga & Miller, 2006; 
Alexander et al., 2014) 
SspH2 
-E3 ubiquitin ligase 
-Interacts with actin-binding protein 
filamin 
-Exploits the NLR co-chaperone 
activity of SGT1 to subvert immunity 
(Edward et al, 2003; Haraga 
& Miller, 2006) 
SteA* 
-Localized to the Golgi apparatus 
-Required for the colonization in mice 
model 
-Formation of SIFs 
-Control of membrane dynamics of 
Salmonella containing vacuoles 
(Geddes et al., 2005; 
Domingues et al., 2014) 
SteB* -Required for the formation of biofilms 
-Required for full virulence 
(Geddes et al., 2005; Dong et 
al, 2008) 
SteC 
-Serine/threonine kinase 
-Localized to the SCV and SIFs 
-Formation of a F-actin network 
surrounding the SCV 
-Regulates the host actin cytoskeleton 
by targeting the MAPK MEK 
-Inhibits Cdc42-mediated signaling 
through binding to the exchange factor 
Cdc24  
(Poh et al., 2008; Fernandez-
Pinar et al., 2012; Odendall et 
al., 2012) 
SteD 
-Mediates MARCH8-dependent 
ubiquitination of MHC II 
- Inhibits T Cell activation 
(Bayer-Santos et al., 2016) 
SteE* Unknown (Ramos-Morales, 2012) 
!
Some of the effectors mentioned above (GtgE, PipB2, SpvC, SpvD, SspH1, 
SlrP, AvrA, SteA, SteB, and SteE) are secreted and translocated by both SPI-1 and SPI-
2 T3SS. 
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I.4. Role of SPI-2 effectors in the interaction of Salmonella with the 
host cell 
The SPI-2 T3SS is involved in many intracellular events. T3SS-2 secreted 
effectors function mainly in the maintenance and positioning of the SCV, whereas 
others act in the modulation of host immune signaling and/or target the host 
cytoskeleton (Fig. 5) (Holden & Figueira, 2012). 
I.4.1. Maintenance and positioning of the SCV by SPI-2 effectors 
 Salmonella is able to modify the endocytic pathway to create a compartment 
suitable for its growth (Steele-Mortimer, 2008; Bakowski et al., 2008). The SPI-1 T3SS 
 
Figure 5. Function of the SPI-2 T3SS effectors and their involvement in the intracellular survival of 
Salmonella. Maintenance of the SCV is achieved through the action of SifA, SopD2, SseJ and PipB2 
(orange boxes), and positioning near the Golgi apparatus by SseF and SseG (purple boxes). SteC, SspH2, 
SrfH and SpvB modulate the actin cytoskeleton (blue boxes). Other effectors target innate immune 
signaling (SspH1, SseL and SpvC; pink boxes) (taken from Holden & Figueira, 2012). 
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effector SopB phosphatase is involved in both the formation and maturation of SCV 
(Perrett & Zhou, 2013). Then, SPI-2 T3SS delivery of effectors, like SifA, induces the 
formation of tubular structures called Salmonella-induced filaments (SIFs) that extend 
from SCVs throughout the host cell cytoplasm, supported by microtubules (Figs. 4 and 
5) (Schroeder et al., 2011). SifA is involved in the formation of SIFs and the 
maintenance of SCV integrity through its interaction with GTPase Rab7 and SKIP 
(SifA and kinesin-interacting protein) (Malik-Kale et al., 2011; Zhao et al., 2015). In 
the absence of SifA or SKIP, an increased recruitment of kinesin to the SCV membrane 
occurs (Boucrot et al., 2005). This is mediated by SPI-2 T3SS effector, PipB2 that is 
involved in kinesin-driven SCV membrane dynamics and the radial extension of SIFs 
along microtubules (Knodler & Steele-Mortimer, 2005).  
SopD2 localizes to the SIFs, SVC membranes, late endosomes and lysosomes. It 
is involved in SIFs formation and vacuolar membrane dynamics. (Figs. 4 and 5). In 
addition, SopD2 blocks delivery of endocytic cargoes to lysosomes and interacts with 
Rab7 by impairing its ability to bind its kinesin-binding effectors RILP and FYCO1 
(Jiang et al., 2004; Schroeder et al., 2010; D'Costa et al., 2015). 
Parallel to the formation of SIFs, the SCV moves from the cellular periphery to a 
juxtanuclear position at the microtubule organization center (MTOC), where Golgi 
stacks accumulate. Close contact between the SCV and the Golgi apparatus seems to 
play an important role in facilitating the acquisition of cellular components required for 
proliferation (Holden & Figueira, 2012; Yu et al., 2016). Bacterial division leads to the 
formation of microcolonies within the SCV through the action of both SPI-2 T3SS 
effectors SseF and SseG (Ramsden et al., 2007). SseF is involved in the formation of 
microtubule bundles and maintenance of the perinuclear position of SCV by recruiting 
dynein to SCV (Fig. 5) (Kuhle & Hensel., 2004; Abrahams et al., 2006). SseG is 
responsible for directing this positioning (Deiwick et al., 2006). Both SseF and SseG 
interact with mammalian protein ACBD3 (acyl-CoA binding domain containing 3) to 
anchor SCVs at the Golgi Network (Yu et al., 2016). Both effector proteins are 
considered to increase SIFs formation by modulating the aggregation of endosomal 
compatments, as sseFΔ sseGΔ mutant Salmonella induce less SIFs compared to wild 
type bacteria. On the other hand, other two SPI-2 T3SS effectors SseJ and SpvB 
antagonize SIFs formation. Salmonella mutants lacking either sseJ or spvB show an 
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increased number of SIFs (Ramsden et al., 2007). SseJ has phospholipase A and 
cholesterol acetyl transferase activities and modifies the membrane lipids of the SCV, 
thus facilitating fusion with other intracellular compartments (Lossi et al., 2008; 
Kolodziejek & Miller, 2015). 
I.4.2. Modulation of the actin cytoskeleton SPI-2 T3SS effectors 
At an early stage of infection SPI-1 effectors cause actin cytoskeleton 
rearrangements (Holden & Figueira, 2012; Raymond et al., 2013). Several hours later, 
Salmonella begins to replicate and induces the assembly of a dense F-actin meshwork in 
the proximity of SCVs in different cell types, including macrophages, epithelial cells 
and fibroblasts, in a SPI-2 T3SS-dependent manner (Holden & Figueira, 2012). SteC, 
which shows similarity to the human kinase Raf1, is the effector initiating this process, 
being its kinase activity necessary for actin meshwork formation (Fig. 5) (Poh et al., 
2008). SteC has been also shown to inhibit Cdc42-mediated signaling through binding 
to the exchange factor Cdc24 when expressed in the yeast model Saccharomyces 
cerevisiae (Fernández- Piñar et al., 2012). 
SrfH and SspH2 localize as well to the SCV-associated F-actin meshwork, but 
do not appear to contribute to its formation. In fact, purified SspH2 leads to the 
inhibition of actin polymerization, suggesting that it might be counteracting the effect of 
SteC. SspH2 interacts with host cell actin regulators α-filamin and profilin-1 (Miao et 
al., 2003; Srikanth et al., 2011; Holden & Figueira, 2012). 
Another effector that interferes with the actin cytoskeleton is SpvB, a protein 
encoded by the spv operon in the Salmonella virulence plasmid. It contributes to the 
alteration of actin cytoskeleton by ADP ribosylation of monomeric actin (Fig. 5) 
(Lesnick et al., 2011; Srikanth et al., 2011). A spvB mutant caused increased actin 
meshwork formation in HeLa cells (Miao et al., 2003), suggesting that the target of 
SpvB might be the F-actin meshwork formed as a result of the action of SteC (Holden 
& Figueira, 2012). 
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I.4.3. Modulation of host immune signaling by SPI-2 T3SS effectors 
 During infection, Salmonella is able to inhibit the inflammatory process in order 
to evade the immune response and promote its intracellular survival (Fig. 4). It 
modulates the expression of certain host cell genes by negatively regulating the NF-κB 
pathway through the ubiquitination of PKN1 (PKC-related serine/threonine-protein 
kinase) by SspH1, resulting in the inhibition the synthesis of the proinflammatory 
cytokine IL-8 (Fig. 5) (Haraga &Miller, 2006; Rohde et al., 2007). On the other hand, in 
infected macrophages there is an increase in the anti-inflammatory cytokine IL-10 
dependent on the action of SpiC through the activation of the protein kinase-A (PKA) 
(Uchiya et al., 2004). 
Another SPI-2 T3SS effector that modulates the immune signaling during 
infection is SpvC. This effector possesses a phosphothreonine lyase activity on MAPKs 
(Fig. 5) (Li et al., 2007). By inhibiting these pathways, SpvC exerts an anti-
inflammatory effect; its overexpression causes the downregulation of the release of 
TNF-α and IL-8 from infected macrophages and epithelial cells, respectively 
(Mazurkiewicz et al., 2008; Haneda et al., 2012). 
I.5. The Salmonella translocated effector SteA 
SteA is among the group of Salmonella effectors that can be translocated by both 
the SPI-1 and the SPI-2 T3SSs (Geddes et al., 2005; Cardenal-Muñoz & Ramos-
Morales, 2011; Cardenal-Muñoz et al., 2014). It was first identified in a screening for 
new secreted effector proteins based on transposon mutagenesis coupled with the CyaA 
fusion method (Geddes et al., 2005). It was later isolated in a screen that aimed to unveil 
Salmonella Typhi genes that inhibited yeast growth when overexpressed (Alemán et al., 
2009). Although SteA does not contribute directly to intracellular replication of S. 
Typhimurium (Figueira et al., 2013, Domingues et al., 2014), a ΔsteA mutant shows 
virulence defects in mouse models of systemic and persistent infection (Geddes et al., 
2005, Lawley et al., 2006). It has been also reported that SteA localizes to the trans-
Golgi network (TGN), when ectopically expressed in uninfected mammalian cells or 
delivered by S. Typhimurium into infected host cells (Geddes et al., 2005). However, in 
a different study, bacterially translocated SteA was shown to localize to Salmonella-
induced tubules enriched in the TGN marker 1,4-galactosyltransferase (GalT) (Van 
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Engelenburg & Palmer, 2010). Amongst other Salmonella T3SS effectors, it has been 
recently shown by Domingues et al (2014) that SteA contributes to the control of SCV 
membrane dynamics and SIFs formation, since cells infected with ΔsteA mutant 
Salmonella cells showed fewer SIFs and abnormal vacuoles (with more than one 
bacterium in each vacuole) with microcolonies displaying an excessive accumulation of 
LAMP1 that were frequently more compact than those formed by wild type bacteria 
(Domingues et al., 2014). These authors also showed that SteA is functionally linked to 
SseF and SseG and suggested that it might contribute directly or indirectly to the 
regulation of microtubule motors on the SCV. 
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 S. cerevisiae AS A HETEROLOGOUS MODEL FOR THE II.
IDENTIFICATION AND CHARACTERIZATION OF BACTERIAL 
PROTEIN EFFECTORS 
II.1 S. cerevisiae as a tool for the study of human proteins and drug 
screening 
 For over fifty years S. cerevisiae has been used as a model organism for the 
study of cellular processes that occur in eukaryotic cells, such as transcription and 
translation of DNA, RNA processing, cell signaling, regulation of cytoskeleton and 
intracellular trafficking (Duina et al., 2014). The high conservation of these processes in 
yeast, the ease of laboratory management and rapid growth, the relative simplicity of 
yeast genetics, and the existence of a wide variety of molecular tools, along with the 
fact that its genome sequence was published in 1996 (first sequenced eukaryotic 
genome) and more than 75% of its ORFs have known or predicted functions, have 
contributed to consider this microorganism as a key eukaryotic cell model. In addition, 
wide accessible information at a variety of web sites and databases on the molecular 
biology of S. cerevisiae and its applications as a cellular model is available (i.e. 
Saccharomyces Genome Database SGD). Around thirty percent of human genes known 
to be involved in diseases have orthologues in yeast, especially those that encode cell 
cycle regulators, components of signal transduction systems or metabolic routes. Due to 
the functional conservation from lower to higher eukaryotes, studies in yeast can 
provide much information on gene function in humans. For example, studies in yeast 
have contributed to the understanding of mechanisms regulating cell division and 
apoptosis whose alteration leads to cancer (Madeo et al., 2002; Hartwell, 2002). In 
addition, the expression of human cDNAs in yeast allows functional complementation 
studies and identification of genes that are capable of interacting functionally with 
particular human cDNAs expressed in yeast. Actually, a systematic humanization of 
yeast by replacing over 400 essential yeast genes with their human orthologues revealed 
that about half of them could functionally replace their yeast counterparts (Kachroo et 
al., 2015). Moreover, it is even possible the study of proteins implicated in human 
diseases that have no counterparts in yeast, but are capable of interfering with growth in 
this model (Tucker, 2002). For example, this is the case of humanized yeast systems 
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with some proteins implicated in oncogenesis, such as the module p53/Mdm2 (Di 
Ventura et al., 2008), or the PI3K/PTEN/Akt pathway (Rodríguez-Escudero et al., 
2005; Andrés-Pons et al, 2007; Cid et al., 2008; Rodríguez-Escudero et al., 2009), and 
in neurodegenerative diseases, such as α-synuclein involved in Parkinson (Outeiro & 
Lindquist 2003; Auluck et al., 2010). Humanized yeast systems also served as platforms 
to develop high throughput screenings for the identification of chemical inhibitors of 
human proteins, such as drugs binding G-protein coupled receptors (GPCRs), involved 
in mental disorders, metabolic disorders, neurodegenerative diseases, cardiovascular 
diseases, and cancer (Overington et al., 2006; Schütz et al., 2016). 
 S. cerevisiae has also become one of the eukaryotic model choice systems for 
the development of genomic technology. Besides the application of the DNA 
microarray technology and proteomics, different genomic mutant collections have been 
obtained, both diploid and haploid, in which each strain carries a genetically engineered 
version of each of the approximately 6200 annotated ORFs, which can be used for 
large-scale phenotypic assays (Giaever et al., 2002; Boone et al., 2007) Also, a genomic 
collection of GFP fusions has been developed for subcellular localization assays (Huh et 
al., 2003), as well as genomic collections of epitope-tagged proteins for expression and 
co-immunoprecipitation experiments, and fusions to the binding and activation domain 
of Gal4 for two-hybrid assays (Ghaemmaghami et al., 2003).Whole genome deletion 
mutant collections also allow searching for synthetic lethality by combination with other 
mutations or the action of chemical compounds (Boone et al., 2007). 
II.2 S. cerevisiae as a model system for the identification and 
characterization of bacterial virulence effectors 
Among the possible applications of the yeast model, is the functional 
characterization of bacterial protein effectors secreted by the T3SS to subvert cellular 
processes with the aim of pathogen survival and contributing to disease (Rodríguez-
Escudero et al., 2005; Popa et al., 2016). Such effector proteins must be expressed de 
novo in yeast because such secretory system is unable to inject proteins through the 
fungal cell wall. This model system allows the study of effectors from pathogens 
difficult to grow or manipulate, requiring only the DNA of the pathogen in question. 
The expression of bacterial effectors in yeast often results in a variety of robust 
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phenotypes or growth alterations, which can generate hypotheses about their role in 
pathogenesis, that can be further confirmed by new tests in yeast or other cell models 
prior to infection experiments in animals. The effect in yeast due to the expression of 
bacterial effector proteins is in many cases a very specific and sensitive indicator of the 
action of these proteins in the host cell. In a recent review on this topic, it is stated that, 
upon expression in yeast, T3SS bacterial effectors caused a perturbation of conserved 
cellular processes, with 84% of cases accompanied by growth inhibition. The most 
frequently observed effects are Rho GTPase signaling modulation, cytoskeleton 
disruption, MAPK signaling interference, cell death modulation, trafficking 
perturbation, and membrane alterations (Popa et al., 2016).  
Among virulence factors of pathogenic bacteria of both plants and animals that 
inhibited growth when expressed in yeast, are found effectors secreted by Pseudomonas 
syringae (Salomon et al., 2012), Pseudomonas aeruginosa (Stirling & Evans, 2006; 
Burstein et al., 2015), Shigella flexneri (Slagowski et al., 2008)! , Legionella 
pneumophila (Campodonico et al., 2005; Derre & Isberg, 2005; O'Brien et al., 2015) , 
Chlamydia trachomatis (Sisko et al., 2006), Escherichia coli (Rodríguez-Escudero et 
al., 2005a; Popa et al., 2016), Coxiella burnetti (Rodríguez-Escudero et al., 2016) and 
Yersinia enterocolitica (Nejedlik et al., 2004). In the particular case of Salmonella, 
several effectors have been described to have an inhibitory effect on yeast growth, and 
our research group has studied some of them. Table III summarizes the list of 
Salmonella T3SS bacterial effectors studied in S. cerevisiae and the specific phenotypes 
that their expression causes on yeast cells. The versatility of yeast and its compliance 
for high-throughput functional studies have contributed to the prosperity and the success 
of this heterologous system that, in recent years, has been used to study more than 100 
effectors (Siggers & Lesser, 2008; Curak et al., 2009; Popa et al., 2016). 
A very important factor to consider in relation to growth inhibition is the 
strength of the promoter used in the heterologous expression. Expression of bacterial 
virulence factors in yeast is usually done under the control of an inducible promoter in 
order to control the possible growth inhibitory effect. To this end, the strong promoter 
of the GAL1 gene, inducible by galactose (Rodríguez-Pachón et al., 2002), or the 
weaker promoter of the CUP1 gene, controlled by the presence copper (Mao et al., 
2002; Peng et al., 2015) are often used. As for the number of copies, either centromeric 
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(1-3 copies) or 2 micron-derived plasmids (40-60 copies) can be used, but also a single 
copy can be integrated in the yeast genome by direct homologous recombination 
(Siggers & Lesser, 2008). Moreover, the fusion of the protein effector to an epitope 
such as GST or GFP may also influence its inhibitory effect. An example is Map of 
EPEC; its amino-terminal GST fusion inhibits growth while the carboxy-terminal GFP 
fusion does not (Rodríguez-Escudero et al., 2005). 
To monitor S. cerevisiae growth inhibition, there are many options such as 
optical density measurement in liquid medium, measurement of the cellular respiration 
using colorants, and the most used one is the serial dilution spot assay in solid medium 
(Sisko et al., 2006). In addition, yeast can be used to check subcellular localization 
patterns, using GFP-tagged proteins and fluorescence microscopy (Huh et al., 2003), as 
well as to study the alterations in the morphology of cytoskeleton and organelles, 
endocytosis and vesicle trafficking or signal transduction pathways caused by the 
expression of the bacterial protein (Siggers & Lesser, 2008). 
Moreover, a variety of available yeast proteomic and genomic tools can be also 
used to identify and characterize bacterial effectors. Interacting proteins, effector 
targets, and transcriptional response may be monitored using techniques such as yeast 
two-hybrid, multi-copy suppression profiling, and transcriptomics. Recently, yeast 
genetics have been thoroughly exploited in order to check effector-effector interactions 
by screening all known 300 Legionella pneumophila effector proteins using a SGA 
(synthetic genetic array) screen in S. cerevisiae (Urbanus et al., 2016). When the 
heterologous expression of the effector causes yeast growth inhibition, the target of the 
effector can be identified using the PGA (pathogenic genetic array) technique, that 
allows the transformation of the vector expressing the effector in the whole yeast mutant 
collection to identify suppressors (Curak et al., 2009). Figure 6 shows a summary of 
functional assays and genomic tools used to study bacterial effectors in yeast. 
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Table III. List of S. Typhimurium effectors studied in S. cerevisiae  
Effector Phenotypes in yeast Reference 
AvrA 
Growth inhibition and inhibits 
the high osmolarity glycerol 
(HOG) MAPK pathway 
(Du & Galan, 2009) 
SopE2 Growth inhibition, activation of MAPK signaling 
(Rodríguez-Pachón et al., 
2002) 
SptP Growth inhibition, inhibition of MAPK signaling 
(Rodríguez-Pachón et al., 
2002) 
SopB 
Growth inhibition, actin 
depolarization, disruption of 
cytoskeleton, inhibition of 
MAPK signaling, interaction 
with yeast Cdc42  
(Alemán et al., 2005; 
Rodríguez-Escudero et al., 
2006; Rodríguez-Escudero 
et al., 2011)  
SteC 
Growth inhibition, disruption of 
actin cytoskeleton, inhibition of 
MAPK signaling, interaction 
with GEF Cdc24 
(Aleman et al., 2009; 
Fernandez-Pinar et al., 
2012) 
SseF Growth inhibition (Aleman et al., 2009) 
SspH2 No alteration of cell cycle or effect on cell viability 
(Bhavsar et al., 2013) 
SspA Growth inhibition, disruption of actin cytoskeleton 
(Lesser & Miller, 2001) 
SifA 
Changes yeast peroxisome 
abundance and morphology by 
altering Rho1 activity 
(Vinh et al., 2010)  
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Figure 6. S. cerevisiae functional assays and genomic tools used to study bacterial effectors. Bacterial 
ORFs may be studied through expression in yeast using the indicated methodologies. (adapted from 
Curak et al., 2009) 
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 INTRACELLULAR MEMBRANE TRAFFICKING IN YEAST III.
III.1 Membrane trafficking in yeast: generalities 
In yeast cells, both soluble and transmembrane proteins are generally produced 
at or transferred to the endoplasmic reticulum (ER), and afterwards transported to their 
precise target compartments in order to accomplish their function, undergo 
modification, or be degraded. After being translocated to the ER, newly synthesized 
proteins are directed to the Golgi through COP-II (anterograde transport), and some 
proteins are recycled or transported back to the ER from the Golgi through COP-I 
vesicles (retrograde transport). From the Golgi, some of them will be secreted through 
the secretory (SEC) pathway, or transported to the PM. Others will be targeted directly 
to the vacuole through the alkaline phosphatase (ALP) pathway or through endosomes 
via the carboxypeptidase Y/vacuolar protein sorting (CPY/VPS) pathway. PM-derived 
proteins can be internalized by endocytosis (END pathway) and translocated to the early 
endosome (EE) where they are sorted; some proteins undergoing sorting towards the 
vacuole and others being redirected to the trans-Golgi network (TGN) via the recycling 
pathway (RCY), where they are readdressed to the PM (Feyder et al., 2015). Figure 7 
summarizes the membrane trafficking pathways in yeast. 
III.1.1 Endocytosis 
In eukaryotic cells, the endocytic pathway (END) allows proteins from the 
extracellular medium and plasma membrane to be internalized and delivered either to 
the vacuole for degradation or to the TGN for recycling (Fig. 7) (Conibear, 2010). Two 
main types of endocytosis are known: receptor mediated endocytosis, triggered after the 
binding of the ligand by its receptor, and fluid-phase endocytosis during which vesicles 
sequester extra-cellular material non-specifically (Feyder et al., 2015). 
In S. cerevisiae, endocytosis consists of 3 main stages: Endocytic site initiation, 
invagination and scission, and finally release. The initiation site is formed by the 
recruitment of clathrin via AP-2 adaptor complex, leading to the formation of the early 
coat where cargo proteins are clustered. The initiation is finished by the formation of a 
late coat through recruitment of ENTH (epsin N-terminal homology) and ANTH 
(AP180 N-terminal homology) domains-containing proteins named epsins, Ent1/Ent2, 
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and Sla2. Afterwards the WASP (Wiskott-Aldrich syndrome family protein)/myosin 
module is recruited, leading to actin polymerization and plasma membrane invagination. 
Once the invagination is completed, the fission module starts releasing vesicles into the 
cytoplasm (Feyder et al., 2015). 
The END pathway starts by the formation of the early endosomes (EE), fed by 
endocytic vesicles. Proteins undergoing recycling are directed from EE to the TGN via 
the recycling pathway (RCY) (Fig. 7), from where they can be secreted via the 
 
 
Figure 7. Intracellular membrane trafficking pathways in yeast. Golgi derived proteins can be either 
secreted (SEC pathway), or transported to the vacuole following two main pathways. Proteins that follow 
the CPY (carboxypeptidase Y) pathway are sorted through clathrin-coated Golgi vesicles and reach the 
vacuole by passing the endosomal/MVB compartments. Proteins that follow the ALP (alkaline 
phosphatase) pathway are sorted directly to the vacuole through different type of Golgi derived vesicles. 
CPY pathway and END pathway converge at the MVB (multivesicular body). At the early endosomes 
(EE), proteins are sorted either to the late endosome (LE)/MVB, or to the Golgi to avoid degradation 
through the recycling pathway (RCY). 
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exocytosis again to the plasma membrane. Early endosomes mature and are 
subsequently are converted to late endosomes, also known as multivesicular bodies 
(MVB) or pre-vacuolar compartments (Clague & Urbé, 2008), which control traffic 
corresponding to cargos that either are essential for proper vacuolar function or should 
be degraded in the vacuole. The MVB fuses with the vacuole, the terminal compartment 
of the endocytic pathway in yeast cells, and liberates its content into the vacuolar lumen 
(Fig. 7). 
III.1.2 Traffic from the Golgi to the vacuole via the VPS/CPY 
pathway 
Many proteins are targeted to the vacuole through the VPS/CPY pathway. The 
VPS genes were identified in a set of genetic screens, generating 61 mutants defective in 
vacuolar protein sorting. The hallmark of all vps mutants is the mis-sorting of CPY, and 
they are classified in 6 classes (A-F) based on the morphology of their vacuoles. Class 
A vps mutant cells show normal vacuoles (1-3) per cell, whereas class B mutants 
display abnormally fragmented vacuoles. In class C vps mutants there are no 
identifiable vacuoles, and class D mutants show a single, large vacuole that fails to 
extend into daughter buds. Finally, class E vps mutants show large vacuoles, with a very 
large and aberrant late endosome/MVB (the class E compartment) adjacent to the 
vacuole (Bowers & Stevens, 2005; Feyder et al., 2015). 
Proteins destined to the vacuole interact with different effectors such as the AP-1 
complex (Phan et al., 1994), epsins Ent3/Ent5 (Duncan et al, 2003), and the Golgi-
associated gamma-adaptin ear homology domain Arf-binding proteins (GGAs) (Hirst et 
al., 2000; Pelham, 2000). These effectors ensure the formation of vesicles at the TGN 
by efficient recruitment of the clathrin coat. The TGN-derived vesicles fuse to 
endosomal membranes (Fig. 7). CORVET (core class C vacuole/endosome tethering) is 
the endosomal tethering complex, and contains the class C Vps11, Vps16, Vps18 and 
Vps33 proteins (class C core) and the class D Vps3 and Vps8 (Peplowska et al., 2007). 
After being delivered to the endosomes, the cargo is directed towards the vacuole, by 
eventual fusion of the late endosome and the vacuole. This fusion requires the tethering 
complex HOPS (homotypic fusion and protein sorting), which is composed of the class 
C core and the class B Vps39 and Vps41 (Fig. 7). Additionally Vam3 (vacuole SNARE) 
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and the Ypt7 GTPase (homologous to the mammalian Rab7) are essential for the fusion 
of the late endosome to the vacuole (Peplowska et al., 2007; Wickner, 2010). 
Two types of proteins are destined to the vacuole via the VPS pathway: vacuolar 
membrane proteins (e.g., the vacuolar ATPase) that remain at the endosomal membrane 
and vacuolar soluble proteins (e.g., vacuolar protease) that are delivered to the 
endosomal lumen. The best example of a soluble protein targeted to the vacuole is the 
CPY, and for this reason the VPS pathway is also named as CPY pathway (Fig. 7). The 
Golgi-modified precursor form of CPY, named p2CPY, binds to Vps10 and the 
complex (p2CPY/Vps10) is sorted towards the late endosome, where it is cleaved to 
generate mature CPY (mCPY) (Bowers & Stevens, 2005). On the other hand, a third 
type of proteins, namely membrane-spanning proteins that have to reach the vacuolar 
lumen (e. g. carboxypeptidase S, Cps1), need to undergo an additional sorting step into 
vesicles budding into the lumen of the late endosome/MVB. Then the MVB content will 
be released into the vacuolar lumen by fusion of the MVB and the vacuole. All 
membrane proteins should be ubiquitinated by the Rsp5 ubiquitin ligase to be 
recognized by the sorting machinery at the MVB (Lauwers et al., 2010). The machinery 
(MVB sorting machinery) that ensures the budding into the endosomal lumen is 
composed of class E Vps proteins, and consecutively assembled into four complexes 
named endosomal sorting complex required for transport (ESCRT) (Fig. 7), each having 
a specific function (table IV) (Bowers & Stevens, 2005; Henne et al., 2011).  
The ESCRT-mediated vesicles or intralumenal vesicles (ILV) formation and 
budding consist of five different stages, involving changes in the membrane and action 
of ESCRT complexes. All stages are summarized in figure 8 (Henne et al., 2011). 
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Table IV. Proteins of the yeast ESCRT complex 
 
Complex Membrane 
binding 
Cargo recognition Intercomplex 
interactions 
ESCRT-0 
-Hse1 
-Vps27 
PI(3)P via 
FYVE domain 
on Vps27 
Via UIM (Ubiquitin-
Interacting Motif) and 
VHS (VPS-27, Hrs 
and STAM) domains 
on Vps27 and Hse1  
Vps27-Vps23 (ESCRT-I) 
ESCRT-I 
-Vps23 
-Vps28 
-Vps37 
-Mvb12 
Weak 
electrostatic 
interactions on 
Vps37 
Via UEV (Ubiquitin 
E2 variant) domain on 
Vps23 and UBD 
(ubiquitin-binding 
domain) on Mvb12 
Vps23-Vps27 (ESCRT-
0) and Vps28-Vps36 
(ESCRT-II) 
ESCRT-II 
-Vps22 
-Vps25 
-Vps36 
PI(3)P via 
GLUE domain 
of Vps36 
Via GLUE (GRAM-
Like Ubiquitin-
binding in EAP45) 
domain of Vps36 
Vps38-Vps28 (ESCRT-I) 
Vps25-Vps20 (ESCRT-
III) 
ESCRT-III 
-Vps2 
-Vps20 
-Vps24 
-Snf7 
Myristoylation 
of Vps20 
Interaction with 
DUBs 
(Deubiquitinating  
Enzymes) 
 to deubiquinate cargo 
Vps20-Vps25 (ESCRT-
II) and MIM domain of 4 
subunits of ESCRT III-
Vps4 
Vps4 
complex 
-Vps4 
-Vps60 
-Vta1 
 
  MIM domain of ESCRT-
III subunits via MIT 
domain 
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Figure 8. Formation of the ESCRT-mediated vesicle. The blue overview shows the events on the 
membrane. (A) The flat membrane (B) undergoes invagination (C) and complete maturation into a 
vesicle that is attached to the membrane by a neck that (D) undergoes constriction and leads (E) to the 
scission of the vesicles. The red and the green overviews are from the perspective of the ESCRT complex 
proteins and the cargo respectively, (A) ESCRT-0 always initiates the pathway by recognition of the 
ubiquitinated cargo, followed (B) by the recruitment of both ESCRT-I and ESCRT-II, leading to the 
clustering of the cargo (cargo enriched zone). (C) ESCRT-III is assembled, and the cargo is 
deubiquinated, (D) followed by the sequestration of the cargo into the vesicle due to the action of the 
ESCRT-III. (E) The ESCRT complex is disassembled by the Vps4-Vta1 complex, where finally the 
cargo is sorted upon vesicle budding (Henne et al., 2011). 
 
 
III.1.3  Traffic from the Golgi to the vacuole via ALP pathway 
Vesicles formed at the TGN can be directly sorted towards the vacuole via the 
ALP pathway (Fig. 7). This pathway was first described in a screen of factors involved 
in transport of alkaline phosphatase (ALP) from Golgi to vacuole. Deletion of adaptor 
protein-3 (AP-3) caused mis-localization of ALP but had no effect on the vacuolar 
transport of membrane-bound carboxypeptidase S (CPS) or soluble carboxypeptidase Y 
(CPY), indicating that AP-3 functions in the cargo-selective protein transport of ALP 
from Golgi to the vacuole (Cowles & Emr, 1997). In contrast, in vacuolar protein 
sorting (vps) mutants (deficient in the fusion of TGN-derived vesicles with the 
endosomes), ALP was correctly delivered to the vacuole, indicating the existence of a 
pathway independent of the endosomes that was named “ALP pathway”. The adaptor 
complex AP-3 (composed of subunits Ap16, Ap15, Apm3 and Aps3) forms the 
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machinery required for the ALP pathway (Odorizzi et al., 1998a), which relies on the  
Ypt7 GTPase (homologous to the mammalian Rab7) and the HOPS tethering complex 
for the fusion of the TGN- derived vesicles with the vacuole (Wickner, 2010). 
III.1.4 Endosome to Golgi retrieval pathway 
Some proteins transported to endosomes are not delivered to the vacuole but 
transported from endosomes to the Golgi (Fig. 7). In yeast, the system responsible for 
this transport is named retromer complex. It was first identified in S. cerevisiae, and was 
found to recycle the CPY receptor Vps10 to the TGN. This complex is formed of five 
proteins that can be divided into two sub-complexes: a trimer of Vps26, Vps29, and 
Vps35, which are responsible for cargo selection, and a dimer of Vps5 and Vps17. 
These last two proteins belong to the family of sorting nexins (Snx), and mediate vesicle 
formation (Seaman et al., 1997, Seaman et al., 1998, Horazdovsky et al., 1997). 
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 PHOSPHOINOSITIDES IN YEAST  IV.
IV.1 Phosphoinositides: Generalities 
The term phosphoinositides refer to all phosphorylated cognates of 
phosphatidylinositol (PI). The inositol ring of PI can be reversibly phosphorylated at 
D3-, D4- or D5- positions. generating PI(3)P, PI(3,5)P2, PI(3,4,5)P3, PI(4)P, PI(4,5)P2 
and PI(5)P. In yeast, only PI(4)P, PI(4,5)P2, PI(3)P, and PI(3,5)P2 have so far been 
encountered (Divecha & Halstead, 2004; Strahl & Thorner, 2007) (Fig. 9). Different 
phosphoinositides have been shown to have a function as membrane signals, therefore 
contributing to specificity in membrane transport. This is supported by the fact that 
phosphatidylinositol (substrate), and phosphoinositides (products), as well as the 
kinases and phosphatases (modifying enzymes) are restrained to specific compartments 
in the cell (Strahl & Thorner, 2007). 
 
Figure 9. Pathways for the synthesis of phosphoinositides in yeast. 
Schematic representation of the implicated phosphoinositide kinases, and their subcellular localization. 
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IV.2 PI(3)P  
Vps34 is the exclusive PI 3-kinase described in yeast (Marat & Haucke, 2016) 
and it was isolated in a screen for mutants defective in sorting from endosome to 
vacuole (reviewed in Marat & Haucke, 2016). Vps34 is present in two complexes in 
yeast, each having different location and function. Complex I contains Vps15, Vps30, 
Atg14 and Atg38, while complex II contains Vps15, Vps30, and Vps38. They are 
involved in autophagy and vacuolar protein sorting respectively (Strahl & Thorner, 
2007; Funderburk et al., 2010; Rostislavleva et al., 2015; Marat & Haucke, 2016) In 
order to exert its activity, Vps34 has to be recruited to cellular membranes from the 
cytosol and activated by the Ser/Thr kinase Vps15 (Fig. 10). Despite the fact that Vps34 
has been localized to both endosome and Golgi (Stack et al., 1993; Stack, 1995; 
Rostislavleva et al., 2015), it is considered that Vps34 alternatively acts at early 
 
 
Figure 10. Distribution of phosphoinositides in yeast. PI(3)P is mainly synthesized in early endosomes 
by the PI 3-kinase Vps34. PI(3,5)P2 is generated from the PI(3)P pool by the action of the PI(3)P 5-kinase 
Fab1 at the late endosome and the vacuole. PI(4)P can be generated from two main pools at the plasma 
membrane and the Golgi and nucleus, involving the phosphatidylinositol-4-kinases Stt4 and Pik1 
respectively. PI(4,5)P2 is synthesized  in the plasma membrane by PI(4)P 5-kinase Mss4 from the 
conversion of its precursor PI(4)P. 
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endosome compartments, and is not directly involved in the sorting from the Golgi 
(Gurunathan et al., 2002). A conserved RING domain called FYVE domain (whose 
name reflects the first four proteins found to contain it: Fab1p, YOTB, Vac1p and Early 
Endosome Antigen 1), is essential for recruitment of PI(3)P-binding proteins to 
membranes in both mammalians and yeast cells. In addition, PI(3)P can also bind to 
proteins displaying the Phox homology domain (PX) (Cullen, 2001). PI(3)P has been 
found to play a general role in endocytic traffic mediated by such FYVE and PX 
domains-containing effector proteins (Birkeland & Stenmark, 2004). Moreover, in 
specialized phagocytic cells PI(3)P is, involved in autophagy, as replacement of the wild 
type allele with a mutant in the lipid kinase domain block the autophagic pathway, and 
vps34Δ mutant yeast cells also show inhibition of autophagy (Kihara et al., 2001; Obara 
et al., 2008; Obara & Ohsumi, 2011).!
IV.3 PI(3,5)P2  
! PI(3,5)P2 is one of the less abundant phosphoinositides in yeast (<0,01% of 
phospholipids), exerting its functions through binding to effector proteins, such as Ent3 
and Ent5, in late endosome or vacuoles (Takatori et al., 2016) (Fig. 10). Fab1 is a 
FYVE domain harboring protein, so it is among the PI(3)P effectors above described. 
Fab1 is the PI(3)P 5-kinase and generates PI(3,5)P2 from the PI(3)P pool (Fig 9). Fab1 
is not necessary for Golgi to vacuole trafficking; however fab1∆ mutant cells show an 
increased vacuole with reduced vacuolar hydrolases due to defects in vacuolar 
acidification (Gary et al., 1998). In addition, Fab1 participates in the formation of the 
multivesicular body (MVB) and/or the fusion of endosomes with the vacuoles 
(Wurmser & Emr, 1998). Also Fab1 plays a role in the transport of cargoes from the 
vacuole to the Golgi, since S. cerevisiae fab1∆ mutants lacking detectable levels 
PI(3,5)P2 show defects on such retrograde trafficking (Bryant et al., 1998). In addition 
to that, Fab1 participates in the sorting of intra-luminal vacuolar proteins, since 
carboxypeptidase S is defectively sorted a in a fab1∆ mutant (Odorizzi et al., 1998). 
 The Fab1 complex in S. cerevisiae consists of 3 main components: Fab1, Fig4, 
and Vac14 (Fig. 11B), which are conserved in mammalian cells (PIKfyve, Sac3 and 
Vac14 respectively). These components assure the synthesis and the turnover of 
PI(3,5)P2. Fig4 is a PI(3,5)P2 5-phosphatase that plays the role of negative regulator of 
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PI(3,5)P2 signaling (Ho et al., 2012). Vac14 acts as a scaffold protein that nucleates the 
assembly of the Fab1 complex (Jin  et al., 2008) and harbors HEAT motifs (helix-loop-
helix) essential for protein-protein interactions (Fig. 11A) (Jin  et al., 2008; Dove et al., 
2009). Vac14 and Fig4 form a stable complex by binding directly to each other and are 
mutually dependent for interactions with Fab1, which recruits this complex to the 
vacuole (Rudge et al., 2004; Botelho et al., 2008). 
 
 
Figure 11. Fab1 complex. (A) Schematic presentation of Vac14. (B) Fig4 is a PI(3,5)P2 5-phosphatase. 
Fig4 and Fab1 bind to distinct regions of Vac14. Vac14 binds to both Fab1 and Fig4 and may undergo a 
conformational change that brings Fab1 into contact with Fig4. Other components of the complex that 
also interact with Vac14 areVac7 and Atg18 (Jin et al., 2008). 
 
IV.4 PI(4)P 
! In yeast there are three PI 4-kinase encoding genes, STT4, LSB6, and PIK1. Lsb6 
is not essential for yeast viability, and its contribution to cellular PI(4)P levels seems to 
be minor, whereas Stt4 and Pik1 are both essential and responsible for the bulk of this 
phosphoinositide (Yoshida et al., 1994a; Han et al., 2002). However, the overexpression 
of Lsb6 partially suppresses the lethal phenotype of an stt4 mutant and localizes at the 
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plasma membrane and vacuolar membrane in yeast (Han et al., 2002). Thus, most 
PI(4)P in yeast can be generated from two spatially distinct pools. The first one is at the 
PM level, and involves the phosphatidylinositol-4-kinase Stt4. And the second one 
involves Pik1, that generates PI(4)P at the Golgi and the nucleus (Garcia-Bustos et al., 
1994; Cutler, 1997; Strahl et al., 2005). Due to the different localization of both kinases, 
the two pools of PI(4)P remain functionally separated. The reservoir of PI(4)P at the 
Golgi has an important role in the secretory route (formation of secretory vesicles), as 
evidenced by the fact that a pik1 mutant shows defects in Golgi-plasma membrane 
traffic (Hama et al, 1999). PI(4)P is an essential regulator of Golgi function, such as that 
of the TGN sorting hub, and it is involved in exocytosis by regulation of the sequential 
activation of Rab family GTPases. Sec2 (RAB GEF) binds simultaneously to PI(4)P at 
the Golgi and to the Rab GTPase Ypt32. Then Sec2 also activates the Rab GTPase 
Sec4, which recruits the exocyst effector Sec15 (Odorizzi et al.,2000; Santiago-Tirado 
& Bretscher, 2011; Mayinger, 2012). However, high PI(4)P levels may inhibit docking 
or fusion of secretory vesicles to the plasma membrane (Ling et al., 2014). Also, in 
thermosensitive pik1-101 mutant cells, the uptake of the endocytic marker FM4-64 is 
blocked at endosomes. In addition, Golgi-localized Pik1 is required for autophagy 
(Wang et al., 2012). Moreover, in a pik1 mutant the anterograde transport form ER to 
Golgi was blocked indicating the necessity of PI(4)P in the fusion of COPII vesicles 
with the Golgi (Lorente-Rodríguez & Barlowe, 2011). In sum, PI(4)P pools at the Golgi 
are a key to multiple processes: in the SEC and END pathways, as well as in autophagy. 
 Stt4 is recruited to the PM through interaction with both Erf3 and Ypp1adaptors 
(Wu et al., 2014). Stt4 has been implicated in actin cytoskeleton organization and 
vacuolar morphology. This protein is required for normal trafficking of the essential 
aminophospholipid phosphatidylserine from the endoplasmic reticulum (ER) to the 
Golgi/vacuole, but its activity is dispensable for protein trafficking between these 
compartments (Audhya et al., 2000). In addition, PI(4)P at the plasma membrane has an 
important role in cell signaling and maintenance of cell wall integrity in yeast. The first 
evidence of its participation in signaling was based on the fact that the phenotype of 
sensitivity to staurosporine of a stt4 mutant (Staurosporine and Temperature Sensitive) 
was rescued by overexpression of Pkc1 (Protein serine/threonine kinase of the yeast cell 
wall integrity MAPK pathway) (Satoshi et al., 1994a). Moreover, PM-localized Stt4 has 
INTRODUCTION 
68 
 
been shown to be necessary for activation of the Pkc1-mediated Slt2 MAPK cascade 
(Audhya & Emr., 2002). It is also required for autophagy, as shown by the defect in 
trafficking to the vacuole of the ubiquitin-like protein Atg8 displayed by a stt4-4 ts 
mutant (Wang et al., 2012). Furthermore, PI(4)P at the plasma membrane acts as 
precursor for the production of the essential pools of PI(4,5)P2 by Mss4 (Roy & Levine, 
2004).!
IV.5 PI(4,5)P2 a key to plasma membrane dynamic  
 Although PI(4,5)P2 counts for only 1% of membrane phospholipids, it is the 
most abundant phosphoinositide in the yeast cell. In S. cerevisiae PI(4,5)P2 is 
synthesized in the plasma membrane by the PI(4)P 5-kinase Mss4 (Multicopy 
Suppressor of Stt4) through the conversion of its precursor, the PI(4)P generated in the 
plasma membrane by Stt4 (Desrivieres et al., 1998). The MSS4 gene is essential for 
yeast and was isolated as a suppressor of a thermosensitive stt4 mutant (Yoshida et al., 
1994b). Mss4 is implicated in the organization of the actin cytoskeleton during 
polarized growth (Desrivieres et al., 1998). PI(4,5)P2 functions mainly at the plasma 
membrane level, by recruiting a diversity of proteins bearing specific PI(4,5)P2-binding 
domains, involved in endocytosis, cell polarity or signal transduction (Sun et al., 2005; 
He et al., 2007; Fernández-Acero et al., 2015). In fact, it has been described that this 
phosphoinositide forms part of microdomains at the PM, specialized lipid rafts which 
act as signaling platforms by concentrating substrates and enzymes in the same 
environment (McLaughlin & Murray, 2005; Johnson & Rodgers, 2008). It has also been 
described the presence of PI(4,5)P2 in the nucleus, where it seems to regulate RNA 
processing (Barlow et al., 2010; Keune et al., 2011), as well as in vacuolar membranes, 
where it cooperates with PI(3)P in coordinating ESCRT assembly for dynamic events 
(Mima & Wickner, 2009). Finally, this phosphoinositide has also been related to the 
regulation of transmembrane proteins, playing a role as cofactor of some ion channels 
and transporters (Suh & Hille, 2008). 
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IV.6 Regulation of phosphoinositides in yeast 
In yeast, phosphoinositide levels are down-regulated by seven poly-
phosphoinositide phosphatases that remove different phosphates (Fig. 12), which are 
grouped into three classes according to their catalytic domains (Strahl & Thorner, 2007, 
Hughes, 2000): proteins of the first class display a catalytic domain similar to the one in 
the Sac1 phosphatase (Sac1, Fig4, Inp51/Sjl1, Inp52/Sjl2 and Inp53/Sjl3); the second 
class encompasses proteins with a catalytic domain with similarity to PI 5-phosphatases 
that dephosphorylate phosphorylated substrates in the 5' position of the inositol ring 
(Inp51/Sjl1, Inp52/Sjl2, Inp53/Sjl3, and Inp54), which in addition to having a domain of 
this type also contain a Sac1 domain; the third group is represented by the Ymr1 
phosphatase, which has similarity to mammalian myotubularin. As we can see in figure 
12, many of these proteins display a redundant activity in yeast, although it seems that 
Sac1 acts preferably on PI(4)P (Foti et al., 2001), Fig4 on PI(3,5)P2 and the PI 5-
phosphatases Inp51/Sjl1 and Inp54 on PI(4,5)P2 (Strahl & Thorner, 2007). Regarding 
the functional involvement of these proteins, none of them is essential but their lack has 
been linked to defects in organization of the actin cytoskeleton, secretion, endocytosis, 
vacuolar function and cell wall maintenance (Strahl & Thorner, 2007). 
 
 
Figure 12. Substrate specificity of phosphoinositide phosphatases in yeast. 
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I. MICROORGANISMS  
I.1 Saccharomyces cerevisiae strains 
The yeast strains used all along this study are detailed in table V 
Table V. S. cerevisiae strains  
Strain Genotype Source 
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 EUROSCARF 
YPH499 MATa ade2-10 trp1-63 leu2-1 ura3-52 his3-
Δ20 lys2-801 
(Sirkoski & Hieter, 1989) 
YES95 YPH499 ; pik1-63::TRP1 Roelants & Thorner 
(University of California at 
Berleley, CA, USA 
YFR201 YPH499 ; stt4Δ::HIS3 [CEN LEU2 stt4-4ts] Roelants & Thorner 
(University of California at 
Berleley, CA, USA 
SD18-1d MATa his3Δ leu2 rme1 ura3 trp1 
mss4::HIS3MX6 [YCplac111-MSS4] 
Desrivieres & Hall 
(Biozentrum University of 
Basel, Switzerland) 
SD19-3a 
1d 
MATa his3Δ leu2 rme1 ura3 trp1 
mss4::HIS3MX6 [YCplac111-mss4-2ts] 
Desrivieres & Hall 
(Biozentrum University of 
Basel, Switzerland) 
VHY87 MATα leu2-3, 112 ura3-52 his4 can1R 
TRP1::DsRed-HDEL 
M. Cyert, (Stanford 
University, CA, USA) 
SEY6210 MATα leu2-3,112 ura3-52 his3-Δ200 trp1-
Δ901 suc2-Δ9 lys2-801 
Botelho et al (2008) 
RBY64 SEY6210; VAC14-HA::TRP1 Botelho et al (2008) 
Y00575 BY4741; ypt7::kanMX4 EUROSCARF 
Y05072 BY4741; vps10::kanMX4 EUROSCARF 
Y02783 BY4741; vps16::kanMX4 EUROSCARF 
Y04329 BY4741; vps3::kanMX4 EUROSCARF 
Y00405 BY4741; vps8::kanMX4 EUROSCARF 
Y04462 BY4741; vps45::kanMX4 EUROSCARF 
Y05381 BY4741; vps27::kanMX4 EUROSCARF 
Y03416 BY4741; vps23::kanMX4 EUROSCARF 
Y02826 BY4741; vps22::kanMX4 EUROSCARF 
Y06211 BY4741; vps20::kanMX4 EUROSCARF 
Y06211 BY4741; vps10::kanMX4 EUROSCARF 
Y05072 BY4741; vps2::kanMX4 EUROSCARF 
Y01370 BY4741; vps26::kanMX4 EUROSCARF 
Y05295 BY4741; vac14::kanMX4 EUROSCARF 
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Table V. Continued 
Strain Genotype Source 
Y07080 BY4741; fab1::kanMX4 EUROSCARF 
Y01120 BY4741; fig4::kanMX4 EUROSCARF 
Y05700 BY4741; atg18::kanMX4 EUROSCARF 
Y06152 BY4741; bem2::kanMX4 EUROSCARF 
Y01146 BY4741; cla4::kanMX4 EUROSCARF 
Y01370 BY4741; pep8::kanMX4 EUROSCARF 
Y00975 BY4741; vps29::kanMX4 EUROSCARF 
Y02132 BY4741; vps30::kanMX4 EUROSCARF 
Y01271 BY4741; vps35::kanMX4 EUROSCARF 
Y05269 BY4741; vps38::kanMX4 EUROSCARF 
Y01933 BY4741; ypt35::kanMX4 EUROSCARF 
Y04735 BY4741; vma21::kanMX4 EUROSCARF 
Y06992 BY4741; voa1::kanMX4 EUROSCARF 
Y00887 BY4741; dyn3::kanMX4 EUROSCARF 
Y03883 BY4741; vma1::kanMX4 EUROSCARF 
Y01323 BY4741; lsb6::kanMX4 EUROSCARF 
I.2  Bacterial Strains  
Escherichia coli DH5α (F– Φ80lacZΔM15 Δ (lacZYA-argF) U169 recA1 
endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1) was used routinely for 
plasmid amplification. 
II. CULTURE MEDIA 
 The composition of the culture media used in this work is detailed in table VI. 
The water used for dissolution was deionized through Millipore purification systems. 
The media were autoclaved at 121°C and 1 atmosphere ovepressure for 20 minutes. To 
obtain solid media, 2% w/v agar were added to the usual composition. 
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Table VI. Culture media used for E. coli, and S. cerevisiae 
Media Composition Utility Source 
LB (Luria-Bertani) 1% bactrotryptone, 
0.5% yeast extract, 
and 0.5% NaCl 
Rich medium that is 
commonly used in 
bacterial culture. 
Often ampicillin 
(100µg/ml) or 
kanamycin (50 
µg/ml) are added to 
the sterilized 
medium to select 
for cells that contain 
a specific genetic 
element such as a 
plasmid resistant to 
one of these 
antibiotics 
(Sambrook et al., 
1989) 
YPD (Yeast extract 
Peptone Dextrose) 
1% yeast extract, 
2% peptone, and 
2% glucose 
Complete medium 
used for yeast 
growth 
(Sherman et al., 
1986) 
YPDA(Yeast 
extract Peptone 
Dextrose Adenine) 
1% yeast extract, 
2% peptone, 2% 
glucose, and 0.01% 
adenine 
Rich medium 
supplemented with 
adenine to facilitate 
strains with ade2 
genotype 
(Sherman et al., 
1986) 
Synthetic medium 
SD: Synthetic 
Dextrose 
2% glucose, 0.1% 
nitrogen base for 
yeast, 0.5% 
ammonium sulfate, 
and 0.19% of amino 
acids mix 
(Formedium) 
Syntethic medium 
for yeast growth 
supplemented with 
correspondent 
amino acids 
necessary for the 
selection and 
maintenance of 
transformants 
harboring different 
auxotrophic 
markers. 
(Sherman et al., 
1986) 
Synthetic medium 
SR: Synthetic 
Raffinose 
1,5% glucose, 0,1% 
nitrogen base for 
yeast, 0.5% 
ammonium sulfate, 
and 0.19% of amino 
acids mix 
(Formedium) 
Same composition 
as SD medium, 
except for  glucose 
that is replaced by 
raffinose to prevent 
the repression of  
the GAL1 promoter 
(Sherman et al., 
1986) 
!
! !
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III. MANIPULATION OF MICROORGANISMS 
III.1 General conditions of growth 
The conditions of culture incubation were as following: 
- E. coli: 37 ̊C, and 200-220 rpm for incubations in liquid medium 
- S. cerevisiae: 30 ̊C for normal growth conditions with agitation between 180 and 
220 rpm. In the majority of experiments, samples were inoculated in liquid YPD 
or SD (when the strain used was transformed with a plasmid) and grown O/N 
until the culture reached the stationary phase of growth. Strains transformed with 
plasmids under the control of GAL1 promoter were inoculated in SR medium 
O/N. The following day cells were inoculated at OD600 of 0.2 in SR liquid 
medium containing galactose 2% (w/v) and were incubated for 4-5 hours. The 
presence of galactose in culture medium induces the expression of genes under 
the control of GAL1 promoter. 
III.2 Strains conservation 
Yeast strains were conserved at -80 ̊C in 50% (v/v) glycerol solution. The E.coli 
strains harboring plasmids were conserved as well at -80 ̊C in 25% (v/v) glycerol after 
their growth in LB liquid medium with the appropriate antibiotic. 
III.3  Serial dilution drop growth assays 
Starting from cultures in stationary phase where the density of cells was adjusted 
to an OD600 of 0.5, and serial decimal dilutions were realized in 96-well plates. Finally, 
with the help of the replicator (VP407AH Multi-blot replicator from V&P Scientific, 
Inc.) 5 µL of each dilution were seeded onto the appropriate solid medium. As the 
OD600 of 1 is approximately equal to 107 cells/mL, in the first drop 2.5x104 cells were 
seeded, and 25 cells in the fourth and last drop. Plates were incubated for 48-72 hours at 
30 ̊C and/or 37 ̊C. 
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IV. MOLECULAR BIOLOGY TOOLS AND DNA MANIPULATION 
For basic molecular biology techniques, like polymerase chain reaction (PCR), 
plasmid extraction from E. coli through alkaline lysis, restriction enzymes digestions, 
DNA 5´ end dephosphorylation, etc., standard protocols were used (Sambrook et al., 
1989). 
IV.1 Plasmid extraction from E.coli 
Plasmids from E.coli were extracted using the alkaline lysis protocol and 
occasionally by using the commercial kit NZYMiniprep (NZYTECH). For the alkaline 
lysis protocol, E.coli was grown in LB medium with 100 µg/ml ampicillin at 37 °C 
overnight (O/N) with shaking. The following day 1.5 mL of the culture were transferred 
to an Eppendorf tube, and span down at high speed for 1 min at room temperature. The 
supernatant was discarded and 100 µl of resuspension solution (Buffer I: 50mM 
Glucose, 10mM EDTA, and 25mM Tris-HCl pH 8) were added to the tube, and mixed 
by vigorous vortexing until the pellet was completely re-suspended. Then 200 µl of 
freshly prepared lysis buffer (buffer II: 0.2 N NaOH, 1% SDS) were added, and mixed 
gently by inverting the tube 6-8 times until the solution turned transparent and became 
more viscous. Finally the neutralizing buffer was added (Buffer III: 29.4% potassium 
acetate and 11.5% of acetic acid glacial) and mixed my inverting the tube 6-8 times. 
The mix was centrifuged at 13,000 rpm for 5 min and the supernatant was precipitated 
by 2 volumes 100% ethanol at -20 ̊C for 20 min, followed by 10 min centrifugation and 
washing with 70% ethanol. The pellet was dried by leaving the tube open at 37 ̊C in a 
heat blocker until the ethanol was evaporated and the pellet was re-suspended in 20µL 
of distilled DNAse-free water. When DNA extracted was used for sequencing, the 
NZYMiniprep kit was used following the manufacturer’s instructions. 
IV.2 Transformation of E.coli 
For plasmid transformation, the protocol developed by Hanahan (1983) was 
used as follows: 100 µL of competent cells were incubated for 30 min on ice with 1 µL 
of DNA plasmid or with 10 µL of DNA from the ligation reaction. Subsequently a 
thermic shock was performed for 90 sec at 42 ̊C and cells were again incubated 2 min 
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on ice. Then 4 volumes of LB were added to the mix and cells were incubated for 1 h 
shaking at 37 ̊C. Finally, cells were span down and the pellet was cultured in LB plates 
with 100 µg/ml ampicillin at 37 ̊C for 24 h. 
IV.3  Yeast transformation 
In order to transform yeast, the conventional transformation protocol with 
lithium acetate (Ito et al., 1983) was used as follows: from a pre-inoculum in YPD, 
yeast cells were grown until they reached an OD600 of 1. Ten mL of the culture were 
taken and re-suspended with a mix of 40% of polyethtylene glycol 4000, 0.2M lithium 
acetate and 1µL/mL dithiothreitol (DTT). 0.6 mg of DNA were added and incubated for 
10 min at room temperature. Subsequently cells were incubated for 30 min at 45 ̊C, and 
then inoculated in selective media SD, in function of the auxotrophic marker of the 
plasmid for 3 days at 30 ̊C. 
IV.4  DNA manipulations and cloning  
The DNA oligonucleotides (Sigma) and plasmids used in this work are detailed 
in tables VII and VIII respectively. To construct plasmids pYES2-GFP-SteAWT and 
pYES3-GFP-SteAWT (Table VIII), we used both pEG(KG)-SteAWT and pYES3-GFP. 
First, plasmid pEG(KG)-SteAWT was digested by BamHI and the SteA-encoding DNA 
fragment was ligated into that site of pYES2-GFP or pYES3-GFP plasmids. To 
construct pYES3-GFP-derivatives expressing mutant SteA proteins (GFP-SteAK29A, 
GFP-SteAK33A, GFP-SteAK36A, GFP-SteA3K-3A, and GFP-SteA2k2R-4A, DNA of pGEX-
4T-2 derivatives bearing steA mutant alleles (provided by L. J. Mota, ITBQ, Lisbon) 
was digested with BamHI and XhoI and the appropriate DNA fragments were ligated 
into equivalent sites of pYES3-GFP. The accuracy of the nucleotide sequence of the 
inserts in the constructed plasmids was checked by DNA sequencing at the Centro de 
Genómica UCM. To construct plasmid pEG(KG)-SteAK36A, an overlapping PCR was 
performed using the pEG(KG)-SteAWT as template and 4 oligonucleotides, 2 external to 
amplify the whole gene (SteA-1 and SteA-2) and 2 internal harboring the point mutation 
(K36A-F and K36A-R) (Table VII). Then the PCR product was digested with BamH1 
and cloned into pEG(KG). 
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Enzymes and kits used for plasmid constructions were Expand high fidelity PCR 
system (Roche), restriction enzymes (NZYTEC, and Sigma), T4 DNA Ligase (Life 
Technologies and Roche), DNA clean & concentrator GeneClean® turbo kit (MPbio), 
according to the instructions of the manufacturers.  
IV.5  Oligonucleotides used 
The oligonucleotides (Sigma) used in this study are detailed in the following 
table VII (the sequences recognized by the restriction enzymes are underlined). 
Table VII. Oligonucleotides used in this study and their usage. The sequences recognized by the 
restriction enzymes are underlined. 
Oligonucleotide Sequence Utility 
SteA-1 CGGGATCCATGCCATATACATCAGTTTCT Used to construct 
pEG(KG)-SteA 
SteA-2 CGGGATCCTTAATAATTGTCCAAATAGTT
ATG 
Used to construct 
pEG(KG)-SteA 
SteA2-GFP CGGGATCCATAATTGTCCAAATAGTTATG
G 
Used to construct 
YCpLG-SteA-
GFP 
SteA2-GFP CGGGATCCATAATTGTCCAAATAGTTATG
G 
Used to construct 
pYES3-GFP-
SteA 
K36A-F ATAAATTATCAACAAAAATCATGGCAGG
CATCTTGTATGTGCTTACCGCAG 
Used to construct 
pEG(KG)SteAK36
A 
K36A-R CTGCGGGTAAGCACATACAAGATGCCTG
CCATGATTTTTGTTGATAATTTAT 
Used to construct 
pEG(KG)-
SteAK36A 
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Table VIII. Plasmids used in this work and their characteristics 
Name Characteristics and use Source 
pGEX-
SteA3K-3A 
Derivative of pGEX-4T-2 encoding GST-SteA with lysines 
29, 33 and 36 of SteA substituted by alanines (AmpR) 
(Dominguez 
et al.,2015) 
pGEX-
SteA2K2R
-4A 
Derivative of pGEX-4T-2 encoding GST-SteA with lysines 
154 and 156, and arginines 159 and 161 of SteA substituted 
by alanines (AmpR) 
(Dominguez 
et al.,2015) 
pGEX-
SteAK29A 
Derivative of pGEX-4T-2 encoding GST-SteA with lysine 
29 of SteA substituted by alanine  (AmpR) 
(Dominguez 
et al.,2015) 
pGEX-
SteAK33A 
Derivative of pGEX-4T-2 encoding GST-SteA with lysine 
33 of SteA substituted by alanine  (AmpR) 
(Dominguez 
et al.,2015) 
pGEX-
SteAK36A 
Derivative of pGEX-4T-2 encoding GST-SteA with lysine 
36 of SteA substituted by alanine (AmpR) 
(Dominguez 
et al.,2015) 
pEG(KG) Vector to express GST fusion proteins in yeast (URA3) (Mitchell et 
al., 1993) 
pEG(KG)-
SteA 
Derivative of pEG(KG) encoding GST-SteA (URA3) Isabel 
Rodríguez-
Escudero 
pEG(KG)- 
SteAK36A 
Derivative of pEG(KG) encoding GST-SteA with lysine 36 
of SteA substituted by alanine (URA3) 
This study 
pEG(KG)-
SteA(98-210) 
Derivative of pEG(KG) encoding GST-SteA carboxy 
terminus (URA3) 
Isabel 
Rodríguez-
Escudero 
YCpLG-
GFP 
Yeast galactose-inducible expression vector (LEU2) (Rodríguez-
Escudero et 
al., 2005) 
YCpLG-
SteAWT-
GFP 
Derivative of YCpLG encoding SteAWT fused to the N-
terminus of GFP (LEU2) 
Isabel 
Rodríguez-
Escudero 
YCpLG-
SteA(1-97)-
GFP 
Derivative of YCpLG encoding SteA amino terminus fused 
to the N-terminus of GFP (LEU2) 
Isabel 
Rodríguez-
Escudero 
pYES2 Vector for inducible expression of recombinant proteins in S. 
cerevisiae (URA3) 
Life 
Technologies 
pYES2-
GFP 
Derivative of pYES2 encoding GFP (URA3) (Rodríguez-
Escudero et 
al., 2005) 
pYES2-
GFP-
SteAWT 
Derivative of pYES2-GFP encoding SteAWT fused to the 
C-terminus of GFP (GFP-SteAWT) (URA3) 
This study 
pYES3/CT S. cerevisiae expression vectors derived from the parental 
pYES2 vector (TRP1) 
Life 
Technologies 
pYES3-
GFP 
Derivative of pYES3/CT encoding GFP (Rodríguez-
Escudero et 
al., 2005) 
pYES3-
GFP- 
SteAWT 
Derivative of pYES3-GFP encoding SteAWT-GFP (TRP1) This study 
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Table VIII. Continued 
!
Name Characteristics and use Source 
pYES3-
GFP-
SteAK29A 
Derivative of pYES3-GFP encoding SteA-GFP with lysine 
29 of SteA substituted by alanine (TRP1) 
This study 
pYES3-
GFP- 
SteAK33A 
Derivative of pYES3-GFP encoding SteA-GFP with lysine 
33 of SteA substituted by alanine (TRP1) 
This study 
pYES3-
GFP- 
SteAK36A 
Derivative of pYES3-GFP encoding SteA-GFP with lysine 
36 of SteA substituted by alanine (TRP1) 
This study 
pYES3-
GFP-
SteA3K-3A 
Derivative of pYES3-GFP encoding SteA-GFP with 
lysines 29, 33 and 36 of SteA substituted by alanines fused 
to C-terminal of GFP (TRP1) 
This study 
pYES3-
GFP-
SteA2K2R-4A 
Derivative of  pYES3-GFP encoding SteA-GFP with 
lysines 154 and 156, and arginines 159 and 161 substituted 
by alanines (TRP1) 
This study 
YCpLG-
PI3K 
Derivative of  YCpLG encoding the catalytic subunit 
(p110α) of mammalian class I phosphatidylinositol 3-
kinase 
(Rodríguez-
Escudero et 
al., 2005) 
YCpLG-
PI3K(K802
R) 
Derivative of YCpLG-PI3K bearing a catalytically inactive 
(‘kinase-dead’) allele of mammalian class I PI3K. 
(Rodríguez-
Escudero et 
al., 2005) 
pEG(KG)-
SteA(1-97) 
Derivative of pEG(KG) encoding GST-SteA amino 
terminus (URA3) 
Isabel 
Rodríguez-
Escudero 
pRS426GF
P2xPH(PL
Cδ) 
Plasmid constitutively expressing a fusion of GFP to two 
copies in tandem of the PH-domain of  PLCδ (URA3) 
(Stefan et al., 
2002) 
YEPlac112
-ILV6-
mCherry 
Derivative of YEplac112 expressing the mitonchondrial 
marker ILV6-mCherry (TRP1) 
(Rodríguez-
Escudero et 
al., 2011) 
pGPD426-
Lact-
C2mCherry 
Yeast expression plasmid encoding Lact-C2-mCherry (Fairn et al., 
2011) 
pEG(KG)-
SopBWT 
Derivative of pEG(KG) encoding GST-SopB (URA3) (Rodríguez-
Escudero et 
al., 2005) 
pEG(KG)-
SopBR468A 
Derivative of pEG(KG) encoding GST-SopB with arginine 
468 of SopB substituted by alanine (URA3) 
(Rodríguez-
Escudero et 
al., 2005) 
pMR072 HA-VOA1 (1xHA inserved after Asp25. Plasmid is 
pRS316-based 
(Ryan et al, 
2008) 
pESC-TRP-
mCherry-
SidC 
Derivative of pESC-TRP Julia M. 
Coronas-
Serna 
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V. PROTEIN DETECTION THROUGH WESTERN-BLOTTING 
V.1 Preparation of yeast protein extracts 
The yeast samples for protein immunodetection were collected on ice in cold 
Falcon tubes (10 ml for cells suspensions at OD600=1), centrifuged to eliminate any 
remaining media and re-suspended in 100µl of ice-cold lysis buffer (50 mM TrisHCl 
pH=8, 10% [v/v] glycerol, 1% [v/v] TritonX-100, 0.1% [w/v] SDS, 150 mM NaCl, 50 
mM NaF, 1 mM sodium orthovanadate, 50 mM β-glycerophosphate, 5 mM sodium 
pyrophosphate, 5 mM EDTA pH=8 and protease inhibitors) at 4 ̊C in Eppendorf tubes. 
The protein extracts were obtained through mechanical rupture by glass beads 
(Sartorius) as described (Martin et al., 2000), adapting the rupture pulses in the Fast-
prep (FP120/BIO101 ThermoSavant) to 3 repeats of 30 seconds. The protein 
concentration of the supernatants was measured at 280 nm in a spectrophotometer 
Beckman DU 640 and normalized with loading buffer 2x (Tris-HCl 0.1 M pH=6.8, 20% 
[v/v] glycerol, 4% [w/v] SDS, bromophenol blue and 10% DTT 1M). The extracts were 
finally boiled for 10 min. and centrifuged to eliminate potential cellular debris prior to 
their load into the polyacrylamide gel. 
V.2  Proteins electrophoresis 
 For the separation of the proteins from the extract, polyacrylamide gels 
constituted by a 5% concentrator gel and an 8%, 10% or 15% separator gel under 
denaturing conditions with SDS were used. It was done in cuvettes (Bio-Rad) at a 
constant voltage of 150-180 V. An electrophoresis buffer was used with the following 
composition: 196mM glycine, 0.1% SDS, 50mM Tris-HCl pH 8.3. The molecular 
weight marker used was provided by Invitrogen or Bio-Rad.  
 Once proteins were separated on the polyacrylamide gel, they were transferred 
from the gel to nitrocellulose membranes (Hybond, Amersham) and paper Whatman 
3MM Chr was used as protective and absorbent material. Transfer cuvettes were used 
(Bio-Rad) at a constant voltage of 100 V for 1 h. The transfer buffer used is composed 
of 5.8 g/l Tris, 2.9 g/l glycine and 0.37 g/l SDS, and 20% of the final volume of ethanol 
was added just prior to use. 
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V.3  Immunodetection 
Membranes were probed with the appropriate antibodies and developed 
according to the manufacturer´s conditions using the Quantitative Fluorescent Imaging 
System Odyssey from Li-Cor Biosciences. Membranes were blocked for at least 1 h at 
room temperature (or overnight at 4 ̊C) with 5% skimmed milk. TPBS buffer (PBS plus 
Tween-20) was used for incubations and washes. After blocking, membranes were 
incubated with the primary antibody in 1% skimmed milk for 2h at RT or overnight at 
4 ̊C. Then the membranes were washed several times with TPBS and incubated with the 
secondary antibody, also in 1% skimmed milk (≈1h at RT) in the dark. The primary 
antibodies used were, rabbit polyclonal anti-G6PDH (Sigma) at 1:50.000, rabbit 
polyclonal anti-GST (Santa Cruz Biotechnology) at 1:200, rat monoclonal anti-HA 
clon11 (Covance) at 1:1000, rat monoclonal anti-GFP (JL-8) (Clontech) at 1:2000, and 
rat monoclonal anti-HA high affinity (100 ng/ml) (Roche).  
The secondary antibodies used were: IRDye 800CW goat anti-rabbit (Green), 
IRDye 680CW Goat anti-rabbit (Red) and IRDye 680CW goat anti-rabbit (Red) all at 
1:5000 (Li-Cor Biosciences). 
VI. YEAST LIVE-CELL IMAGING  
Microscopy of live yeast cells for GFP detection was performed in an Eclipse 
TE2000U microscope (Nikon, Melville, NY, USA) fitted with an Orca C4742-95-12ER 
digital camera (Hamamatsu, Japan) and then processed by using HCImage System 
(Hamamatsu, Japan). Yeast cells harboring GFP fusion vectors were cultured overnight 
in selective SR medium and then refreshed in the same medium to adjust OD600 to 0.2 at 
the time of adding galactose to a 2% (w/v) concentration. After 4 h at 30ºC, cells 
suspensions were mounted on slides for live microscopy observation. For ts mutant 
strains, cells were refreshed and incubated in the presence of 2% (w/v) galactose at 24ºC 
for 4 h and then shifted to 37ºC for 2 h. For FM4-64 (Molecular Probes TM, 
ThermoFischer Scientific) staining, the fluorochrome was added to a cell suspension in 
SR medium to a concentration of 24 µM and incubated for 60 min prior to observation. 
In order, to stain the vacuolar lumen, the marker 7$amino$4$chloromethylcoumarin 
(CMAC, C2110 Molecular Probes, Invitrogen) was added to a final 10 µM 
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concentration in 100 µL of culture and incubated for 5 minutes at 25 ̊C Then, the cells 
were washed three times with PBS before microscopic observation. 
VII. CO-PURIFICATION ASSAY (GST Pull-down) 
 Transformants were grown overnight in selective SR medium. The next day, 
cells were sub-cultured in SR medium supplemented with galactose with final 
concentration of 2%, for 6 h, thus inducing protein expression in fusion to different 
epitopes. Protein extracts were obtained as described in section V.1 but varying slightly 
the composition of lysis buffer, which in this case contained less detergent (without 
SDS or Triton X-100) in order to promote co-purification of proteins. After equaling the 
amount of protein, a small sample was taken to be used as raw extract control, which 
was processed by boiling in loading buffer. On the remaining sample 30 µL of the 
matrix Glutathione Sepharose 4B (GE Healthcare Life Sciences) were added, previously 
equilibrated with 50% lysis buffer. In order to foster contact with the matrix, extract 
volume was increased (to 300 µL) with lysis buffer. After one hour incubation at 4 °C 
with stirring rotation, three washings of the matrix were performed with the same cold 
buffer and finally samples were eluted by boiling the sample in 20 µL of loading buffer 
2X SDS-PAGE for 5 mins in order to separate the proteins from the matrix. These 
samples were loaded onto polyacrylamide gels for immunodetection by Western 
blotting, along with the raw extracts previously separated. 
VIII. IN VIVO CO-IMMUNOPRECIPITATION OF MEMBRANE 
PROTEINS USING CROSSLINKER DSP  
 Cells transformed with different combinations of plasmids were grown overnight 
in SR medium. The next day cells were sub-cultured in 100 mL of SR medium 
supplemented with galactose 2% (v/v) until the cultures reached an OD600 of 0.5-0.7. 
Afterwards cells were harvested and re-suspended in 5 mL PBS, and the crosslinker 
DSP (Thermo Scientific) was added at a final concentration of 2.5m M for 15 mins in 
agitation. Then 500 µL of Tris-HCl pH 8 20mM were added for 15 mins in order to stop 
the reaction. Cells were harvested again by centrifugation at 3000 rpm for 3 mins.  
MATERIALS & METHODS 
85 
!
 For protein extraction, treated cells were washed once with MilliQ water, re-
suspended in 500 µl of RIPA buffer [50 mM Tris pH 7.6, 150 mM NaCl, 1% Triton X-
100, 0.1% SDS, 1% deoxycholic acid] and vortexed 3 times along with 0,5 mm 
diameter glass beads (Sartorius). Then the extracts were centrifuged for 5 min at 4 °C at 
maximum speed, 300 µL of the supernatant were transferred to a new tube, and 20 µL 
were separated in a new tube as input. 
 To co-immunoprecipitate the desired proteins, 50 µL of Protein G Dynabeads® 
were incubated first with 1 µg anti- HA High Affinity antibody (Roche) for 4 hours at 
4 ̊C, then the protein extract was added to the beads and incubated O/N at 4 ̊C. 
Afterwards, Dynabeads®-antibody-proteins complex were washed 3 times using 200 
µL RIPA buffer for each wash. Then proteins were eluted by placing the tube on the 
magnet and removing the supernatant, then the beads were re-suspended in 20µL 
elution buffer and heated for 10 min at 70 ºC. Finally, the tube was placed again on the 
magnet and the supernatant was removed and analyzed by Western blotting. 
 
IX. EVALUATION OF CELL DEATH AND OXIDATIVE DAMAGE 
BY FLOW CYTOMETRY 
 For the analysis of cellular lysis, oxygen-free radicals (ROS) and variations of 
the mitochondrial membrane potential (MMP), yeast transformants were grown 
overnight in 10 mL of SR medium at 30 ̊C. Then cells were sub-cultured in 10 mL SR 
medium supplemented with galactose 2% (v/v) for 16 h. Afterwards, 1 mL of the 
culture was taken for each treatment. Rhodamine 123 (5 µg/mL) was added for 2 h. 
dihydroethidium (2.5µg/mL) for 5 min and propidium iodide (0.004%) for 2 min; 
samples were diluted 1:10 in PBS to avoid excessive quantity of cells. Three thousand 
cells were analyzed per second on a FACScan (Becton Dickinson) on the FL2 log scale. 
WinMDI 2.7 software was used to handle the graphics obtained. 
X. Phalloidin staining 
The appropriate yeast strain was grown O/N at 30 ̊C in selective SR medium. 
The second day cells were refreshed in 10 ml of SR medium to an OD600nm of 0.3 and 
incubated for 4 hours at 30 ̊C. Then cells were fixed by adding 1 ml of formaldehyde 
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directly to the culture medium to a final concentration of 2-4% (from a commercial 37% 
liquid stock) and then incubated for 1 h at 4 ̊C. Afterwards, cells were harvested by 
spinning at 3000 rpm for 2 min, washed three times with buffer 1 [1M KH2 PO4, 0.1M 
MgCl2, 0.2M EGTA pH 7.5], and H2O), and then re-suspended in 100 µL of buffer 1. 
Fifty µL of 1% Triton X-100 were added to the mix and incubated at room temperature 
for 2 min. Then cells were washed three times with PBS, re-suspended in 100 µL of 
PBS, and 10 µL of rhodamine-phalloidin were added and incubated in the dark for 1 h. 
Then, cells were washed and re-suspended in 100 µL of PBS. Finally, cells were 
observed under fluorescence microscopy. 
XI. BIOINFORMATIC SUPPORT  
 During the realization of this thesis, the following databases and bioinformatics 
tools were used: 
Pubmed (PMC). Digital repository of scholarly articles that have been published within 
the biomedical and life sciences journal literature developed by the National Center for 
Biotechnology Information. http://www.ncbi.nlm.nih.gov/pubmed 
NCBI Conserved Domain Database (CDD) https://www.ncbi.nlm.nih.gov/cdd/ 
Saccharomyces Genome Database (SGD). Server of Stanford University with access 
to different tools for S. cerevisiae sequence analysis, projects of functional genomics, 
literature review, etc. http://www.yeastgenome.org/  
Basic Local Alignment Search Tool (BLAST). Enables a researcher to compare a 
query sequence with a library of sequences. http://www.ncbi.nlm.nih.gov/blast/Blast.cgi 
ClustalW. Used to detect similarities and differences between two or more sequences. 
http://embnet.vital-it.ch/software/ClustalW.html  
Psi-blast based secondary structure prediction (PSIPRED). Permit to predict protein 
secondary structure. http://bioinf.cs.ucl.ac.uk/psipred/ 
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I. STUDY OF THE EFFECT OF THE EXPRESSION OF SteA IN 
Saccharomyces cerevisiae 
I.1. The SteA protein is unique to the Salmonella genus 
SteA is among a group of 9 Salmonella enterica serovar Typhimurium effector 
proteins that can be translocated by both the SPI-1 and the SPI-2 T3SSs (Geddes et al., 
2005; Cardenal-Muñoz & Ramos-Morales, 2011). It is a short protein of 210 amino 
acids that does not display any known conserved domains according to CDD (NCBI 
Conserved Domain Database).  
We decided to check the similarity of SteA sequence of S. Typhimurium with 
other proteins deposited in databases by using the basic local alignment search tool 
BLAST-P (NCBI). The results showed high conservation of the SteA sequence (more 
than 85% identity) among S. enterica subsp. enterica serovars (Fig. 13). SteA sequence 
is also conserved in S. enterica subsp. arizonae and S. bongori but with only 34.62% 
and 37.5% of identity compared with S. enterica subsp. enterica serovar Typhimurium, 
respectively. This does not only reflect a lower identity, but also the fact that SteA is a 
larger protein in these Salmonellae. However, no significant similarity was found with 
proteins from other Enterobacteriaceae or any other bacterial species. This indicates 
that SteA is rather specific for the genus Salmonella (Fig. 13). 
I.2. Expression of SteA in S. cerevisiae impairs cell growth 
  Our group previously reported the isolation of a fragment of the S. enterica 
subsp. enterica serovar Typhi steA gene in a screen aimed to unveil Salmonella genes 
that inhibited yeast growth when overexpressed (Alemán et al., 2009). Due to the high 
similarity found between SteA in S. Typhi and S. Typhimurium we decided to study 
whether SteA of S. Typhimurium also interfered with yeast growth. We developed a 
GST-SteA fusion to be expressed from the strong galactose-regulatable GAL1 promoter 
in S. cerevisiae. As shown in figure 14, overexpression of GST-SteA in yeast led to 
growth inhibition at both 28 and 37 ºC incubation temperatures. Nevertheless, only 
severe overexpression led to toxicity, because the observation of this phenotype 
required double selection in medium lacking both uracil and leucine, which forces a 
high number of copies of the URA3 leu2-d pEG(KG) expression plasmid (Mitchell et 
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al., 1993). Thus, SteA of S. Typhimurium causes toxicity in yeast when highly 
overproduced. 
 
 
 
Figure 13. Phylogenetic tree of SteA like proteins. 
Dendrogram of the full amino acid sequences of SteA in S. enterica subsp. enterica serovar Typhimurium 
(SALTY) and their orthologues in different species, subspecies and serovars. S. Senftenberg (SALSE), S 
enterica subsp. enterica serovar. Typhi (SALTI), S. enterica subsp. arizonae (SALCE), S. bongori 
(SALBC), S. enterica subsp. enterica serovar Berta (SALBE), S. enterica subsp. enterica serovar Infantis 
(SALIN), S. enterica subsp. enterica serovar Thompson (SALTH), S. enterica subsp. enterica serovar 
Anatum (SALAN), and S. enterica subsp. enterica serovar Newport (SALNE). The box at the right shows 
the percentage of identity between the full amino acid sequence of each SteA orthologue and that of SteA 
from S. enterica subsp. enterica serovar Typhimurium (SALTY). 
 
I.3. The first 97 amino acids of SteA are necessary and sufficient to 
induce toxicity in S. cerevisiae 
Since full length SteA is toxic, we decided to check whether a specific region of 
the protein was responsible for the growth inhibitory effect. In the absence of further 
structural clues, we chose to split the protein in two halves between amino acids 97 and 
98, thus intending not to distort putative secondary structures, as this site seems to map 
between two β-strands downstream a predicted α-helix in the secondary structure, as 
deduced by PSIPRED analysis (Fig. 14). The first 97 amino acids were sufficient to 
induce toxicity at 28 ºC, although with a reduced efficiency as compared to full-length 
SteA. In contrast, the GST-SteA98-210 truncated version did not cause toxicity at any 
temperature, as compared to GST alone (Fig. 15). Therefore the N-terminal region 
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comprising the first 97 amino acids of SteA is necessary and sufficient to impair yeast 
growth when overexpressed. 
 
Figure 14. PSI-PRED secondary structure prediction for the SteA sequence. 
The predicted secondary structure of Salmonella Typhimurium effector protein SteA from PSIPRED 
(http://bioinf.cs.ucl.ac.uk/psipred) is depicted. The blue bars for each amino acid represents the 
confidence of each prediction. The taller the bar, the higher the confidence. 
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I.4. SteA causes mitochondrial condensation in S. cerevisiae 
  A number of pathogenic bacteria effectors target mitochondria to modulate the 
host apoptotic machinery, as the vacuolating cytotoxin A (VacA) of Helicobacter pylori 
that engages the mitochondrial fission machinery to induce host cell death (Jain et al., 
2011). Thus, we wanted to check if the toxicity of SteA might be related to significant 
changes in the mitochondrial morphology when expressed in yeast. 
  As shown in figure 16A, S. cerevisiae cells co-expressing either full length SteA 
or the truncated version SteA1-97 with the fluorescent mitochondrial acetohydroxyacid 
synthase Ilv6-DsCherry as a marker for this organelle (Huh et al., 2003), showed altered 
mitochondrial morphology. Instead of several normal elongated mitochondria per cell, 
SteA and SteA1-97-expressing cells usually showed large condensed mitochondrial 
compartments. In agreement with the higher toxicity displayed by full-length SteA, the 
percentage of cells showing condensed mitochondria was higher in cells expressing 
SteA than in those expressing the N-terminal region (Fig. 16B). In contrast, yeast 
expressing the SteA98-210 version did not show any significant increase in the percentage 
of cells showing abnormal mitochondria (Fig. 16B). Thus, SteA causes mitochondrial 
condensation when overproduced in yeast, and its amino-terminal half is necessary and 
sufficient to induce this effect. 
!
 
 
Figure 15. Effect of overexpression of full length or truncated GST-SteA versions on S. 
cerevisiae growth. Ten-fold serial dilutions of cells (YPH499) expressing either GST, full length 
GST-SteA or truncated halves, GST-SteA1-97 and GST-SteA98-210 from pEG(KG)-based plasmids, 
were spotted and incubated for 72 h in solid SC(-Ura-Leu) agar supplemented with glucose 
(repression conditions) or galactose (induction conditions) at 28 ̊C. 
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Figure 16. Mitochondrial morphology in yeast cells expressing full length SteA or its truncated 
versions. 
Differential Interference Contrast (DIC) microscopy and fluorescence images of the same fields showing 
cell morphology (left panels) and localization of ILV6-RFP (expressed from pILV6) (right panels) of S. 
cerevisiae YPH499 expressing GST, full length or truncated GST-SteA from pEG(KG)-based plasmid 
after 4h incubation in SC-R (-Ura-Leu-Trp) media containing 2% galactose (w/v). All scale bars indicate 
5µm. (B) Quantification of the percentage of cells with condensed mitochondria. Bars in graphs indicate 
the standard deviation from three different clones; at least 100 cells were counted for each clone. 
 
I.5. Expression of SteA in S. cerevisiae does not alter the morphology 
of the endoplasmic reticulum  
Since the mitochondria and the endoplasmic reticulum (ER) connect together at 
multiple contact sites to form specific domains, termed mitochondria-ER associated 
membranes (MAMs) (Marchi et al., 2014), we thought that SteA might also be affecting 
the ER morphology. In order to test this, full length SteA, as well as truncated versions 
of SteA were co-expressed in yeast cells with the fluorescent ER marker HDEL-
DsCherry (that localizes at the perinuclear and peripheral ER). As revealed by 
fluorescence microscopy, SteA did not cause ER morphological alterations when 
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overproduced in yeast (Fig. 17). 
 
 
 
 
Figure 17. Endoplasmic reticulum morphology in yeast cells expressing full length or truncated 
GST-SteA versions. 
Differential Interference Contrast (DIC) microscopy and fluorescence images showing cell morphology 
(left panels) and localization of HDEL-DsRed (right panels). VHY87 cells harboring the HDEL-DsRed 
were transformed with pEG(KG)-based plasmid expressing either GST, full length GST-SteA or 
truncated versions (GST-SteA1-97and GST-SteA98-210) as indicated. Cells were grown in SC-R (-Ura) and 
induced by the addition of galactose to 2% (w/v) followed by incubation for 4h. All scale bars indicate 
5µm. 
 
I.6. Expression on SteA in yeast does not disorganize the actin 
cytoskeleton  
The actin cytoskeleton is a dynamic structure that participates in cellular 
functions including the maintenance of cell morphology and polarity (Anesti & 
Scorrano, 2006). In yeast, interactions between mitochondria and the cytoskeleton are 
essential for normal mitochondrial morphology, motility and distribution (Boldogh & 
Pon, 2006). Therefore, we examined the effect of SteA expression in S. cerevisiae on 
the actin cytoskeleton. 
S. cerevisiae expressing either the GST alone or full-length GST-SteA and 
stained with fluorochrome-conjugated phalloidin showed a normal distribution of actin, 
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with actin cables extending along the mother-daughter cell axis, and cortical patches 
showing a marked polarized distribution in nascent buds (Fig. 18). Therefore, SteA does 
not affect the actin cytoskeleton in yeast cells. 
 
 
Figure 18. Actin cytoskeleton morphology in yeast cells expressing SteA 
Bright field microscopy and fluorescence images showing cell morphology (left panels) and actin staining 
(right panels). YPH499 strain was transformed with pEG(KG)-based plasmid expressing either GST or 
full length GST-SteA, and cells were grown in SC-R (-Ura-Leu-Trp), induced by the addition of galactose 
to 2% (w/v) incubated for 4h, and then stained with rhodamine phalloidin. All scale bars indicate 5µm.  
 
I.7. SteA does not affect the mitochondrial outer membrane potential 
when expressed in yeast 
  In order to determine the molecular mechanism behind the toxicity of SteA in 
yeast, we decided to test whether mitochondrial membrane potential (MMP) which is a 
marker related to programmed cell death (Madeo et al., 2007) was affected upon 
overexpression of SteA in S. cerevisiae. To this end, cells were transformed with 
plasmids expressing GST, GST-SteA, GST-SteA1-97 or GST-SteA98-210 and were 
incubated in the presence of rhodamine 123 as a fluorescent marker for loss of MMP. 
No significant variation in the percentage of rhodamine-positive cells was observed in 
any of the cultures (Fig. 19). Thus, in spite of severely affecting mitochondrial 
morphology, SteA does not affect the MMP when overexpressed in yeast.!!
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I.8. SteA overexpression does not lead to the production of reactive 
oxygen species in yeast 
  Since cell death or growth impairment are associated in many cases with 
intracellular production of reactive oxygen species (ROS) (Perrone et al., 2008), we 
decided to check if the overexpression of this effector caused the formation of ROS. For 
this purpose, yeast cells expressing GST, GST-SteA, GST-SteA1-97 or GST-SteA98-210 
were treated with dihydroethidium (DHE). The superoxide-driven conversion of non-
fluorescent DHE into fluorescent ethidium can be readily monitored by flow cytometry. 
Compared to cells expressing GST alone, which showed a percentage of positive cells 
of 1,61%, none of the transformants expressing any of the SteA versions tested showed 
a significant increase in the percentage of cells above the gating threshold (Fig. 20). 
Therefore SteA does not lead to the production of ROS, and the toxicity caused by its 
overexpression cannot be related to oxidative damage by these reactive species. 
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Figure 19. Study of the mitochondrial membrane potential in yeast cells expressing SteA. 
Flow cytometric analyses on yeast strain YPH499 (A) expressing GST alone, (B) full length GST-SteA or 
(C, D) the indicated truncated versions of GST-SteA, all from pEG(KG)-based plasmids. Cells were 
incubated O/N in SC-R (-Ura -Leu) and then were induced for 16 h in SC-R (-Ura -Leu) supplemented 
with 2% galactose (w/v), and dihydroethidium (DHE) (2.5 µg/ml) was added to the suspension for 5 min 
at 30 ̊C. Then cells were diluted 1:10 in PBS and analyzed. M2 indicates the fluorescence positive interval 
over the gating threshold and the percentage of cells beyond the threshold is shown in red in each graphic 
(right panels). 
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Figure 20. Detection of reactive oxygen species (ROS) in yeast cells expressing SteA. 
Flow cytometric analyses on yeast strain YPH499 (A) expressing GST alone, (B) full length GST-SteA or 
(C, D) the indicated truncated versions of GST-SteA, all from pEG(KG)-based plasmids. Cells were 
incubated O/N in SC-R (-Ura -Leu) and then were induced for 16 h in SC-R (-Ura -Leu) supplemented 
with 2% galactose (w/v), and dihydroethidium (DHE) (2.5 µg/ml) was added to the suspension for 5 min 
at 30 ̊C. Then cells were diluted 1:10 in PBS and analyzed. M2 indicates the fluorescence positive interval 
over the gating threshold and the percentage of cells beyond the threshold is shown in red in each graphic 
(right panels). 
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I.9. SteA does not affect the selective permeability of the plasma 
membrane when expressed in S. cerevisiae 
  Necrotic cell death is characterized by a plasma membrane rupture (Eisenberg et 
al., 2010) that can be detected by staining with propidium iodide (PI), a nucleic acid-
binding red-fluorescent compound not permeant to living cells. During apoptosis, the 
cell membrane can suffer many changes including a gradual increase in permeability 
that may eventually lead to secondary necrosis (Nelson et al., 2011). To further 
investigate SteA toxicity, we decided to check the loss of selective permeability of the 
plasma membrane by treating cells expressing GST, GST-SteAWT, GST-SteA1-97 or 
GST-SteA98-210 with this dye. None of the transformants expressing SteA or its 
truncated versions compared to cells expressing GST alone showed a significant 
increase in the percentage of PI-positive cells (Fig. 21). All together, these results 
indicate that overexpression of SteA in yeast, in spite of causing an altered 
mitochondrial morphology, does not lead to MMP loss or mitochondrial dysfunction-
related oxidative damage, and that growth inhibition is not related to enhanced cell 
death either by apoptosis or necrosis. 
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Figure 21. Analysis of plasma membrane permeability in yeast cells expressing SteA. 
Flow cytometric analyses on yeast strain YPH499 (A) expressing GST alone, (B) full-length GST-
SteA or (C, D) the indicated truncated versions of GST-SteA, all from pEG(KG)-based plasmids. 
Cells were incubated O/N in SC-R (-Ura -Leu) and then were induced for 16 h in SC-R (-Ura -Leu) 
supplemented with 2% galactose (w/v), and propidium iodide (PI) (0.05 mg/ml) was added to the 
suspension for 2 min at 30 ̊C. Then cells were diluted 1:10 in PBS and analyzed. M1 indicates the 
fluorescence positive interval over the gating threshold and the percentage of cells beyond the 
threshold is shown in red in each graphic (right panels).  
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I.10. SteA does not affect the vacuolar morphology in S. cerevisiae 
  To assess the effect of SteA on vacuolar morphology, cells were transformed 
with pEG(KG) plasmids expressing GST and GST-SteA, and the vacuoles were stained 
with the 7-amino-4-chloromethylcoumarin (CMAC) which accumulates in the vacuolar 
lumen. CMAC fluorescence relies on the acid pH of this compartment. Then cells were 
visualized under fluorescence microscopy. All cells showed a normal vacuolar staining, 
suggesting a normal vacuolar morphology (Fig. 22). Therefore, SteA toxicity in S. 
cerevisiae is not related to  apparent changes in vacuolar morphology or maturation. 
  
 
 
Figure 22. CMAC vacuole staining in S. cerevisiae expressing SteA. 
Differential Interference contrast (DIC) and fluorescence images microscopy showing cell morphology 
(DIC; upper panels) and CMAC vacuolar lumen staining (lower panels) in S. cerevisiae YPH499 strain 
transformed with pEG(KG)-based plasmids expressing either GST or GST-SteA, after 4 h of incubation 
in SC-R (-Ura -Leu) medium containing 2% galactose (w/v). Cells were stained adding CMAC at 0.6 
µM, and incubated 5 min at 25 ̊C. All scale bars indicate 5 µm.  
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II. STUDY OF THE LOCALIZATION OF SteA IN S. cerevisiae 
II.1. SteA is associated with the host cell plasma membrane and 
vacuole when expressed in S. cerevisiae 
In order to study SteA localization in vivo, we developed both GFP-SteAWT 
(GFP fused to the N-terminus of SteA) and SteAWT-GFP (GFP fused to the C-terminus 
of SteA) for expression in wild-type S. cerevisiae. Interestingly, both fusions localized 
at yeast plasma membrane (PM) and vacuoles. In vacuoles, GFP-SteA localized at the 
lumen but also concentrated more conspicuously at the vacuolar membrane, especially 
at vacuole-to-vacuole contact areas (Fig. 23A and C); whereas SteA-GFP mainly 
decorated the vacuolar lumen (Fig. 23B). Vacuolar localization was confirmed by co-
staining cells expressing SteA-GFP with FM4-64 [N-(3-triethylammoniumpropyl)-4-(p-
diethylaminophenyl-hexatrienyl) pyridinium dibromide], an endocytic marker that 
marks the vacuole membrane (Fig. 23B). PM localization was confirmed by co-
expression of GFP-SteA with Lact-C2-mCherry (the lactadherin C2 domain binds 
phosphatidylserine at the PM), which showed a co-localization of both proteins (Fig. 
23C). Overall these results reveal the association of SteA to the plasma and vacuolar 
membranes as a feature of this effector when expressed in yeast, which can provide 
important clues for its behavior in the host cell. 
 
II.2. The amino-terminal region of SteA localizes to the ER when 
expressed in S. cerevisiae 
Since the amino-terminal half of SteA is responsible and sufficient for toxicity, 
we decided to check the localization of a SteA1-97-GFP fusion protein. Expressed in 
yeast, SteA1-97-GFP had a different localization in the cell, faintly marking the PM and 
the nuclear periphery, suggesting localization at the ER. This was confirmed by co-
staining nuclei with DAPI (Fig. 24A) and with the ER marker HDEL-DsRed. As shown 
in figure 24B the amino-terminal region of SteA localized to both yeast perinuclear and 
peripheral ER. This result implies that important determinants for the localization of 
SteA to the PM and the vacuole lie in the carboxi-terminal half of the protein.!
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Figure 23. Plasma membrane and vacuolar localization of SteA in S. cerevisiae. 
(A) Differential Interference Contrast (DIC) microscopy and fluorescence images showing cell 
morphology (left panel) and localization of GFP-SteA (right panel) of S. cerevisiae YPH499 transformed 
with pYES3GFP-SteA after 4 h incubation in SC-R (-Leu -Trp) medium containing 2% galactose. (B) 
Fluorescence microscopy images showing SteA-GFP expressed in S. cerevisiae YPH499 after induction 
in media containing galactose for 4 h and treatment for 1 h with the endocytic marker FM4-64 (to 
counterstain the vacuolar membrane; red). (C). Fluorescence microscopy images showing GFP-SteA 
(pYES3GFP-SteA) localization (inverted in single channel to black and white image; green in merged 
image) and Lact-C2-mCherry (inverted in single channel to black and white image; red in merged image) 
of S. cerevisiae YPH499 transformed with pYES3GFP-SteA after 4 h of induction in medium containing 
galactose. 
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Figure 24. ER localization of SteA1-97-GFP in S. cerevisiae. 
(A). Localization of SteA1-97-GFP (YCpLG-SteA1-97-GFP). Cells were grown in SC-R (-Leu) and induced 
by the addition of galactose to 2% (w/v) followed by incubation for 4 h and then counterstained with 
DAPI to allow visualization of the nuclei (DAPI is artificially colored in red to improve contrast) (B). 
VHY87 strain cells harboring the HDEL-DsRED were transformed with the YCpLG plasmid expressing 
SteA1-97-GFP and cells were grown in SC-R (-Leu) and induced by the addition of galactose to 2% (w/v) 
followed by incubation for 4 h. All scale bars indicate 5 µm.  
 
II.3. SteA localization is not actin-dependent  
In order to check whether the localization of SteA was dependent on actin 
function, GFP-SteA was expressed in S. cerevisiae and cells were treated with the actin 
filament disrupting compound latrunculin B. GFP-SteA did not show any change in 
either PM or vacuolar localization in cells exposed to latrunculin B as compared with 
control untreated cells. The fact that the localization of SteA is preserved after 
depolymerization of cellular actin suggests that the actin cytoskeleton is not required for 
recognition of cellular membranes by SteA (Fig. 25). 
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Figure.25 SteA localization in yeast cells treated with latrunculin B. 
Differential Interference Contrast (DIC) microscopy (left panels) and fluorescence images (right panels) 
respectively showing the localization of GFP-SteA in S. cerevisiae YPH499 cells transformed with 
pYES3GFP-SteA. Cells were grown in SC-R (-Leu) and induced by the addition of galactose to 2% (w/v) 
for 4 h and treated for 1 h with latrunculin B (0,5 µg/mL) (right panels) or DMSO (left panels). All scale 
bars indicate 5 µm. 
 
II.4. SteA plasma membrane localization in yeast requires the 
phosphoinositide 4-kinase Stt4 
Phosphoinositides are key markers for specific cellular membranes in eukaryotic 
cells. PI(3)P tags endocytic and vacuolar compartments, the PM is typically marked by 
PI(4,5)P2, and PI(4)P is characteristic of Golgi membranes and acts as a precursor of 
PI(4,5)P2 at the PM (Dickson et al., 2014). In S. cerevisiae, most PI(4)P is generated by 
two phosphatidylinositol 4-kinases (PI4Ks) with distinct subcellular localizations (De 
Matteis et al., 2013) that produce distinct pools of this phosphoinositide on different 
intracellular membranes. Pik1 localizes at the Golgi and accounts for 45% of the 
cellular PI(4)P, and Stt4 localizes at the PM and supports the production of 40% of 
PI(4)P. A third kinase, Lsb6, accounts for the remaining PI(4)P cellular content 
(Audhya et al., 2000) (Fig. 26A). Yeast constitutes an attractive experimental model to 
study the possible involvement of spatially regulated phosphoinositide pools such as 
those of PI(4)P in the subcellular localization of SteA in eukaryotic cells because, 
although PIK1 and STT4 genes are essential, we can use temperature-sensitive (ts) 
conditional mutants in which most of the cellular PI(4)P would be either at the PM 
(pik1-ts mutant) or at the Golgi (stt4-ts mutant) at the restrictive temperature. In 
addition, we used as well a lsb6∆ mutant, since LSB6, contrary to STT4 and PIK1, is not 
an essential gene. 
 To this end, we expressed GFP-SteA in S. cerevisiae stt4-ts mutant and lsb6∆ 
mutant backgrounds and SteA-GFP in a pik1-ts mutant background. We used SteA-GFP 
GFP-SteA GFP-SteA
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and GFP-SteA in the different yeast mutants to account for the markers available for 
transformation in the respective strains. Fluorescence microscopy of GFP-SteA (Fig. 
26B), SteA-GFP (Fig. 26C) and GFP-SteA (Fig. 26D) in these mutant backgrounds 
revealed that inactivation of Stt4 consistently led to disappearance of the PM pool of 
GFP-SteA, whereas the vacuolar localization was not affected. Only 9.6% of stt4-ts 
mutant cells at the restrictive temperature showed GFP-SteA located at the PM (Fig. 
26E). In contrast, neither inactivation of Pik1-Ts at 37 ºC nor the absence of Lsb6 
affected the subcellular localization of SteA-GFP and GFP-SteA respectively, as 
compared to wild type cells (Fig. 26C and D). Therefore, the localization of SteA at the 
yeast PM is dependent on the activity of the PM-localized Stt4 but not of the Golgi-
localized Pik1 nor minor Lsb6, suggesting that PI(4)P might be critical for targeting 
SteA to the PM. 
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Figure 26. Effect of PI(4)P depletion on SteA localization 
(A) Scheme of the activity of S. cerevisiae PI 4-kinases Pik1, Stt4 and Lsb6, and the subcellular 
membranes in which they function. Differential contrast microscopy (DIC; left panels) and fluorescence 
images (right panels) of (B) S. cerevisiae YPH499 (WT) or YFR201 (isogenic stt4-ts) strains, grown at 
24ºC after GFP-SteA induction from plasmid pYES3GFPSteA in SR (-Trp) containing 2% galactose for 4 
h and then shifted to 37°C for 1 h; (C) S. cerevisiae YPH499 (WT) or YES95 (pik1-ts) strains expressing 
SteA-GFP from plasmid YCpLG-SteAGFP cultured as in B; (D) S. cerevisiae BY4741 (WT) or Y01323 
(lsb6Δ::KanX4) expressing GFP-SteA from plasmid pYES2GFP-SteA, after 4 hours of incubation in SR 
(-Ura) media containing 2% galactose. Scale bars indicate 5 µm. (E) Percentage of cells showing plasma 
membrane GFP fluorescence processed as in B, C and D. Bars indicate the standard deviation from three 
different clones; at least 100 cells were counted for each clone. 
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II.5. PI(4, 5)P2 is not crucial for SteA plasma membrane localization 
PI(4)P at the yeast PM is the precursor of PI(4,5)P2, a typical marker of the PM 
(Strahl & Thorner, 2007), synthesized in situ by the PI(4)P 5-kinase Mss4 (Fig. 27A). 
Therefore, we hypothesized that maybe the lack of PI(4,5)P2 at the PM as a 
consequence of PI(4)P depletion, rather than the lack of PI(4)P on itself, was the cause 
for the absence of association of GFP-SteA with the PM in the stt4-ts mutant. To test 
this hypothesis, we expressed GFP-SteA in a S. cerevisiae mss4-ts mutant. We 
confirmed that when this mutant expressed the PI(4,5)P2-specific reporter PH(PLCδ)-
GFP (Stefan et al., 2002), the PM signal observed at permissive temperature (28ºC) was 
lost at the restrictive temperature (37°C) (Fig. 27C). In contrast, GFP-SteA still 
localized at the PM when expressed in mss4-ts mutant cells at the restrictive 
temperature (Fig. 27B), indicating that the lack of PI(4,5)P2 at the PM does not alter the 
localization of GFP-SteA.  
We used an alternative approach to eliminate the PI(4,5)P2 by expressing the 
mammalian class I phosphatidylinositol 3-kinase (PI3K) catalytic subunit p110α fused 
to a C-terminal prenylation signal, which fully depletes the PM pool of this 
phosphoinositide by turning it into PI(3,4,5)P3 (Rodríguez-Escudero et al., 2005). A 
catalytically inactive version (p110-KD) was used as a control. As shown in figure 27C, 
class I PI3K activity did not impair the localization of GFP-SteA at the PM. Overall, 
these results are consistent with PI(4)P, and not PI(4,5)P2, being critical for targeting of 
SteA to the yeast PM. 
 
II.6. SteA localization is independent of endosomal-vacuolar 
compartment membrane phosphoinositides PI(3)P and PI(3, 5)P2 
  PI(3)P and PI(3,5)P2 are characteristic of yeast endosomes and the vacuole (Fig. 
28A). We also wanted to test whether these phosphoinositides were essential for the 
subcellular localization of SteA. Deletions in the non-essential genes VPS34, coding for 
class III phosphatidylinositol 3-kinase, and FAB1 coding for the yeast PI(3)P 5-kinase, 
did not lead to changes in the PM and vacuole localization of SteA (Fig. 28B). 
Therefore, SteA localization is not dependent on PI(3)P and PI(3,5)P2. 
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Figure 27. Localization of SteA in yeast cells deficient in PI(4,5)P2 
(A) Schematic representation of the activity of relevant yeast S. cerevisiae phosphatidyl 4-kinases Stt4, 
the phosphatidylinositol-4-phosphate 5-kinase Mss4, and the human phosphatidylinositol-4,5-
bisphosphate 3-kinase PI3K (p110α). (B) Differential Interference Contrast (DIC) and fluorescence 
images showing cell morphology (left panels) and localization of SteA-GFP (right panels) in S. cerevisiae 
YPH499 or SD19-3a (mss4- ts) strains, analyzed at the restrictive temperature after induction of GFP-
SteA expression from plasmid pYES3GFP in SC-R (-Trp) supplemented with 2% galactose (w/v). (C) 
The SD19-3a (mss4-ts) strain was transformed with pRS426GFP-2xPH(PLCδ) (expressing PH-PLC fused 
to GFP; Stefan et al., 2002), incubated in SC-R (-Ura -Trp) with 2% galactose (w/v) for 4 h at 28°C and 
then shifted to 37°C for 1 h. (D) The S. cerevisiae YPH499 strain was co-transformed with pYES3-GFP-
SteA and plasmids expressing the catalytic subunit of mammalian class I phosphatidylinositol 3-kinase 
fused to a C-terminal CAAX prenylation signal (WT p110α) or a kinase dead K802R point mutant 
(p110α-KD). Protein expression in the co-transformants was induced for 6 h in SC-R (-Ura -Trp) 
supplemented with 2% galactose (w/v). All scale bars indicate 5 µm. 
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II.7. SteA co-localizes with the PI(4)P-binding domain of the 
Legionella pneumophila effector SidC 
  The above results suggest that PI(4)P is a major determinant for SteA binding to 
eukaryotic membranes. The Legionella pneumophila effector SidC binds to PI(4)P in 
mammalian cells (Ragaz et al., 2008). This binding activity was mapped to a fragment 
that does not have any sequence homology with any known PI-binding domain. This 
fragment, named P4C [PI(4)P-binding of SidC], was suggested to function as PI(4)P-
binding probe (Weber et al., 2006). 
  In order to confirm by other strategy that SteA binds PI(4)P at the PM, we 
decided to co-express the PI(4)P probe P4C with SteA in yeast. SidC (P4C) was cloned 
into a yeast expression vector fused to the mCherry tag. WT S. cerevisiae was 
 
 
Figure 28. Effect of depletion of both PI(3)P and PI(3,5)P2 on SteA localization in yeast cells. 
(A) Schematic representation of yeast phosphoinositide 3-kinase Vps34, and 1-phosphatidylinositol-3-
phosphate 5-kinase Fab1. (B) Differential Interference Contrast (DIC) and fluorescence images showing cell 
morphology (left panel) and localization of GFP-SteA (right panel) in S. cerevisiae YPH499 strain (left 
panel) or in YPH499 isogenic strains carrying a deletion in genes VPS34 and FAB1 expressing GFP-SteA 
from pYES3GFP plasmid, incubated in SC-R (-Trp) containing 2% galactose (w/v) for 4 hours. All scale 
bars indicate 5µm. 
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transformed with P4C-mCherry and either GFP- or GFP-SteA-expressing plasmids. 
P4C localized faintly to the PM and predominantly in intracytoplasmic spots consistent 
with the Golgi, indicating that yeast reproduces the localization described in mammalian 
cells (Fig. 29A). It co-localized with SteA at the PM (Fig. 29B) but not in 
intracytoplasmic membranes. Control cells expressing GFP and P4C-mCherry showed 
20% of cells displaying P4C localized at the PM, while cells co-expressing GFP-SteA 
and P4C-mCherry showed a higher percentage (40%) (Fig. 29C), indicating that SteA-
expressing cells have more P4C at the PM. These results, in addition to supporting that 
SteA binds to PM PI(4)P, hint that SteA expression might lead to enhanced PI(4)P 
levels at the yeast PM. 
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II.8. Tethering SteA to the plasma membrane when expressed in 
Saccharomyces cerevisiae requires basic residues near its N- terminus 
  The results above indicate that SteA might bind to the PM by recognition of 
PI(4)P. To understand how SteA binds to this phosphoinositide we examined the 
primary structure of SteA to search for known lipid binding motifs, such as phox 
homology (PX), pleckstrin homology (PH), or phosphotyrosine binding (PTB) domains 
(Kutateladze, 2010). We could not find any of these motifs, but we found two clusters 
of positively charged residues, one in its N-terminal half (Lys29, Lys33 and Lys36) and 
the other in its C-terminal half (Lys154, Lys156, Arg159 and Arg161) that might be 
responsible for electrostatic interactions with the negatively charged phosphoinositides.  
 
Figure 29. Co-localization of GFP-SteA with the PI(4)P probe SidC(P4C) in yeast cells. 
(A) Differential Interference Contrast (DIC) and fluorescence images showing cell morphology (left 
panel) and localization of P4C-mCherry (right panel) in S. cerevisiae YPH499 expressing both GFP 
from pYES2GFP plasmid and P4C-mCherry from pESC-TRP-mCherry (B) Fluorescence microscopy 
images showing GFP-SteA
 
from plasmid pYES2GFP and P4C-mCherry from plasmid pESC-TRP-
mCherry co-expressed in S. cerevisiae YPH499 after induction in SC-R (-Ura-Trp) supplemented with 
2% galactose (w/v) for 4 h at 30°C. The scale bar indicates 5µm. (C) Quantification of the percentage 
of cells showing SidC(P4C)-mCherry in control cells vs. cells expressing GFP-SteA. Bars in graphs 
indicate the standard deviation from three different clones; at least 100 cells were counted for each 
clone. 
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 To test the involvement of these amino acids in the attachment of SteA to 
PI(4)P, we generated individual and combined mutations in these residues, and tested 
the localization of the different SteA versions in vivo in yeast cells by transforming S. 
cerevisiae with plasmids expressing GFP-SteA, GFP-SteA3K-3A (all three Lys26, Lys33 
and Lys36 changed to Ala), GFP-SteA2K2R-4A (all four Lys154, Lys156, Arg159 and 
Arg161 changed to Ala), GFP-SteAK29A, GFP-SteAK33A or GFP-SteAK36A (Fig. 30A). 
Protein expression was checked by immunoblotting, which showed that WT and mutant 
GFP-SteA proteins accumulated at similar levels (Fig. 31). As shown in figure 30A, 
changing all basic residues in the C-terminal cluster of SteA to alanines (GFP-SteA2K2R-
4A) did not affect localization of the protein, as this mutant version displayed a 
percentage of cells with PM-localized SteA similar to that of cells expressing WT SteA 
(Fig. 30B). In contrast, substitution of the three N-terminal basic residues led to 
complete loss of both PM and vacuolar localization (Fig. 30A and B), displaying instead 
a dotted pattern. All individual mutants GFP-SteAK29A, GFP-SteAK33A or GFP-SteAK36A 
failed to localize to the PM (Fig. 30A and B). However, while GFP-SteAK29A, GFP-
SteAK33A kept intact their vacuolar localization, GFP-SteAK36A behaved like the triple 
mutant, showing a puncta-like pattern that appeared neither associated to the PM or to 
the vacuole (Fig. 30A). Therefore, Lys36 is essential for both PM and vacuolar 
localization of SteA in S. cerevisiae, while the two other neighboring lysine residues are 
only required for efficient interaction with the plasma membrane. 
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Figure 30. Effect of the mutation of basic residues on SteA localization in yeast cells. 
(A) Differential Interference Contrast (DIC) and fluorescence images showing cell morphology (left 
panels) and localization (right panels) of GFP-SteAWT, GFP-SteA2K2R-4A, GFP-SteA3K-3A, GFP-SteAK29A, 
GFP-SteAK33A and GFP-SteAK36A expressed in S. cerevisiae YPH499 from pYES3GFP-based plasmids 
after 4 h incubation in SC-R (-Trp) media containing 2% galactose. All scale bars indicate 5µm. (B) 
Quantification of the percentage of cells showing PM-localized SteA. Bars in graphs indicate the standard 
deviation from three different clones; at least 100 cells were counted for each clone. 
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II.9. The basic residue K36 of SteA is necessary to induce toxicity and 
mitochondrial condensation in S. cerevisiae 
   To check whether the basic residue K36 is essential or not for growth inhibitory 
effect in S. cerevisiae, yeast cells were transformed with plasmids expressing GST, 
GST-SteA or GST-SteAK36A. As shown in figure 32, GST-SteAK36A did not induce 
toxicity in yeast compared to GST and GST-SteA. Thus the residue K36 is necessary to 
induce toxicity of SteA when expressed in S. cerevisiae. 
 To test whether K36 was also required for the mitochondrial condensation caused 
by SteA, yeast cells were transformed with the plasmid expressing GST-SteAK36A along 
with the mitochondrial marker Ilv6-DsCherry. As shown in the figure 33, no significant 
changes in mitochondrial morphology were observed in cells expressing the mutant 
version of SteA. These results support the idea that the toxicity of SteA in yeast is 
related with the condensation of mitochondria and confirm that the basic residue K36 is 
necessary both for proper SteA subcellular localization and for induction of this 
phenotype. 
 
 
Figure 31. Expression of different SteA versions in yeast cells analysed by immunoblotting. 
(A) Yeast YPH499 cells were transformed with pYES3GFP and pYES3GFP-SteA plasmids encoding 
wild type SteA or the mutant versions indicated. Yeast lysates obtained after 4 h of expression induction 
in SC-R (-Trp) media containing 2% galactose and analyzed by immunoblotting with anti-GFP and anti-
glucose-6-phosphate dehydrogenase (G6PDH) antibodies (both used at 1:1000), and appropriate 
secondary antibodies. The arrows indicate the full length GFP-SteA bands.  
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II.10. Expression of SteA from the GFP fusion vectors does not induce 
toxicity and mitochondrial condensation in S. cerevisiae  
Since GST-SteA induces toxicity when overexpressed in yeast, requiring double 
selection in order to force a higher number of copies of pEG(KG) plasmid (see I.2), we 
decided to check if GFP-SteA and SteA-GFP versions are toxic. Yeast cells expressing 
either GFP-SteA from episomic plasmids, pYES2GFP or pYES3GFP (URA3, and TRP1 
respectively), or SteA-GFP from centromeric YCpLG plasmid (LEU2) did not show a 
significant growth inhibition (Fig. 34). Thus, these results confirm the above 
 
 
Figure 32. Effect of mutation on the lysine 36 of the GST-SteA on growth inhibition of S. cerevisiae. 
Ten-fold serial dilutions of cells (YPH499 strain) expressing either GST, GST-SteA or GST-SteAK36A all 
from pEG(KG)-based plasmid, were spotted and incubated for 72 h in solid SC(-Ura-Leu) agar 
supplemented with glucose (repression conditions) or galactose (induction conditions) at 30°C.  
 
Figure 33. Mitochondrial morphology in yeast cells expressing GST-SteAK36A 
(A) Differential Interference Contrast (DIC) and fluorescence images showing cell morphology (left 
panel) and localization of the mitochondrial marker Ilv6-RFP (right panels) in S. cerevisiae YPH499 
expressing GST or GST-SteA
K36A
 from pEG(KG)-based plasmids after 4 h incubation in SC-R (-Ura-
Leu-Trp) media containing 2% galactose (w/v). All scale bars indicate 5µm. (B) Quantification of the 
percentage of cells with condensed mitochondria. Bars in graphs indicate the standard deviation from 
three different clones; at least 100 cells were counted for each clone. 
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observation that a strong expression, such as that obtained with the pEG(KG) plasmid, 
is necessary to induce toxicity in yeast.!
  
 
 
Figure 34. Effect of expression of full length GFP-SteA and SteA-GFP on S. cerevisiae growth. 
Ten-fold serial dilutions of yeast cells expressing (A) GFP and GFP-SteA (pYES3GFP-based plasmid), 
(B) GFP, and GFP-SteA (pYES2GFP-based plasmid), (C) GFP and SteA-GFP (YCpLG-GFP-based 
plasmid) expressed in S. cerevisiae YPH499, spotted and incubated for 72 h in solid (A) SC (-Trp), (B) 
SC(-Ura), (C) SC(-Leu) agar supplemented with glucose (repression conditions) or galactose (induction 
conditions) at 30°C.  
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III. STUDY OF SteA VACUOLAR LOCALIZATION in S. 
cerevisiae 
III.1. Rab GTPase Ypt7 is not required for SteA localization in yeast 
Ypt7 is the yeast homolog of the mammalian small GTPase Rab7, and is 
involved in the regulation of endocytic traffic from late endosome/MVB to the vacuole, 
being required for homotypic vacuole fusion (Schimmöller & Riezman., 1993).! ypt7 
null mutants have been shown to display small fragmented vacuoles (Kashiwazaki, et 
al., 2009). Ypt7 interacts as well with the cargo selection/retromer complex for 
retrograde sorting from endosomes to Golgi (Liu et al., 2012). Some bacterial effectors 
manipulate the activity of Rab GTPases thus favoring the survival of the intracellular 
pathogen (Ham et al., 2011). Therefore, we wanted to check whether SteA requires 
Ypt7 in order to be localized to the yeast vacuole. Wild type yeast and ypt7∆ strains 
were transformed with plasmid expressing GFP-SteA. As shown in figure 35B SteA 
localized at the PM and also at the abnormal vacuoles displayed by ypt7∆ mutant cells. 
Therefore, the Ypt7 Rab is dispensable for SteA targeting to the vacuole. 
! !
 
Figure 35. Localization of SteA in a ypt7 mutant, defective at sorting at the MVB level. 
(A) Schematic representation of protein Ypt7 implicated in sorting at MVB and homotypic vacuole 
fusion. (B) Differential Interference Contrast (DIC) and fluorescence images showing cell morphology 
(left panel) and localization of GFP-SteA (right panel) expressed in S. cerevisiae BY4741 (WT) and 
Y00575 (BY4741; ypt7::kanMX4) from plasmid pYES2GFP-SteA, after 4 h incubation in SC-R (-Ura) 
media containing 2% galactose (w/v).   
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III.2. Mutation in Class A Vps genes do not affect SteA vacuolar 
localization, whereas in Class C vps mutants SteA is retained in pre-
vacuolar endosomes 
  To know whether recruitment of SteA to the vacuole requires specific trafficking 
pathways we studied localization of GFP-SteA in a set of vacuolar protein sorting 
mutants (vps) affected in different stages of vesicle transport towards the vacuole 
(Bowers & Stevens, 2005). 
  In wild type cells, the precursor p2 form of the carboxypeptidase Y (CPY) is 
transported to the vacuole where it is processed to mature mCPY form (Fig. 36A). 
However, vps mutants mis-sort a portion of p2CPY to the secretory pathway (Bower & 
Stevens, 2005). Pep1/Vps10 is the CPY receptor that controls the trafficking of CPY out 
of the late Golgi to the late endosome or MVB, also known as pre-vacuolar 
compartment (Fig. 36A) (Marcusson et al., 1994). The vps10 mutant belongs to the 
class A vps mutants that display a wild type vacuolar morphology. In order to check if 
the function of Vps10 was essential to target SteA towards the vacuole, we transformed 
the wild type and an isogenic strain harboring a deletion in the VPS10 gene with a 
plasmid expressing GFP-SteA. As shown in figure 36C, PM and vacuolar GFP-SteA 
signals were not significantly affected by the mutation of the typical class A pep1/vps10 
mutant. 
  Class C Vps act at two distinct protein trafficking steps: fusion of late Golgi 
vesicles with late endosomes/MVB, and fusion of the latter to the vacuole (Bowers & 
Stevens, 2005). Therefore, class C mutants accumulate fusion-incompetent endosomes 
and vesicles in the cytoplasm of the cell and lack identifiable vacuoles. SteA localized at 
the PM and accumulated in putative abnormal endosomes in class C vps16 mutant (Fig. 
36D).  
  Thus these results suggest that Class A Vps proteins are not required for SteA 
targeting to the vacuole whereas the lack of Class C Vps proteins does not affect SteA 
trafficking through the endocytic pathway but impedes SteA vacuolar localization due 
to the absence of distinguishable vacuoles. 
! !
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III.3.  SteA requires class D Vps proteins to localize at the vacuole  
  We next checked mutants affected in class D Vps function. These proteins are 
required for fusion of vesicles with the late endosome/MVB and their absence leads to 
the presence of a single large vacuole that fails to extend into daughter cells (Bowers & 
  
Figure 36. Localization of SteA in Golgi-to-vacuole traffic mutants 
(A) Schematic presentation of vacuole protein sorting (Vps) proteins implicated in different stages of the 
endosomal trafficking; p2CPY binds to Vps10 and the complex is sorted towards late endosome, where it 
is cleaved to generate mature CPY (mCPY). (B) Differential Interference Contrast (DIC) and 
fluorescence images showing cell morphology (left panel) and localization of GFP-SteA (right panel) 
expressed in S. cerevisiae BY4741 (WT) from plasmid pYES2GFP-SteA, after 4 h incubation in SC-R (-
Ura) media containing 2% galactose (w/v). (C) S. cerevisiae Y05072 (BY4741; vps10::kanMX4) 
expressing GFP-SteA processed and analyzed as in B. (D) S. cerevisiae Y02783 (BY4741; 
vps16::kanMX4) expressing GFP-SteA processed and analyzed as in B. All scale bars indicate 5 µm.  
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Stevens, 2005). To analyze the effect of the lack of some of those class D Vps proteins, 
wild type yeast and isogenic strains harboring vps3∆, vps8∆ or vps45∆ mutations were 
transformed with plasmid expressing GFP-SteA. The vps3 and vps8 mutant cells did not 
lose SteA PM localization. In contrast to the WT cells, they did not show SteA in the 
vacuole but it seemed to accumulate in large puncta adjacent to the vacuole. In vps45 
mutant cells SteA accumulated in small dots throughout the cytoplasm adjacent or not to 
the vacuole, as well as, peculiary, losing PM localization (Fig. 37C). These results 
suggest that Class D proteins are required for targeting GFP-SteA to the vacuole. 
   In order to identify the nature of the dots where SteA accumulated in class D 
mutants, we stained both vps8∆ and vps45∆ mutants transformed with GFP-SteA with 
the endosomal FM4-64 fluorescent marker. As shown in figure 39, the GFP-SteA signal 
in these compartments did not co-localize with FM4-64, csuggesting that they are not 
late endosomes. 
 
III.4. Protein sorting at the multivesicular body involving Class E Vps 
proteins is essential for the traffic of SteA to the vacuole 
  In order to investigate further the involvement of other elements of the endocytic 
traffic in targeting SteA to the yeast vacuole, we decided to work with class E vps 
mutants (Fig. 38A). Class E Vps proteins are involved in the sorting of proteins at the 
MVB for delivery to the vacuole (Bowers & Stevens, 2005). The class E vps mutants 
displayed a large and aberrant endosome/MVB (the class E compartment) adjacent to 
the vacuole that contains vacuolar hydrolases and vacuolar membrane proteins, and are 
defective in protein recycling to the late Golgi. 
  Wild type and some class E vps mutant strains from the EUROSCARF deletion 
collection were transformed with GFP-SteA. In contrast to WT cells, in vps27∆, 
vps23∆, vps22∆ and vps20∆ corresponding to ESCRT 0, ESCRT I, ESCRT II, and 
ESCRT III complexes, respectively, GFP-SteA localized faintly at the vacuolar 
membrane and accumulated in a compartment adjacent to the vacuole, but not in the 
vacuolar lumen (Fig. 38B). These data suggest that in class E mutants, SteA was not 
able to be sorted into luminal MVB vesicles, and was retained in the class E 
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compartment. Thus, SteA is targeted to the yeast vacuolar lumen by ESCRT-mediated 
sorting at the MVB. 
  In order to confirm that the GFP-SteA-marked compartments that appear in class 
E mutants are late endosomes/MVB, we took two class E mutant vps (vps20∆, and 
vps23∆) transformed with GFP-SteA and stained endosomal membranes with the FM4-
64 fluorescent marker. As shown in figure 39, unlike in class D mutants GFP-SteA 
cytoplasmic spots co-localized with FM4-64 in class E mutants, confirming that the 
compartment adjacent to the vacuole where SteA accumulates in these mutants is indeed 
the class E compartment. 
 
!  
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Figure 37. Alteration of SteA vacuolar localization in Class D vps mutants 
(A) Schematic presentation of the indicated Vps proteins in different stages of endosomal trafficking. (B) 
DIC and fluorescence microscopy images showing cell morphology (left panels) and localization of GFP-
SteA (right panels) in S. cerevisiae BY4741 (WT) expressing GFP-SteA from pYES2GFP-SteA, after 4 h 
incubation in SC-R (-Ura) media containing 2% galactose (w/v).(C) S. cerevisiae Y04329 (BY4741; 
vps3::kanMX4), Y00405 (BY4741; vps8::kanMX4) and Y04462 (BY4741; vps45::kanMX4) expressing 
GFP-SteA from pYES2GFP-SteA were processed and analyzed as in B. All scale bars indicate 5 µm. 
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Figure 38. Alteration of SteA vacuolar localization in Class E vps mutants 
(A) Schematic presentation of the indicated Vps proteins implicated in different stages of endosomal 
trafficking. (B) DIC and fluorescence microscopy images showing cell morphology (left panels) and 
localization of GFP-SteA (right panels) in S. cerevisiae BY4741 (WT) transformed with pYES2GFP-
SteA, after 4 hs incubation in SC-R (-Ura) media containing 2% galactose (w/v). (C) Transformants of 
the BY4741 strain derivatives deleted in indicated Class E VPS genes were processed and analyzed as in 
B. All scale bars indicate 5 µm. 
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III.5. Endosome to Golgi retrograde transport is not required for SteA 
targeting to the yeast vacuole 
Since we had checked the effect of the mutation of different classes of vps 
mutants, we decided to check the GFP-SteA localization also in class F mutants, like 
vps26∆, which possess one large vacuole often surrounded by fragmented vacuolar 
structures (Bowers & Stevens, 2005). Vps6 is one the proteins of the retromer complex 
and, therefore, mutant cells lacking this protein are defective in the endosome to Golgi 
retrograde protein transport. We did not notice any difference in the vacuolar 
localization of SteA in the vps26∆ mutant (Fig. 40C). Thus, a functional retromer is not 
required for proper SteA localization to the yeast vacuole.  
 
 
 
 
Figure 39. Co-localization analysis of GFP-SteA with the endocytic marker FM4-64 in class D 
and E vps mutants. Fluorescence microscopy images showing GFP-SteA in S. cerevisiae BY4741 
derivative strains Y00405, Y04462, Y06211 and Y03416 (vps8::kanMX4, vps45::kanMX4, 
vps20::kanMX4 and vps23::kanMX4, respectively) expressing GFP-SteA from pYES2GFP-SteA 
plasmid after induction in SC-R(-Ura) supplemented with 2% galactose (w/v) for 4 hours and treated 
with the endocytic marker FM4-64 for 1 h. All scale bars indicate 5 µm. 
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Figure 40. Localization of SteA in Golgi-to-vacuole Class F vps mutants 
(A) Schematic representation of Vps26 implication in endosomal to Golgi retrograde trafficking. (B) DIC 
and fluorescence microscopy images showing cell morphology (left panels) and localization of GFP-SteA 
(right panels) in S. cerevisiae BY4741 (WT) expressing GFP-SteA from pYES2GFP-SteA, after 4 h 
incubation in SC-R (-Ura) media containing 2% galactose (w/v). (C). S. cerevisiae derivative from 
BY4741, Y01370 (vps26::kanMX4) expressing GFP-SteA from plasmid pYES2GFP-SteA was processed 
and analyzed as in B. All scale bars indicate 5 µm. 
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IV. Search for interactors of SteA in S. cerevisiae 
IV.1.  Components of the Fab1 complex interact genetically with SteA 
 The S. cerevisiae Fab1 phosphoinositide phosphate kinase is a conserved large 
protein, homologous to mammalian PIKfyve, associated with membrane PI(3)P and 
involved in PI(3,5)P2 biosynthesis (Shisheva, 2008; Rusten et al., 2006). A mutant 
lacking Fab1 function is affected in later stages of the endocytic pathway, displaying 
defects in retrograde trafficking from the vacuole to the Golgi and trafficking of some 
proteins into the vacuole via MVB (Dove et al., 2002). Fab1 binds to Vac14 and the 
phosphoinositide 5-phosphatase Fig4 and forms a vacuole-associated signaling complex 
(Botelho et al., 2008). Interestingly, in a work with our collaborator John Brumell based 
on proteomic experiments using mammalian cell extracts (HEK293T expressing SteA), 
we found a possible interaction of SteA with Vac14, the scaffold protein of the PIKfyve 
complex. So we wanted to test the effect of the absence of the components of the Fab1 
complex on the effect of SteA in S. cerevisiae cell growth. Wild type BY4741 and 
isogenic vac14∆, fab1∆, and fig4∆ mutant strains were transformed with plasmids 
expressing either GST or GST-SteA, and spot growth assays on agar were performed. 
As shown in figure 41B, SteA overexpression caused a stronger growth inhibition in 
cells harboring either vac14∆ or fab1∆, but not fig4∆, than in the wild type strain. Thus, 
these results denote a phenotypic enhancement of the toxic effect of SteA as a 
consequence of the lack of Vac14 and Fab1. 
 
IV.2. SteA does not interact physically with Vac14 
 Genetic interactions not always reflect a direct physical interaction of the 
proteins encoded. However, in the knowledge that SteA may physically bind to the 
Vac14-Fab1 complex in higher cells (Brumell Lab, unpublished results), we wanted to 
check whether SteA physically interacted with Vac14 in yeast. We performed a co-
purification experiment in a glutathione matrix with cellular extracts expressing GST or 
GST-SteA and HA-tagged Vac14 and then pulled down the proteins using antibody anti-
GST. Then Western blots were developed using anti-GST and anti-HA antibodies. As 
observed in figure 42, we did not see any specific physical interaction between SteA and 
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Vac14 by this approach, since GST-SteA pulled down Vac14-HA to the same extent as 
GST alone did. 
 
!  
 
 
Figure 41. Effect of deletion of the Fab1 complex subunits on GST-SteA-induced growth inhibition 
of S. cerevisiae. (A) Schematic representation of the Fab1 complex. (B) Ten-fold serial dilutions of 
BY4741 (WT) and the indicated isogenic mutants cells, expressing either GST or full length GST-SteA 
from pEG(KG) or pEG(KG)-SteA respectively, were spotted and incubated for 72 h in solid SC(-Ura-Leu) 
agar supplemented with glucose (repression conditions) or galactose (induction conditions) at 30°C. 
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IV.3. SteA targeting to the vacuole does not requires Fab1 complex 
components  
 After studying the effect of the mutation of the components of the Fab1 
complex, we decided to check whether the Fab1 complex affects SteA trafficking 
towards the vacuole. To this end, wild type S. cerevisiae and isogenic strains harboring 
mutations in components of the Fab1 complex (vac14∆, fab1∆, and fig4∆) were 
transformed with a plasmid expressing GFP-SteA. None of the mutants showed any 
changes in GFP-SteA signal at the vacuole (Fig. 43). Therefore trafficking of SteA 
towards the vacuole does not require the Fab1 complex. 
 
Figure 42. Co-purification assay of SteA and Vac14. 
Western blotting analysis of proteins extracts (lysates) and proteins retained (pulldown) in a co-
purification experiment using a glutathione matrix (Glutathione Sepharose). Yeast strain RBY64 
(VAC14-HA::TRP1) was transformed with plasmid pEG(KG) or pEG(KG)-SteA expressing GST or GST-
SteA respectively. Cells were grown in SC-R (-Ura-Trp) supplemented with galactose 2% (w/v) for 4 
hours. The antibodies used were anti-HA (right panel) in order to detect Vac14-HA, and anti-GST (left 
panel) to analyze the presence of GST and GST-SteA. 
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IV.4. Search for possible SteA interactors among known negative 
genetic interactors of vac14 and fab1 mutants 
  In order to detect cellular functions that may account for SteA genetic interaction 
with vac14 and fab1, we looked into the list of negative genetic interactors with these 
mutants available at SGD and selected those common to both of them. We came up with 
eleven possible candidates genes that, when deleted, had been reported to negatively 
affect growth of vac14 and fab1 mutants (Table IX). First, we checked the growth 
inhibitory effect of SteA overexpression in cells harboring mutations in each of these 
eleven genes. As shown in figure 44, four (marked in red) of the selected mutants 
(lacking Cla4, Vps3, Vps35 or Vps1), showed a phenotypic enhancement of SteA-
induced toxicity, indicating a negative genetic interaction with SteA overexpression. 
Interestingly, 3 out of these 4 mutants are involved in vacuolar protein sorting in yeast 
(vps1Δ, vps3Δ, and vps35Δ). 
  We checked the localization of GFP-SteA in these mutants. As already shown in 
Fig. 37, class D mutant vps3Δ displayed an altered GFP-SteA localization. However, 
neither in class A vps35Δ nor in class F vps1Δ mutant cells, the vacuolar localization of  
 
 
Figure 43. Localization of GFP-SteA in Fab1 complex mutant yeast cells. 
DIC and fluorescence microscopy images showing cell morphology (left panels) and localization of GFP-
SteA (right panels) in S. cerevisiae BY4741 (WT) or the indicated isogenic mutant strains [Y05295 
(vac14::kanMX4), Y07080 (fab1::kanMX4) and Y01120 (fig4::kanMX4)], expressing GFP-SteA from 
plasmid pYES2GFP-SteA, after 4 h of incubation in SC-R (-Ura) media containing 2% galactose (w/v). 
All scale bars indicate 5 µm. 
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SteA was affected (Fig. 45). No changes in SteA localization were observed in mutant 
cells lacking the protein kinase Cla4 (Fig. 45). 
 
Table IX. List of the 11 genes described to display a negative genetic interaction with both fab1 and 
vac14, and their cellular function in S. cerevisiae according to the yeast genome database (SGD). 
 
Gene/ORF Description 
ATG18 / YFR021W -Phosphoinositide binding protein 
-Vesicle formation in autophagy and the cytoplasm-to-
vacuole targeting (Cvt) pathway 
CLA4 / YNL298W -Cdc42p-activated signal transducing kinase 
-Involved in septin ring assembly, vacuole inheritance, 
cytokinesis, sterol uptake regulation 
PEP8 / YJL053W -Endosome-to-Golgi retrograde protein transport 
BEM2 / YER155C -Rho GTPase activating protein 
-Control of cytoskeleton organization, cellular 
morphogenesis, ad bud emergence 
VPS3 / YDR495C -Component of CORVET complex 
-Required for the sorting and processing of soluble 
vacuolar proteins 
-Assembly of the V-ATPase 
-Acidification of the vacuolar lumen 
VPS29 / YHR012W -Endosomal protein 
-Endosome-to-Golgi retrograde protein transport 
VPS30 / YPL120W -Subunit of phosphatidylinositol (PtdIns) 3-kinase 
complexes I (autophagy) and II (vacuolar protein 
sorting) 
VPS35 / YJL154C -Endosomal subunit of membrane-associated retromer 
complex 
VPS1 / YKR001C -Dynamin-like GTPase 
-Actin cytoskeleton organization 
-Late Golgi retention of some proteins 
YPT35 / YHR105W -Unknown function 
-Contains a phox (PX) homology domain 
-Binds to PI(3)P, and proteins involved in ER-Golgi 
transport 
VPS38 / YLR360W -Functions in carboxypeptidase Y (CPY) sorting 
-Binds Vps34 and Vps30 to promote production of 
PI(3)P 
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Figure 45. Localization of GFP-SteA in mutant strains showing phenotypic enhancement of SteA-
induced toxicity. DIC microscopy showing cell morphology (left panels) and fluorescence microscopy 
showing localization of GFP-SteA (right panels) in S. cerevisiae BY4741 (WT) and its derivatives deleted 
in the indicated genes, expressing GFP-SteA from plasmid pYES2GFP-SteA, after 4 h incubation in SC-
R (-Ura) media containing 2% galactose (w/v). All scale bars indicate 5µm. 
 
 
Figure 44. Effect of the absence of common vac14 and fab1 negative genetic interactors on SteA-
induced growth inhibition in S. cerevisiae. 
Ten-fold serial dilutions of wild type BY4741 (WT) and the indicated isogenic mutant strains 
transformed with plasmid pEG(KG) or pEG(KG)SteA expressing GST or GST-SteA respectively. 
Cells were spotted and incubated for 72 h in solid SC (-Ura-Leu) agar supplemented with glucose 
(repression conditions) or galactose (induction conditions) at 30 ̊C. 
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IV.5. Voa1 is a phenotypic suppressor of SteA-induced growth 
impairment in yeast 
 Based on the results above described (IV.1 and IV.4) and following a similar 
rationale, we wanted to check the effect of overexpressing SteA and its localization in 
mutants reported to show common negative genetic interaction with mutants lacking 
Vps35, Cla4, Vps1 or Vps3. We found in the SGD database that mutants deleted in 
VOA1, VMA21, VMA1, and in the gene encoding the dynein light intermediate chain 
Dyn3 are among those interactors. These were interesting putative SteA targets because 
the vacuolar ATPase complex might be a binding-target for SteA that could explain its 
vacuolar localization, and because a dynein defect might account for the abnormal 
mitochondrial morphology observed. In S. cerevisiae the vacuolar ATPase (V-ATPase) 
complex is divided into two main sectors, the V0 and V1. V0 is responsible of 
translocating protons, resulting in acidification of the organelle, and the V1 catalyzes 
ATP hydrolysis. Voa1 and Vma21 are involved in the assembly of V0 in the ER, and 
Vma1 is one of the subunits of the V1 domain (Ryan et al., 2008).  
 We first tested the effect of deleting these genes on SteA-induced growth 
inhibition by performing serial dilution spot assays in wild type S. cerevisiae and the 
corresponding isogenic mutant strains transformed with plasmids expressing either GST 
or GST-SteA. As shown in figure 46, none of the mutants led to significant phenotypic 
enhancement of SteA overexpression but instead cells harboring voa1∆ showed 
phenotypic suppression. Thus, SteA might be targeting Voa1 in S. cerevisiae. 
IV.6. SteA does not interact with Voa1 in S. cerevisiae 
   Since Voa1 showed a phenotypic suppression of SteA-induced growth effect, we 
wanted to check whether SteA interact physically with Voa1. To do this, we performed 
a co-immunoprecipitation experiment using antibodies anti-HA to immunoprecipitate 
HA-Voa1 in cells co-expressing GFP-SteA. As shown in figure 47, we did not find a 
specific interaction of HA-Voa1 with GFP-SteA over non-specific binding of HA-Voa1 
to the GFP alone control. 
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Figure 47. Co-purification assay of SteA and Voa1. 
Western blotting analysis of protein lysates and proteins retained (co-IP) by co-immunoprecipitation 
assay. Yeast YPH499 cells expressing both GFP (pYES3-GFP) and HA-Voa1 (pMR072-HA-Voa1), or 
GFP-SteA (pYES3-GFP-SteA) and HA-Voa1 were grown in SC-R (-Ura-Trp) and galactose 2% (w/v) for 
4 h and immunoblotted. The antibodies used were anti-HA (right panel) in order to detect HA-Voa1 , and 
anti-GFP (left panel) to analyze the presence of GFP and GFP-SteA. 
 
 
Figure 46. Effect of deletion of genes encoding proteins of the vacuolar ATPase complex and the 
dynein light intermediate chain on SteA-induced growth inhibition of S. cerevisiae.  
Ten-fold serial dilutions of wild type BY4741 (WT) and the indicated isogenic mutant strains expressing 
either GST or GST-SteA from plasmid pEG(KG) or pEG(KG)SteA, respectively, were spotted and 
incubated for 72 h in solid SC(-Ura-Leu) agar supplemented with glucose (repression conditions) or 
galactose (activation conditions) at 30 ̊C. 
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IV.7.  SteA vacuolar localization is not altered in vma1∆, vma21∆, 
voa1∆ and dyn3∆ S. cerevisiae mutants 
   We also checked if the vacuolar localization of SteA was affected in these 
mutants but, as shown in figure 48, none of the cells showed significant changes in SteA 
vacuolar localization compared to wild type cells. So Vma1, Vma21, Voa1, and Dyn3 
are not involved in targeting SteA to the vacuole in yeast. 
 
 
Figure 48. SteA vacuolar localization is not altered in deletion mutants related to vacuolar ATPase 
or dynein. 
Differential Interference Contrast (DIC) and fluorescence images showing cell morphology (left panel) 
and localization of GFP-SteA (right panel) in S. cerevisiae BY4741 (WT) or the indicated isogenic 
mutant strains transformed with the plasmid expressing GFP-SteA after 4 h incubation in SC-R (-Ura) 
media containing 2% galactose (w/v). All scale bars indicate 5µm.  
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I. SteA: A Salmonella T3SS effector protein that triggers 
mitochondrial condensation in S. cerevisiae 
! Salmonella is an intracellular facultative pathogen found in the gastrointestinal 
tract of avian, mammalian and reptilian hosts (Malik-Kale et al., 2011) that, like other 
pathogenic enterobacteria, has developed a complex system of effector proteins that are 
injected into the cytoplasm of the host cell by specialized secretion systems. Once inside 
the cell, these effector proteins are able to manipulate diverse biochemical mechanisms 
and cellular structures with two main objectives: to allow the entrance of the bacterium 
across the plasma membrane of the host intestinal epithelium cells and to assure its 
intracellular survival inside the SCV, avoiding the activation of the immune defense 
mechanisms (Garmendia et al., 2003; Kuhle & Hensel, 2004). In order to do this, 
Salmonella relies on T3SSs (encoded by SPI-1 and SPI-2) secreting two sets of bacterial 
effectors. Each effector protein is secreted at the opportune moment and acquires the 
most appropriate intracellular localization. In this way, all these effectors act in a 
concerted way, exerting a great variety of effects on different cellular biochemical 
pathways (Figueira & Holden, 2012; LaRock et al., 2015). In addition, certain effectors 
may have more than one biochemical activity, which may be manifested at the same 
time or at different times of infection (Dean, 2011). Among Salmonella effectors, there 
are some proteins whose elimination does not cause a significant loss of virulence due 
to the existence of other effectors that perform a similar function, so that the effects of 
their individual elimination are masked and only small variations occur in the phenotype 
of the infected cell, which may be difficult to detect. A good example of this is the case 
of SopE, SopE2 and SopB that redundantly mediate the positive regulation of Rho 
GTPases required in the directed phagocytosis process, so that only in a triple mutant 
sopEΔsopE2ΔsopBΔ the ability of Salmonella to invade non-phagocytic cells is 
completely inhibited (Molero et al., 2009; Ramos-Morales, 2012). However, there are 
other effector proteins whose function is crucial for the infection process, to the point 
that their lack results in a total or partial loss of the virulence of the bacterium, which 
can manifest itself in its inability to invade non-phagocytic cells, to survive in 
macrophages or to produce death in animal infection models. These effectors could 
therefore be unequivocally considered factors of virulence. This seems to be the case of 
DISCUSSION 
140 
!
SteA, whose absence significantly attenuated virulence in mouse models of systemic 
and persistent infection, with failure in spleen colonization (Geddes et al., 2005; Lawley 
et al., 2006). 
Until the year 2005, the gene steA (STM1583) was described in the genome of 
Salmonella Typhimurium LT2 as encoding a putative cytoplasmic protein. It was later 
described that the protein encoded by this gene was secreted by both the SPI-1 and SPI-
2 TTSSs, and was named SteA (Salmonella translocated effector A) (Geddes et al., 
2005). Our bioinformatic analysis shows that the amino acid sequence of SteA is highly 
conserved among different S. enterica subsp. enterica serovars, but much less in other 
S. enterica subspecies or in S. bongori. This does not only reflect a lower sequence 
identity, but also the fact that SteA is a longer protein in these Salmonellae. In addition, 
the lack of significant similarity found with proteins from both other 
Enterobacteriaceae and any other bacterial species, indicates that SteA is specific for 
the genus Salmonella. Genes found only in Salmonella, may have been acquired after 
the divergence from other Enterobacteriaceae (e.g. Escherichia coli or Klebsiella), or 
may have been lost from these genera. Many S. Typhimurium genes related with 
pathogenesis fall in this class, such as SopD and SipA (McClelland et al., 2001). This is 
also the case of steA. In spite of its importance in S. Typhimurium virulence, no 
functional studies specifically focused on SteA had been published at the beginning of 
this work. Interestingly, SteA of S. Typhi, which shows 88% similarity with that of S. 
Typhimurium, was found in a previous work of our group when searching for 
Salmonella effectors that caused growth inhibition when overexpressed in yeast 
(Alemán et al., 2009). Therefore, we decided to use the S. cerevisiae yeast model to try 
to detect the effects of the expression of S. Typhimurium SteA in eukaryotic cells. 
Although limitations of this model should be taken into consideration, such as the 
absence of possible posttranscriptional modifications that may occur in the real 
infection scenario or the fact that the cellular target of the proteins may not be 
conserved in yeast, it is also noteworthy that in many cases this model has given 
important clues to understand the function of bacterial effector proteins (Popa et al., 
2016). 
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In our study, we found that the overexpression of S. Typhimurium SteA 
provokes inhibition of yeast cell growth, accompanied by a severe defect in the 
mitochondrial morphology characterized by the condensation of mitochondria. This 
study allowed assigning a functional role to the amino-terminal domain of SteA, since 
we have shown that it was sufficient to induce both growth inhibition and changes in the 
mitochondrial morphology when overexpressed in yeast cells. One interesting result 
was that the basic residue K36, required for SteA binding to PI(4)P, was necessary to 
induce such effects. Thus, these results allowed us to define this N-terminal region, 
where the K36 residue resides, as a SteA functional region, and suggest that the toxicity 
of SteA in yeast cells is related to mitochondrial condensation, although we ignore the 
molecular mechanism. Remarkably, the basic residue (K36) is conserved among 
Salmonella enterica and bongori, indicating that this lysine is maintained in even the 
most divergent species of Salmonella and pointing its importance for Salmonella SteA 
function. 
Many biochemical and genetic studies in S. cerevisiae have shown that 
mitochondria bind to the actin cytoskeleton, which regulates their morphology, transport 
and positioning (Anesti & Scorrano, 2006; Boldogh & Pon, 2006). For example, cells 
treated with the actin-depolymerizing latrunculin-B showed mitochondrial 
fragmentation and defects in mitochondrial motility (Drubin et al., 1993); deletion of 
the gene encoding the actin-stabilizing protein tropomyosin I affects mitochondrial 
morphology (Simon et al., 1995); and many act1 actin mutant alleles, whose 
mitochondrial transport is affected or impaired, also show changes and defects in 
mitochondrial morphology (Anesti & Scorrano, 2006). However, our results indicate 
that overexpression of SteA did not seem to specifically disorganize actin in yeast cells, 
suggesting that the mitochondrial condensation observed is not due to defects in the 
actin cytoskeleton. 
 In yeast, mitochondrial morphology and dynamics are controlled by a set of 
proteins localized in mitochondrial outer (OM), intermediate (IMS) or inner membrane 
(IM). The mitochore complex (Mmm1, Mdm10 and Mdm12), located at the outer 
membrane, is one of the classical well-known protein complexes that maintain 
mitochondrial tubular shape and link mitochondria to the actin cytoskeleton for 
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movement and inheritance (Boldogh & Pon, 2006). An additional member of the 
complex, Mdm34, was discovered to tether mitochondria to the ER, and thus, the 
complex was renamed as ERMES (ER-mitochondria encounter structure) (Kornmann & 
Walter, 2010; Vevea et al., 2014; AhYoung et al., 2015). A mutation in any of the 
protein of the mitochore leads to abnormal mitochondria but intact actin cytoskeleton 
(Boldogh & Pon, 2006), as it happens upon SteA overexpression in yeast. In addition, 
the inner membrane protein Mdm33 and the dynamin-related GTPase Dnm1, which 
regulate mitochondrial fission, and the outer membrane protein Gem1 that regulates 
ERMES complex function, are also responsible for the maintenance of normal 
mitochondrial morphology (Bleazard et al., 1999; Grimm, 2012; Michel & Kornmann, 
2012; AhYoung et al., 2015). As a consequence, their loss causes the network of tubular 
mitochondrial membranes to collapse, resembling the effect on mitochondria induced 
by SteA. Those findings together with our results lead us to hypothesize that SteA might 
be affecting the function of one of the components of the ERMES complex or any 
cooperating protein, causing the condensation of mitochondria. Interestingly, our data 
showed that although the overexpression of SteA or SteA(1-97) did not alter ER 
morphology, SteA(1-97)-GFP localized to the ER in yeast. 
 Mitochondria form a dynamic network within the cell, playing a crucial role in 
energy metabolism and signaling pathways such as innate immunity or apoptosis, which 
makes them a target for pathogen interference with host cellular function. Good 
examples are Listeria monocytogenes or Helicobacter pylori that induce mitochondrial 
defects in mammalian cells leading to a loss in the mitochondrial membrane potential 
(Lebreton et al., 2015). As in mammalian cells, loss of selective permeability of the 
plasma membrane (MMP), loss of mitochondrial membrane potential or production of 
reactive oxygen species (ROS) are markers related to apoptosis in yeast.  Our group has 
shown, for example, that the growth defect observed when the Coxiella burnetii effector 
CaeA is overexpressed in yeast cells is due to cell death concomitant to loss of MMP 
and the production of ROS (Rodríguez-Escudero et al., 2016). However, our results 
showed that SteA does not lead to any of the apoptotic-related effects mentioned above, 
suggesting that it does not seem to elicit pro-apoptotic traits. Therefore, further 
investigations are needed in order to understand the mechanism behind SteA-induced 
growth inhibition and mitochondrial morphology changes in yeast cells. 
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II. The ability of SteA to bind PI(4)P is a determinant of its subcellular 
localization within yeast cells 
In this study, we found that SteA i) localizes to both the PM and vacuole when 
expressed in S. cerevisiae, ii) the PM localization is dependent on the ability of SteA to 
bind to the phosphoinositide PI(4)P pools generated by the PI 4-kinase Stt4, and iii)  the 
vacuolar localization of SteA also requires the integrity of the Lys36 residue, essential 
for PI(4)P binding but is independent of typical endosomal phosphoinositides like 
PI(3)P and PI(3,5)P2. In parallel to our work, our collaborator Dr. Luis Jaime Mota from 
ITQB in Lisboa, confirmed by in vitro binding assays that SteA is a PI(4)P-binding 
protein. He also found that interaction with this lipid was necessary for localization of 
SteA at the PM when ectopically expressed in Hela cells, as well as for its presence at 
the SCV membrane and Sifs within host cells upon S. Typhimurium infection 
(Domingues et al., 2016). 
During infection by Salmonella, more than 40 effector proteins are secreted and 
delivered into the host cells by SPI-1 and SPI-2 T3SSs (Niemann et al., 2011; LaRock 
et al., 2015). Each effector protein secreted during infection exerts its activity 
depending on its timely delivery and specific localization within host cells (Galan, 
2009; Hicks & Galan, 2013). As shown for SteA, other Salmonella effectors (SifA, 
SifB, SopD2, PipB, PipB2, SseF, SseG, SseJ, SseL and SteC) localize both at the Sifs 
and SCV membrane in mammalian cells (Schroeder et al., 2011), whereas other effector 
proteins, such as SopB (Patel et al., 2009), SipA (Brawn et al., 2007), SopE and SopE2 
(Vonaesch et al., 2014), have only been found at the SCV membrane. Among these 
effectors, SCV membrane targeting mechanisms had been previously described for 
SopB (Patel et al., 2009), SopE and SopE2 (Vonaesch et al., 2014), and SifA (Reinicke 
et al., 2005), but they did not involve binding to phosphoinositides. In addition, the SseI 
and SspH2 effectors are targeted to the eukaryotic plasma membrane by lipidation 
mediated by a specific subset of host-cell palmitoyltransferases (Hicks et al., 2011). 
Therefore, binding to phosphoinositides had not been previously recognized as a 
mechanism of subcellular targeting of Salmonella effectors. However, effectors of other 
bacterial pathogens are known to exploit host cell phosphoinositides for subcellular 
targeting, such as Pseudomonas aeruginosa effector ExoU that is targeted to the PM by 
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binding to PI(4,5)P2 (Gendrin et al., 2012), and several Legionella effectors (LpnE, 
RidL, SetA, LidA, SidC and SidM), which bind to PI(3)P and/or PI(4)P at the LCV 
(Legionella-containing vacuole) membrane (Weber et al., 2006; Ragaz et al., 2008; 
Brombacher et al., 2009; Weber et al., 2009a; Jank et al., 2012; Finsel et al., 2013). 
These findings together with our own results lead us to hypothesize that, as shown in 
the case of SteA, Salmonella may target translocated effectors to the PM or the SCV 
through binding to phosphoinositides. 
Phosphoinositides are key regulators of cytoskeleton organization, membrane 
trafficking and signal transduction. For this reason, they are exploited by pathogens not 
only to promote specific subcellular localization of bacterial effectors, but to interfere 
with these essential host cell processes (Weber et al., 2009b). For example, Legionellae 
take advantage of the host PI(3)P and PI(4)P metabolism to generate a permissive 
environment for their replication. The Legionella VipD effector catalyzes the removal 
of PI(3)P from endosomal membranes due to its phospholipase A1 activity, blocking 
fusion with! Legionella-containing vacuoles (Gaspar & Machner, 2014). Moreover, 
Legionella utilizes initially the host kinase PI4KIIIa to generate PI(4)P on the bacterial 
PM-derived vacuole to mediate the localization of PI(4)P-binding effectors, as well as 
the host phosphatase Sac1 for metabolizing the PI(4)P to promote their dissociation later 
on (Hubber et al., 2014).  
The phosphoinositide PI(4)P was initially described to modulate membrane 
trafficking at the Golgi complex, but it is currently known that PI(4)P has general roles 
in membrane trafficking and in other cellular processes (De Matteis et al., 2013). In 
fact, it has been reported that PI(4)P is present not only at the Golgi but also at the PM, 
secretory vesicles and endocytic compartments in both yeast and mammalian cells 
(D’Angelo et al., 2008; Szentpetery et al., 2010; De Matteis et al., 2013; Dickson et al., 
2014). Moreover, PI4P has been reported to be on a subset of lysosomal membranes 
under normal conditions, which is required for lysosomal homeostasis (Sridhar et al., 
2013), and some evidences support that PI(4)P is also present in the yeast vacuolar 
membrane (Mayer et al., 2000), predominantly at the vertex ring domain of docked 
vacuoles (Fratti et al., 2004). Localization of PI(4)P in yeast cells is, therefore, in 
agreement with that of the three PI 4-kinases, the predominant essential  plasma 
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membrane-localized Stt4 (Cutler et al., 1997; Audhya & Emr, 2002), the Golgi-
localized Pik1 (Flanagan et al., 1993), and the non-essential vacuolar/plasma membrane 
Lsb6 (Han et al., 2002), although this later kinase can be only observed at the vacuolar 
membrane upon overexpression (Han et al., 2002). Moreover, It has been recently 
reported that Osh1, one of the members of the oxysterol-binding homology (Osh) 
protein family that associates with the PI(4)P at the vacuolar membrane, is involved in 
the counter-transport of this phosphoinositide and ergosterol between the vacuolar and 
perinuclear ER membranes at the nucleus-vacuole junction (NVJ) (Manik et al., 2017). 
Therefore, the vacuolar localization of SteA, particularly at the vacuole-to-vacuole 
contact areas for homotypic fusion, might be dependent on the vacuolar membrane 
PI(4)P pool. 
When we used the PI(4)P-binding domain (P4C) of the Legionella effector SidC 
to check PI(4)P subcellular localization in yeast, we found that the P4C probe localized 
preferentially at the Golgi and was also observed at the PM, in agreement with the 
literature, but not at the vacuole. The same result was obtained by our collaborator Dr. 
Mota by using this probe in HeLa cells (Domingues et al., 2016). Interestingly, the P4C 
probe co-localized with SteA at the PM, which confirmed the binding activity of this 
Salmonella effector to the PI(4)P pool present at this structure, but neither at the Golgi 
(only marked by P4C) nor at the vacuole (only marked by SteA) in yeast cells. The 
individual localization experiments also showed that the GFP-SteA fluorescence signal 
at the PM was more intense than that of P4C-mCherry, suggesting a higher affinity of 
SteA for PI(4)P at this subcellular location. Therefore, these two bacterial derived 
probes could be used in yeast cells to separate the two pools of PI(4)P dependent on Stt4 
and Pik1 at the plasma membrane and Golgi, respectively. A similar result was obtained 
in HeLa cells, in which SteA localizes at some PI(4)P-enriched environments marked 
with P4C (PM, SCV membrane and Sifs) but not at others (Golgi complex) (Domingues 
et al., 2016). These results indicate that the SidC P4C domain and SteA display distinct 
preferences for binding PI(4)P at different locations and suggest that binding of SteA to 
Golgi PI(4)P may need additional, yet unidentified, factors.  
One surprising finding was that cells showed more PM-localized P4C probe 
when it is co-expressed with SteA than when expressed alone. The regulation of the 
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lipid-signaling molecule PI(4)P at the PM is controlled by the oxysterol-binding 
homology (Osh) and the integral ER VAP proteins through activation of the ER-
resident Sac1 PI(4)P phosphatase. Loss of Sac1 in mammalian cells led to a very robust 
increase in GFP-P4CSidC signal both at the plasma membrane and intracellular 
membranes (Dong et al., 2016), and in yeast caused an accumulation of PI(4)P at the 
PM, ER and vacuolar membranes (Roy & Levine, 2004; Tahirovic et al., 2005). 
According to this, elimination of either Osh or VAP proteins results in a 3- to 7-fold 
increase in PI(4)P levels in yeast cells (English & Voeltz, 2013). Taken these findings 
into account, our results suggest that SteA might be increasing PI(4)P levels at the PM 
in yeast cells through inhibition of Sac1 activity either directly or indirectly by 
inhibiting the function of Osh proteins. The Osh family in yeast is composed of seven 
proteins that bind PI(4)P in different locations and are involved in lipid transport 
between membranes (Tong et al., 2016). Among them, Osh2p, Osh3p, Osh6p and 
Osh7p are found in the cell periphery, at putative ER-PM contact sites. Therefore, it is 
plausible to hypothesize that SteA may compete with Osh proteins for binding to this 
phosphoinositide at these sites, hindering Sac1 activation. This could increase binding 
of the P4C probe to the PM as well as accumulation of SteA itself both at the PM and 
the vacuole. 
The amino acid sequence of SteA does not display significant similarity either to 
known eukaryotic PI(4)P binding domains (Kutateladze, 2010) or the PI(4)P binding 
domains of Legionella effectors SidC and SidM (Ragaz et al., 2008; Brombacher et al., 
2009). However, in spite of the general low sequence identity among phosphoinositide-
binding domains, they commonly show strong positive electrostatic potential located on 
the phosphoinositide-binding surface (Cho & Stahelin, 2005). For example, the SidC 
P4C domain includes a positively charged pocket with two essential arginines at the 
binding site for PI(4)P (Luo et al., 2015). Other proteins, such as eukaryotic profilin or 
Wiskott-Aldrich syndrome protein (WASP), recognize and bind to the phosphoinositide 
PI(4,5)P2 through clusters of basic residues (Kutateladze, 2010). In agreement to this, 
although we have not defined the precise PI(4)P-binding domain within SteA, we have 
demonstrated that the association of SteA to this phosphoinositide at the yeast PM and 
vacuole was dependent on a lysine-rich region, and particularly on the K36 residue, 
within a predicted α-helix located at its N-terminal domain. Interestingly, the PI(4)P- 
DISCUSSION 
 
147 
!
and oxysterol-binding protein Osh4 possesses a surface basic region that binds anionic 
lipids (Von Filseck et al., 2015). Similarly to the mutation of K36 of SteA, a mutation 
in the lysine 336 (K336A) within this region of Osh4 abolished both its binding to 
PI(4)P and its sterol/PI(4)P exchange activity. This data support our idea that SteA 
might be competing with Osh proteins for binding to PI(4)P.  
The SteA K36 residue has been shown by our collaborator Dr. Mota to be 
required for in vitro binding of SteA to PI(4)P, as well as for localization of SteA both 
at the PM when ectopically expressed in HeLa cells and at the SCV membrane and Sifs 
in infected HeLa cells (Domingues et al., 2016). Further detailed studies of structure 
and function of the PI(4)P binding activity of SteA are required to understand structural 
details of how phosphoinositide recognition occurs in this case. As discussed above, in 
addition to these findings, we found that the K36 residue was also necessary for SteA-
induced yeast growth inhibition and mitochondrial condensation, confirming that this 
lysine key to the function of SteA and that the toxic effect of this bacterial effector in 
yeast could be related to its interaction with negatively charged lipids in eukaryotic 
cellular membranes. However, in spite of its mis-localization in HeLa cells, the 
SteAK36A mutant protein still complemented the ΔsteA Salmonella mutant phenotypes 
related to the maintenance of SCV during infection (Domingues et al., 2016). This 
suggests that PI(4)P binding would not be necessary for the previously described 
contribution of SteA to the control of SCV dynamics (Domingues et al., 2014), but 
likely required for other cellular functions of SteA during host cell infection. 
Recent work on the communication among cellular organelles has revealed the 
existence of a membrane contact site between vacuoles and mitochondria, named 
vCLAMP (vacuole and mitochondria patch) (Elbaz-Alon et al., 2014). This site is 
marked by Vps39, a component of the homotypic fusion and vacuole protein sorting 
(HOPS) tethering complex (Stroupe et al., 2006). These authors showed that the 
vCLAMP and the above mentioned ER-mitochondria tethering complex ERMES are 
co-regulated and work in parallel in lipid transport between the endomembrane system 
and mitochondria. The absence of one of these contact sites causes expansion of the 
other and elimination of both is lethal, indicating that mitochondria are depending on 
having at least one of them. Therefore, it is tempting to speculate that the possible 
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effects of SteA on vacuolar membrane lipids could affect vCLAMP, altering its 
equilibrium with ERMES and eventually leading to the observed mitochondrial 
condensation. 
In sum, we have found that SteA localizes to the yeast PM and vacuole and that 
binding of SteA to PI(4)P is a determinant of its localization within yeast cell. Further 
studies are needed to clarify if subcellular targeting by phosphoinositide-binding is 
common to several Salmonella effectors and to better understand the effect of SteA 
binding to PI(4)P in yeast. Indeed, the mechanisms determining the membrane 
specificity of the PI(4)P binding pocket of SteA is an interesting problem remaining to 
be solved. Nevertheless, our results are sufficient to indicate that SteA is the first known 
Salmonella PI(4)P-binding effector. 
III. SteA requires vacuolar protein sorting proteins in order to 
localize to the yeast vacuole 
In S. cerevisiae, proteins translocated to the ER are directed to the Golgi 
apparatus where they are sorted between those targeted to the PM or to the external 
medium via the secretory pathway and those targeted to the vacuole either directly 
through the ALP pathway or through endosomes via the VPS/CPY pathway. PM 
proteins can be internalized by endocytosis and transported to endosomes where they 
are sorted either to the vacuole or redirected to the Golgi via the RCY pathway where 
they enter the secretory pathway to be redirected to the PM (Feyder et al., 2015). To 
date, more than 60 VPS genes have been described, based on the vacuolar morphology 
of the corresponding mutants (Bowers & Stevens, 2005). Mapping SteA in different vps 
mutants showed us that SteA is one of those proteins that need the presence of particular 
Vps proteins in order to localize to the yeast vacuole. 
Vps3 and Vps8 are specific subunits of the CORVET complex that interact with 
the Rab5 homolog Vps21 and assure the fusion of TGN derived vesicles to endosomal 
membranes (Peplowska et al., 2007). The corresponding vps3 and vps8 mutants, as well 
as vps45, belong to the class D of vps mutants, characterized for having a single 
enlarged vacuole (Raymond et al., 1992). Most of class D mutants also showed an 
accumulation of small vesicles throughout the cytoplasm that are unable to fuse with 
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LE/MVB (Markgraf et al., 2009). The MVB machinery ensures the delivery of proteins 
to the vacuolar lumen by fusion of the MVB and the vacuole and it is composed of four 
complexes named ESCRT (0, I, II and III), whose components belong to class E Vps 
proteins. Mutants in these proteins show a large aberrant late endosome/MVB adjacent 
to the vacuole, named class E compartment, where vacuolar proteins accumulate due to 
a blockage in their transport to the vacuolar lumen (Bowers & Stevens, 2005; Henne et 
al., 2011). Our data showed that SteA fails to localize to the vacuolar lumen in both 
class D and E vps mutants, only faintly appearing at the vacuolar membrane where it 
accumulates in large puncta. However, while in class E mutants SteA localizes in 
typical FM4-64-marked class E compartments, the SteA-containing dots observed in 
class D mutants are not stained with the endosomal marker FM4-64. All these results 
indicate that SteA is delivered to the vacuole via MVB sorting. However, the nature of 
the puncta in which SteA accumulates in class D mutants is intriguing. It has been 
reported that some components of the HOPS (homotypic fusion and vacuole protein 
sorting) complex, like Vps39, localize to specific patches at the vacuolar membrane, 
which correspond to the vCLAMP. Since Vps39 also accumulate at the vertex ring 
during vacuolar docking (Wang et al., 2002), where SteA is recruited as well, one 
plausible hypothesis is that the contact site between vacuole and mitochondria could be 
also enriched for SteA. Further experiments should be required to validate this 
hypothesis. A second challenge that these results pose is that, as SteA vacuolar 
localization requires the CORVET/HOPS pathway, our hypothesis that PI(4)P could 
also be a determinant for SteA tethering to vacuolar membranes would imply that the 
appearance of pools of this lipid in such compartment should in turn depend on an intact 
Vps pathway. This particular point has not been investigated in depth, to our 
knowledge. 
IV. Overexpression of SteA shows genetic interactions with 
mutations in genes related to vacuole homeostasis 
! Fab1 phosphoinositide kinase is one of the PI(3)P effectors, using this 
phosphoinositide species as a substrate to generate discrete pools of PI(3,5)P2, involved 
in the fusion of the MVB with the vacuole (Mayinger, 2012). Vac14 is the scaffold 
protein that nucleates the assembly of the Fab1 complex at the vacuole (Jin  et al., 2008; 
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Dove et al., 2009). Our results show that SteA overexpression displayed a negative 
genetic interaction with both fab1∆ and vac14∆ mutants. However, subcellular 
localization of SteA is not affected by loss of any of the Fab1 complex proteins, and no 
obvious direct physical interaction was detected by the co-IP strategy we used. These 
results led us to hypothesized that, although the presence of PI(3,5)P2 is not needed to 
target SteA toward the vacuole, SteA might be functionally related with the Fab1 
complex. In agreement, we also found a phenotypic enhancement of SteA toxicity in 4 
out of the 11 mutants (vps3, vps1, cla4 or vps35) known as negative genetic interactors 
of vac14 and fab1 mutants. Of remark, one of these mutants lacks the class D Vps3 
protein, also shown in our work to be required for proper localization of SteA at the 
vacuole, and other was depleted of Cla4, a p21-activated protein kinase (PAK) involved 
in cell polarity regulation that binds PI(4)P in yeast (Santiago-Tirado & Bretscher, 
2011). In the event that SteA is interfering with putative PI(4)P pools or their effectors 
at vacuolar membranes, it is likely that the presence of PI(3,5)P2 is necessary to 
somehow compensate for SteA-induced damage and maintain viability. 
Among mutants reported to show negative genetic interaction, like SteA 
overproduction does, with vps3, vps1, cla4 or vps35 mutants, we found that deletions in 
VMA1 (coding for a component of the vacuolar v-ATPase), VMA21 (coding for a protein 
involved in v-ATPase assembly and function), or DYN3 (subunit of the dynein complex 
related to nuclear migration) also enhanced the toxicity caused by SteA overexpression. 
Interestingly, we found that a v-ATPase-related mutant, voa1∆, was the only mutant 
showing phenotypic suppression for SteA-induced toxicity. Voa1 is the assembly factor 
of the V0 sector to the vacuolar ATPase, and it is localized at the ER of S. cerevisiae 
(Ryan et al., 2008). Independent of its role as a cellular proton pump, the V0 sector has 
been suggested to function in membrane fusion and vesicle formation (Wada et al., 
2008). Further investigations are needed in order to understand why SteA toxicity in 
yeast depends on the presence of Voa1, but it seems that it would be more likely related 
to the role of the v-ATPase as putative regulator of vacuolar morphology and membrane 
trafficking than to its classical pump activity. 
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1. SteA is highly conserved among different S. enterica serovars, and it is specific for 
the Salmonella genus. 
2. Overexpression of SteA in yeast provokes a significant growth inhibition dependent 
on its amino-terminal region. 
3. SteA overexpression leads to defects in the mitochondrial morphology, characterized 
by the appearance of condensed mitochondria. The amino-terminal region of SteA is 
necessary and sufficient to cause this mitochondrial phenotype. 
4. SteA localizes at the plasma membrane and vacuole when expressed in S. cerevisiae, 
whereas the amino-terminal fragment corresponding to the first 97 amino acids of SteA 
localizes to the ER. 
5. The plasma membrane localization of SteA requires the presence of PI(4)P pools 
generated by the PM-associated PI 4-kinase Stt4. 
6. Tethering SteA to the plasma membrane and vacuole in S. cerevisiae requires basic 
residues near its N-terminus, specifically Lys36. This basic residue is also necessary to 
induce both growth inhibition and mitochondrial condensation in yeast cells. 
7. Class D and E Vps proteins are necessary for vacuolar localization of SteA, pointing 
to the importance of sorting at late endosome/MVB in SteA targeting to the vacuole. 
8. Mutants lacking PI(3)P 5-kinase complex subunits Vac14 and Fab1, show a negative 
genetic interaction with SteA overexpression. 
9. Mutations in CLA4, VPS1, VPS3 and VPS35 cause phenotypic enhancement of SteA-
induced growth inhibition. 
10. The absence of Voa1, an ER protein that functions in assembly of the V0 sector of 
V-ATPase, but not that of other V-ATPase subunits, suppresses SteA-induced growth 
inhibition in S. cerevisiae. 
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The Salmonella effector SteA binds phosphatidylinositol
4-phosphate for subcellular targeting within host cells
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Summary
Many bacterial pathogens use specialized secre-
tion systems to deliver virulence effector proteins
into eukaryotic host cells. The function of these
effectors depends on their localization within
infected cells, but the mechanisms determining
subcellular targeting of each effector are mostly
elusive. Here, we show that the Salmonella type III
secretion effector SteA binds specifically to phos-
phatidylinositol 4-phosphate [PI(4)P]. Ectopically
expressed SteA localized at the plasma membrane
(PM) of eukaryotic cells. However, SteA was
displaced from the PM of Saccharomyces
cerevisiae in mutants unable to synthesize the
local pool of PI(4)P and from the PM of HeLa cells
after localized depletion of PI(4)P. Moreover, in
infected cells, bacterially translocated or ectopical-
ly expressed SteA localized at the membrane of the
Salmonella-containing vacuole (SCV) and to
Salmonella-induced tubules; using the PI(4)P-bind-
ing domain of the Legionella type IV secretion
effector SidC as probe, we found PI(4)P at the SCV
membrane and associated tubules throughout
Salmonella infection of HeLa cells. Both binding
of SteA to PI(4)P and the subcellular localization of
ectopically expressed or bacterially translocated
SteA were dependent on a lysine residue near the
N-terminus of the protein. Overall, this indicates
that binding of SteA to PI(4)P is necessary for its
localization within host cells.
Introduction
Salmonella enterica serovars are intracellular facultative
pathogens with a wide host range and causing serious
illnesses in humans. For example, S. enterica serovar
Typhi causes typhoid fever while serovar Typhimurium is
a major cause of gastroenteritis. S. enterica virulence is
related to its capacity to deliver about 40 bacterial effector
proteins into host cells through the Salmonella pathogenicity
island 1 and the Salmonella pathogenicity island 2-encoded
type III secretion systems (SPI-1 and SPI-2 T3SSs) (Figueira
and Holden, 2012; Ramos-Morales, 2012; LaRock et al.,
2015). The SPI-1 T3SS mediates the delivery of effectors
critical for invasion of non-professional phagocytes, such as
epithelial cells (Galán andCurtiss, 1989).Within host cells, the
bacterium is enclosed in a membrane-bound compartment,
known as Salmonella-containing vacuole (SCV), in which the
SPI-2 T3SS is activated andmediates the delivery of effectors
contributing to bacterial intracellular replication (Cirillo et al.,
1998; Hensel et al., 1998). However, in addition to invasion
and intracellular replication, SPI-1 and SPI-2 effectors also
modulate other features of the host–Salmonella interaction,
such as immune signalling (Figueira and Holden, 2012;
Ramos-Morales, 2012; LaRock et al., 2015). Furthermore,
SPI-1 T3SS effectors also contribute to bacterial intracellular
replication (Ramos-Morales, 2012; LaRock et al., 2015), and
some effectors can be translocated into host cells by both the
SPI-1 and the SPI-2 T3SSs (Figueira and Holden, 2012;
Ramos-Morales, 2012; LaRock et al., 2015).
Bacterial effectors exert their function at specific locations
within host cells (Hicks and Galán, 2013). In the case of
intravacuolar bacterial pathogens, effectors frequently local-
izeat themembraneof thepathogen-containing vacuoles. For
example, severalSalmonellaeffectors havebeendetectedon
the SCV membrane and on different Salmonella-induced
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